{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "the patient"], ["treatment", "After therapy with parenteral amiodarone ( 2300 mg in 3 days ) and other measures"], ["drug", "amiodarone"], ["dosage", "2300 mg"], ["route", "parenteral"], ["effect", "jaundice , marked increase in serum transaminase levels and fall in prothrombin time , and histologic changes of severe centrilobular necrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "taking", "type": "adverse event", "roles": [["subject", "a patient , with a 30 - year history of rheumatoid arthritis"], ["subject disorder", "30 - year history of rheumatoid arthritis"], ["treatment", "low dose methotrexate weekly over a 10 - month period"], ["drug", "methotrexate"], ["frequency", "weekly"], ["duration", "10 - month"], ["time elapsed", "10 - month"], ["treatment disorder", "30 - year history of rheumatoid arthritis"], ["effect", "non - Hodgkin lymphoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "accumulation", "type": "adverse event", "roles": [["subject", "patients with renal impairment"], ["subject disorder", "renal impairment"], ["treatment", "alum irrigation"], ["drug", "alum"], ["route", "irrigation"], ["treatment disorder", "renal impairment"], ["effect", "toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "presented", "type": "adverse event", "roles": [["subject", "A 44 - year - old man"], ["age", "44 - year - old"], ["gender", "man"], ["subject disorder", "chronic low back pain"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "naproxen"], ["drug", "naproxen"], ["treatment disorder", "chronic low back pain"], ["effect", "tense bullae and cutaneous fragility on the face and the back of the hands"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurring", "type": "adverse event", "roles": [["subject", "a middle - aged man who suffered from chronic sinusitis"], ["age", "middle - aged"], ["gender", "man"], ["subject disorder", "chronic sinusitis"], ["treatment", "ingesting pseudoephedrine daily for one year"], ["drug", "pseudoephedrine"], ["frequency", "daily"], ["treatment disorder", "chronic sinusitis"], ["effect", "intracerebral hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developing", "type": "adverse event", "roles": [["subject", "a patient with rheumatoid arthritis"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "methotrexate"], ["drug", "methotrexate"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "Lymphoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "relationship", "type": "adverse event", "roles": [["subject", "this patient"], ["treatment", "pantoprazole therapy"], ["drug", "pantoprazole"], ["effect", "AIN"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "exposed", "type": "adverse event", "roles": [["subject", "fetus"], ["treatment", "disulfiram"], ["drug", "disulfiram"], ["effect", "teratogen"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complication", "type": "adverse event", "roles": [["subject", "2 - 16 % of patients"], ["age", "2 - 16 %"], ["population", "2 - 16 %"], ["subject disorder", "pediatric neoplasms"], ["treatment", "L - asparaginase"], ["drug", "L - asparaginase"], ["treatment disorder", "pediatric neoplasms"], ["effect", "Pancreatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complication", "type": "adverse event", "roles": [["treatment", "statin therapy"], ["drug", "statin"], ["effect", "Myopathy , including rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "methotrexate"], ["drug", "methotrexate"], ["effect", "anaphylaxis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Mitomycin - C"], ["drug", "Mitomycin - C"], ["effect", "hemolytic uremic syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complication", "type": "adverse event", "roles": [["treatment", "propylthiouracil ( PTU )"], ["drug", "propylthiouracil"], ["treatment disorder", "hyperthyroidism"], ["effect", "Acute hepatic failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "in", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "chronic diphenylhydantoin therapy"], ["drug", "diphenylhydantoin"], ["effect", "Monoclonal gammopathy and subsequent multiple myeloma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a patient with systemic lupus erythematosus and tubulointerstitial renal disease"], ["subject disorder", "tubulointerstitial renal disease"], ["subject disorder", "systemic lupus erythematosus"], ["treatment", "cyclosporine A"], ["drug", "cyclosporine A"], ["treatment disorder", "systemic lupus erythematosus"], ["effect", "nephrotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "AZ"], ["drug", "AZ"], ["effect", "acute hemorrhagic gastritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resulted", "type": "adverse event", "roles": [["treatment", "19 days of treatment with 5 - fluorocytosine and amphotericin B."], ["drug", "5 - fluorocytosine"], ["drug", "amphotericin B."], ["duration", "19 days"], ["time elapsed", "19 days"], ["combination drug", "5 - fluorocytosine"], ["combination drug", "amphotericin B."], ["effect", "Toxic epidermal necrolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "relationship", "type": "adverse event", "roles": [["treatment", "phenylpropanolamine"], ["drug", "phenylpropanolamine"], ["effect", "stroke"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 61 - year - old woman with no apparent risk factors for liver injury"], ["age", "61 - year - old"], ["gender", "woman"], ["subject disorder", "onychomycosis"], ["treatment", "one week after the final dose of a long - term course of pulse itraconazole therapy ( 200 mg orally twice daily , 1 wk on , 3 wk off , for 24 wk )"], ["treatment disorder", "onychomycosis"], ["effect", "acute hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "a patient suffering from acute hemorrhagic gastritis"], ["subject disorder", "acute hemorrhagic gastritis"], ["treatment", "AZ"], ["drug", "AZ"], ["effect", "chronic renal failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["subject", "a pregnant patient with myotonic dystrophy"], ["subject disorder", "myotonic dystrophy"], ["treatment", "tocolysis with oral ritodrine hydrochloride"], ["drug", "ritodrine hydrochloride"], ["route", "oral"], ["treatment disorder", "myotonic dystrophy"], ["effect", "Rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "normal male volunteers"], ["gender", "male"], ["treatment", "warfarin"], ["drug", "warfarin"], ["effect", "hypoprothrombinemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "precede", "type": "adverse event", "roles": [["treatment", "methotrexate"], ["drug", "methotrexate"], ["effect", "Painful erosion of psoriatic plaques"], ["effect", "bone marrow suppression"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "an acromegalic patient"], ["subject disorder", "acromegalic"], ["treatment", "combined treatment with pegvisomant and octreotide long - acting repeatable"], ["drug", "pegvisomant"], ["drug", "octreotide"], ["treatment disorder", "acromegalic"], ["combination drug", "pegvisomant"], ["combination drug", "octreotide"], ["effect", "hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "promethazine"], ["drug", "promethazine"], ["effect", "coma"]]}, {"trigger": "responding", "type": "potential therapeutic event", "roles": [["subject", "a patient in a promethazine - induced coma"], ["subject disorder", "promethazine - induced coma"], ["treatment", "treatment with flumazenil"], ["drug", "flumazenil"], ["treatment disorder", "promethazine - induced coma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["subject", "patients 1 and 3"], ["population", "1"], ["treatment", "1 month after the second ranibizumab injection"], ["treatment", "1 month after the first ranibizumab injection"], ["drug", "ranibizumab"], ["route", "injection"], ["time elapsed", "1 month"], ["effect", "Ocular hypertension"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "zuclopenthixol"], ["drug", "zuclopenthixol"], ["effect", "Priapism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "association", "type": "adverse event", "roles": [["treatment", "metronidazole therapy"], ["drug", "metronidazole"], ["effect", "Reversible MR imaging and MR spectroscopy abnormalities"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "development", "type": "adverse event", "roles": [["treatment", "rifabutin"], ["drug", "rifabutin"], ["effect", "corneal endothelial deposits"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a child"], ["age", "child"], ["treatment", "calcineurin"], ["treatment", "second hematopoietic stem cell transplant ( HSCT )"], ["drug", "calcineurin"], ["effect", "pain syndrome ( CIPS )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resulting", "type": "adverse event", "roles": [["subject", "a male patient with psoriasis and hypertension"], ["gender", "male"], ["subject disorder", "psoriasis"], ["subject disorder", "hypertension"], ["treatment", "tacalcitol ointment and thiazide"], ["drug", "tacalcitol"], ["drug", "thiazide"], ["treatment disorder", "hypertension"], ["effect", "hypercalciuria and hypercalcemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "calcium hydroxylapatite injection"], ["drug", "calcium hydroxylapatite"], ["route", "injection"], ["effect", "granulomatous reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "interaction", "type": "adverse event", "roles": [["treatment", "MTX and a variety of non - steroidal , anti - inflammatory drugs ( NSAIDs )"], ["drug", "MTX"], ["effect", "acute renal failure , pancytopenia , vomiting , diarrhea , elevated liver transaminases , jaundice , mucosal ulcerations , and pyrexia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["subject", "a patient with alveolar hydatid disease"], ["subject disorder", "alveolar hydatid disease"], ["treatment", "mebendazole"], ["drug", "mebendazole"], ["treatment disorder", "alveolar hydatid disease"], ["effect", "side effects of alopecia and granulocytopenia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "causes", "type": "adverse event", "roles": [["subject", "approximately 0.67 % of patients"], ["population", "0.67 %"], ["treatment", "Niacin"], ["drug", "Niacin"], ["effect", "toxic cystoid maculopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "develop", "type": "adverse event", "roles": [["subject", "tuberculosis patients"], ["subject disorder", "tuberculosis"], ["treatment", "isoniazid"], ["drug", "isoniazid"], ["treatment disorder", "tuberculosis"], ["effect", "histamine reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "adverse effect", "type": "adverse event", "roles": [["treatment", "zuclopenthixol"], ["drug", "zuclopenthixol"], ["effect", "Priapism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "potential therapeutic event", "roles": [["subject", "a patient"], ["subject disorder", "several thromboembolic events"], ["treatment", "interaction of smokeless tobacco with warfarin"], ["drug", "smokeless tobacco"], ["drug", "warfarin"], ["treatment disorder", "several thromboembolic events"], ["combination drug", "warfarin"], ["combination drug", "smokeless tobacco"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "three cases"], ["population", "three"], ["treatment", "cyproterone acetate"], ["drug", "cyproterone acetate"], ["effect", "Hepatotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "of", "type": "adverse event", "roles": [["treatment", "intrathecal methotrexate"], ["drug", "methotrexate"], ["route", "intrathecal"], ["effect", "Neurotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Isonicotinic acid hydrazide"], ["drug", "Isonicotinic acid hydrazide"], ["effect", "anagen effluvium and associated lichenoid eruption"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurring", "type": "adverse event", "roles": [["subject", "one case"], ["population", "one"], ["subject disorder", "onychomycosis"], ["treatment", "pulse therapy with itraconazole"], ["drug", "itraconazole"], ["route", "pulse therapy"], ["treatment disorder", "onychomycosis"], ["effect", "severe symptomatic hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "elicitation", "type": "adverse event", "roles": [["treatment", "trazodone"], ["drug", "trazodone"], ["effect", "movement disorder"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "subsequent", "type": "adverse event", "roles": [["treatment", "high doses of CCNU"], ["drug", "CCNU"], ["dosage", "high doses"], ["treatment disorder", "chronic myeloid leukemia"], ["effect", "Pulmonary fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["subject", "patients with cancer"], ["subject disorder", "cancer"], ["treatment", "5 - fluorouracil ( 5 - FU) - based chemotherapy"], ["drug", "5 - fluorouracil"], ["route", "chemotherapy"], ["treatment disorder", "cancer"], ["effect", "potentially lethal adverse reactions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "administration of parenteral verapamil"], ["drug", "verapamil"], ["route", "parenteral"], ["effect", "sustained hypotension"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["treatment", "Methadone"], ["drug", "Methadone"], ["treatment disorder", "human immunodeficiency viral infection"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "from", "type": "adverse event", "roles": [["treatment", "phytonadione"], ["drug", "phytonadione"], ["effect", "residual effects"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "potential therapeutic event", "roles": [["subject", "A 70 - year - old man"], ["age", "70 - year - old"], ["gender", "man"], ["subject disorder", "atrial fibrillation"], ["treatment", "warfarin"], ["drug", "warfarin"], ["treatment disorder", "atrial fibrillation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "adverse event", "roles": [["subject", "a child with systemic lupus erythematosus"], ["age", "child"], ["subject disorder", "systemic lupus erythematosus"], ["treatment", "prednisolone and azathioprine"], ["drug", "prednisolone"], ["drug", "azathioprine"], ["treatment disorder", "systemic lupus erythematosus"], ["effect", "cryptococcal meningitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "a patient with chronic renal failure"], ["subject disorder", "chronic renal failure"], ["treatment", "acetazolamide"], ["drug", "acetazolamide"], ["treatment disorder", "chronic renal failure"], ["effect", "Acute hemorrhagic gastritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "attributed", "type": "adverse event", "roles": [["treatment", "trazodone"], ["drug", "trazodone"], ["effect", "movement disorder"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "precipitate", "type": "adverse event", "roles": [["treatment", "itraconazole"], ["drug", "itraconazole"], ["effect", "severe and irreversible hepatotoxic events"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "two patients with mycosis fungoides"], ["population", "two"], ["subject disorder", "mycosis fungoides"], ["treatment", "therapy with psoralens plus long - wave ultraviolet radiation ( PUVA )"], ["drug", "psoralens"], ["treatment disorder", "mycosis fungoides"], ["effect", "squamous cell carcinoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a patient with acute promyelocytic leukemia"], ["subject disorder", "acute promyelocytic leukemia"], ["treatment", "all - trans retinoic acid"], ["drug", "all - trans retinoic acid"], ["treatment disorder", "acute promyelocytic leukemia"], ["effect", "Scrotal ulceration"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 61 year - old male patient"], ["age", "61 year - old"], ["gender", "male"], ["treatment", "theophylline"], ["drug", "theophylline"], ["effect", "gynecomastia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "dextran - 40"], ["drug", "dextran - 40"], ["effect", "renal failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "secondary", "type": "adverse event", "roles": [["subject", "a patient with advanced - stage large cell neuroendocrine carcinoma of the cervix"], ["subject disorder", "advanced - stage large cell neuroendocrine carcinoma of the cervix"], ["treatment", "cisplatin therapy"], ["drug", "cisplatin"], ["treatment disorder", "advanced - stage large cell neuroendocrine carcinoma of the cervix"], ["effect", "syndrome of inappropriate antidiuretic hormone ( SIADH )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "taking", "type": "potential therapeutic event", "roles": [["subject", "An 80 - year - old white female , followed up at the Memory Clinic for mild cognitive impairment"], ["age", "80 - year - old"], ["gender", "female"], ["race", "white"], ["subject disorder", "mild cognitive impairment"], ["subject disorder", "paroxysmal atrial fibrillation"], ["treatment", "propafenone 900 mg / d for paroxysmal atrial fibrillation"], ["drug", "propafenone"], ["dosage", "900 mg / d"], ["treatment disorder", "paroxysmal atrial fibrillation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "had", "type": "adverse event", "roles": [["subject", "109 patients"], ["population", "109"], ["treatment", "omeprazole"], ["treatment", "placebo"], ["drug", "omeprazole"], ["effect", "cardiovascular event"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "reaction", "type": "adverse event", "roles": [["treatment", "zomepirac"], ["drug", "zomepirac"], ["effect", "anaphylactoid reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "etanercept"], ["drug", "etanercept"], ["effect", "CD"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "trigger", "type": "adverse event", "roles": [["treatment", "bleomycin"], ["drug", "bleomycin"], ["effect", "acral vascular toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "safety", "type": "potential therapeutic event", "roles": [["subject", "patients with severe recalcitrant nodular acne"], ["subject disorder", "severe recalcitrant nodular acne"], ["treatment", "isotretinoin - Lidose"], ["drug", "isotretinoin"], ["dosage", "Lidose"], ["treatment disorder", "severe recalcitrant nodular acne"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "intractable corticosteroid"], ["drug", "corticosteroid"], ["effect", "severe vision loss"], ["effect", "glaucoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["subject", "this patient"], ["treatment", "parenteral amiodarone"], ["drug", "amiodarone"], ["route", "parenteral"], ["effect", "acute hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "appeared", "type": "adverse event", "roles": [["subject", "his trunk and upper limbs"], ["gender", "his"], ["treatment", "Twenty - four hours after the administration of gemcitabine"], ["drug", "gemcitabine"], ["duration", "Twenty - four hours"], ["time elapsed", "Twenty - four hours"], ["effect", "symmetric , bullous , herpetiform eruption"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "reduced", "type": "potential therapeutic event", "roles": [["treatment", "omeprazole"], ["drug", "omeprazole"], ["treatment disorder", "overt upper gastrointestinal bleeding"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "association", "type": "adverse event", "roles": [["treatment", "phenothiazine overdose"], ["drug", "phenothiazine"], ["dosage", "overdose"], ["effect", "respiratory distress syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "risk", "type": "adverse event", "roles": [["subject", "Patients from endemic areas referred to transplant centers"], ["subject disorder", "graft - versus - host disease"], ["treatment", "long - term prednisone"], ["drug", "prednisone"], ["treatment disorder", "graft - versus - host disease"], ["effect", "disseminated histoplasmosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "tamoxifen"], ["drug", "tamoxifen"], ["effect", "malignant transformation of endometriosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 28 year old white schizophrenic male"], ["age", "28 year old"], ["gender", "male"], ["race", "white"], ["subject disorder", "schizophrenic"], ["treatment", "under risperidone monotherapy for about one year"], ["drug", "risperidone"], ["duration", "one year"], ["time elapsed", "one year"], ["treatment disorder", "schizophrenic"], ["effect", "dyskinetic movements"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "have", "type": "adverse event", "roles": [["subject", "Subjects"], ["treatment", "ivacaftor"], ["drug", "ivacaftor"], ["effect", "pulmonary exacerbation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["treatment", "zolmitriptan"], ["drug", "zolmitriptan"], ["effect", "Spinal cord infarction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "Case 2 , a 29 - year - old woman"], ["age", "29 - year - old"], ["gender", "woman"], ["subject disorder", "chronic myelogenous leukemia"], ["treatment", "a 22 - month use of recombinant interferon alpha - 2b"], ["drug", "recombinant interferon alpha - 2b"], ["duration", "22 - month"], ["time elapsed", "22 - month"], ["treatment disorder", "chronic myelogenous leukemia"], ["effect", "bilateral optic neuritis combined with numbness of the lower extremities as well as bowel and bladder dysfunction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occur", "type": "adverse event", "roles": [["treatment", "chlorpropamide"], ["drug", "chlorpropamide"], ["effect", "intrahepatic cholestasis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Risperidone"], ["drug", "Risperidone"], ["effect", "tardive dyskinesia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "pentazocine"], ["drug", "pentazocine"], ["effect", "fibrous myopathy and localized neuropathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "target", "type": "adverse event", "roles": [["treatment", "99Tc - dimercaptosuccinic acid"], ["drug", "99Tc - dimercaptosuccinic acid"], ["effect", "cyclosporine A nephrotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "maculopathy", "type": "adverse event", "roles": [["treatment", "Niacin"], ["drug", "Niacin"], ["effect", "maculopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "led", "type": "adverse event", "roles": [["treatment", "potential drug interaction between clobazam and etravirine"], ["drug", "clobazam"], ["drug", "etravirine"], ["combination drug", "clobazam"], ["combination drug", "etravirine"], ["effect", "increased concentrations of clobazam and its pharmacologically active metabolite , N - desmethylclobazam"], ["effect", "neurotoxic symptoms"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "two other cases"], ["population", "two"], ["treatment", "long - term cyclophosphamide treatment"], ["drug", "cyclophosphamide"], ["effect", "hepatic angiosarcoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "aetiological factor", "type": "adverse event", "roles": [["treatment", "amphotericin B"], ["drug", "amphotericin B"], ["effect", "cutaneous leucocytoclastic vasculitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "with", "type": "adverse event", "roles": [["treatment", "olanzapine"], ["drug", "olanzapine"], ["effect", "hyperglycemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["subject", "the same patient"], ["treatment", "antiretroviral drug"], ["drug", "antiretroviral drug"], ["effect", "two severe antiretroviral drug adverse reactions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "thiethylperazine maleate ( thiethylperazine )"], ["drug", "thiethylperazine maleate"], ["effect", "successive anaphylactic reaction and extra - pyramidal syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "dextran - 40"], ["drug", "dextran - 40"], ["effect", "Renal failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "5 - fluorouracil and oxaliplatinum combined chemotherapy"], ["drug", "5 - fluorouracil"], ["drug", "oxaliplatinum"], ["route", "chemotherapy"], ["combination drug", "5 - fluorouracil"], ["combination drug", "oxaliplatinum"], ["effect", "Acute lung injury"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "heparin"], ["drug", "heparin"], ["effect", "Type II heparin - induced thrombocytopenia ( HIT )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "drug"], ["drug", "atovaquone"], ["effect", "vortex keratopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "bleomycin and methotrexate"], ["drug", "bleomycin"], ["drug", "methotrexate"], ["effect", "Gangrene of the fingertips"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induce", "type": "adverse event", "roles": [["subject", "children"], ["age", "children"], ["treatment", "CBZ"], ["drug", "CBZ"], ["effect", "simple motor tics"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "propranolol overdose"], ["drug", "propranolol"], ["dosage", "overdose"], ["effect", "Esophageal spasm"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "diagnosed", "type": "adverse event", "roles": [["subject", "She"], ["gender", "She"], ["treatment", "AZ"], ["drug", "AZ"], ["effect", "AZ intoxication"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "massive ingestion of oolong tea"], ["drug", "oolong tea"], ["effect", "Severe rhabdomyolysis"], ["effect", "caffeine intoxication with coexisting hyponatremia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "healed", "type": "potential therapeutic event", "roles": [["treatment", "withholding ATRA"], ["drug", "ATRA"], ["treatment disorder", "ulcer"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resulting", "type": "adverse event", "roles": [["treatment", "Gemfibrozil - warfarin drug interaction"], ["drug", "Gemfibrozil"], ["drug", "warfarin"], ["combination drug", "Gemfibrozil"], ["combination drug", "warfarin"], ["effect", "profound hypoprothrombinemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "clozapine"], ["drug", "clozapine"], ["effect", "eosinophilia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "atovaquone"], ["drug", "atovaquone"], ["effect", "Vortex keratopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "owing", "type": "adverse event", "roles": [["treatment", "thalidomide treatment"], ["drug", "thalidomide"], ["effect", "Sustained ventricular tachycardia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "substitution of acetohexamide for acetazolamide"], ["drug", "acetohexamide"], ["drug", "acetazolamide"], ["effect", "systemic hypoglycemic reaction resulting in head trauma and confusion"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "association", "type": "adverse event", "roles": [["treatment", "Ritalin"], ["drug", "Ritalin"], ["effect", "glaucoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "two - month interruption of interferon administration , natural interferon alpha"], ["drug", "interferon alpha"], ["effect", "neurological manifestations"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["treatment", "an interaction between SSRIs and fentanyl"], ["drug", "SSRIs"], ["drug", "fentanyl"], ["combination drug", "SSRIs"], ["combination drug", "fentanyl"], ["effect", "serotonin syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "dextran"], ["drug", "dextran"], ["effect", "renal failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "secondary", "type": "adverse event", "roles": [["treatment", "pamidronate"], ["drug", "pamidronate"], ["treatment disorder", "hypercalcemia secondary to acute vitamin D intoxication"], ["effect", "hypercalcemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["treatment", "acenocoumarol"], ["drug", "acenocoumarol"], ["effect", "Early overanticoagulation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurring", "type": "adverse event", "roles": [["treatment", "CHOP chemotherapy"], ["drug", "CHOP"], ["route", "chemotherapy"], ["effect", "supravenous hyperpigmentation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["treatment", "metronidazole treatment"], ["drug", "metronidazole"], ["effect", "persistent lactate elevation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "intravesical alum irrigations"], ["drug", "alum"], ["route", "intravesical"], ["effect", "Encephalopathy and seizures"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "to", "type": "adverse event", "roles": [["subject", "these patients"], ["treatment", "SSRI - drugs"], ["drug", "SSRI"], ["effect", "Dermal side reactions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "prescribed", "type": "potential therapeutic event", "roles": [["subject", "A febrile 36 - year - old seaman from Mumbai ( Bombay )"], ["age", "36 - year - old"], ["gender", "seaman"], ["subject disorder", "febrile"], ["subject disorder", "malaria diagnosed empirically onboard ship"], ["treatment", "> 5 times the usual dose of chloroquine"], ["drug", "chloroquine"], ["dosage", "5 times the usual dose"], ["treatment disorder", "malaria diagnosed empirically onboard ship"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["subject", "two cases"], ["population", "two"], ["treatment", "two instillations of epirubicin"], ["drug", "epirubicin"], ["route", "instillations"], ["effect", "primary and secondary perforation of the bladder"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "side effect", "type": "adverse event", "roles": [["treatment", "voriconazole therapy"], ["drug", "voriconazole"], ["effect", "Angio - oedema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "reduced", "type": "potential therapeutic event", "roles": [["treatment", "Oxycodone - gabapentin"], ["drug", "Oxycodone"], ["drug", "gabapentin"], ["treatment disorder", "pain"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "clozapine"], ["drug", "clozapine"], ["effect", "neutropenia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "had", "type": "adverse event", "roles": [["subject", "Five of 70 patients"], ["population", "Five of 70"], ["treatment", "leflunomide therapy"], ["drug", "leflunomide"], ["effect", "weight loss"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "consumption", "type": "adverse event", "roles": [["subject", "a patient with an AVM"], ["subject disorder", "AVM"], ["treatment", "phenylpropanolamine"], ["drug", "phenylpropanolamine"], ["treatment disorder", "AVM"], ["effect", "intracerebral hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["treatment", "therapy with thiethylperazine"], ["drug", "thiethylperazine"], ["effect", "Anaphylactic reaction and unrelated , subsequent , known side effects"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "acyclovir"], ["drug", "acyclovir"], ["effect", "neurotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "arise", "type": "adverse event", "roles": [["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["effect", "Radiation recall"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "L - asparaginase"], ["drug", "L - asparaginase"], ["effect", "pancreatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "the patient"], ["treatment", "Shortly after commencing the drug"], ["drug", "drug"], ["effect", "adverse drug reaction manifesting as Drug Reaction ( or Rash ) with Eosinophilia and Systemic Symptoms ( DRESS ) syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "risperidone"], ["drug", "risperidone"], ["effect", "tardive dyskinesia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "The patient"], ["treatment", "approximately one hour after infusion of the first dose of penicillin"], ["drug", "penicillin"], ["route", "infusion"], ["time elapsed", "approximately one hour"], ["effect", "feeling cold with worsening headache and chills"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "Early - onset pentamidine"], ["drug", "pentamidine"], ["effect", "second - degree heart block and sinus bradycardia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "BCNU"], ["drug", "BCNU"], ["effect", "Fatal pulmonary fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induce", "type": "adverse event", "roles": [["subject", "patients with normal renal function"], ["treatment", "losartan"], ["drug", "losartan"], ["effect", "late - onset angioedema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "association", "type": "adverse event", "roles": [["subject", "Two cases"], ["population", "Two"], ["treatment", "diltiazem"], ["drug", "diltiazem"], ["effect", "widespread cutaneous vasculitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "secondary", "type": "adverse event", "roles": [["treatment", "losartan"], ["drug", "losartan"], ["effect", "angioedema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a young man , affected by rheumatoid arthritis"], ["age", "young"], ["gender", "man"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "2 weeks after the administration of leflunomide"], ["drug", "leflunomide"], ["duration", "2 weeks"], ["time elapsed", "2 weeks"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "rapid - onset short - of - breath , hemoptysis , and severe weakness"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["treatment", "chloroquine"], ["drug", "chloroquine"], ["treatment disorder", "resistant vivax malaria"], ["effect", "Toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["subject", "Patients with vitamin B12 deficiency"], ["subject disorder", "vitamin B12 deficiency"], ["treatment", "nitrous oxide anesthesia"], ["drug", "nitrous oxide"], ["route", "anesthesia"], ["treatment disorder", "vitamin B12 deficiency"], ["effect", "neurologic deterioration"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["subject", "two patients"], ["population", "two"], ["subject disorder", "familiar mediterranean fever ( FMF )"], ["treatment", "high dose colchicine"], ["drug", "colchicine"], ["dosage", "high dose"], ["treatment disorder", "familiar mediterranean fever ( FMF )"], ["effect", "PD"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "two patients"], ["population", "two"], ["treatment", "salazosulfapyridine ( SASP )"], ["drug", "salazosulfapyridine"], ["effect", "infectious mononucleosis - like syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "high - dose carmustine infusion"], ["drug", "carmustine"], ["dosage", "high - dose"], ["route", "infusion"], ["effect", "Myocardial ischemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "receiving", "type": "adverse event", "roles": [["subject", "a bone marrow transplant patient"], ["subject disorder", "bone marrow transplant"], ["treatment", "voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations"], ["treatment", "tacrolimus and lansoprazole"], ["drug", "tacrolimus"], ["drug", "lansoprazole"], ["treatment disorder", "bone marrow transplant"], ["combination drug", "tacrolimus"], ["combination drug", "lansoprazole"], ["effect", "Hepatic drug interaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "withdrawal", "type": "adverse event", "roles": [["treatment", "Gabapentin"], ["drug", "Gabapentin"], ["effect", "status epilepticus"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "amiodarone"], ["drug", "amiodarone"], ["effect", "Atypical ventricular tachycardia ( torsade de pointes )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Colchicine"], ["drug", "Colchicine"], ["effect", "rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "in", "type": "adverse event", "roles": [["treatment", "benzodiazepine"], ["drug", "benzodiazepine"], ["effect", "Spindle coma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "dextran - 40"], ["drug", "dextran - 40"], ["effect", "acute renal failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "found", "type": "adverse event", "roles": [["subject", "he"], ["gender", "he"], ["treatment", "second infliximab infusion"], ["drug", "infliximab"], ["route", "infusion"], ["effect", "transient neutropenia ( 0.5 x 10(9)/L )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "for", "type": "potential therapeutic event", "roles": [["treatment", "Lithium"], ["drug", "Lithium"], ["treatment disorder", "post - traumatic stress disorder"], ["effect", "irritability"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["subject", "a case of psoriasis"], ["subject disorder", "psoriasis"], ["treatment", "vitamin D3 ointment ( 1,24(OH)2D3 ) combined with thiazide diuretics"], ["drug", "vitamin D3"], ["drug", "thiazide diuretics"], ["treatment disorder", "psoriasis"], ["combination drug", "thiazide diuretics"], ["combination drug", "vitamin D3"], ["effect", "Iatrogenic hypercalcemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "fluoxetine"], ["drug", "fluoxetine"], ["effect", "mania"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "found", "type": "adverse event", "roles": [["treatment", "progestin therapy"], ["drug", "progestin"], ["effect", "Extensive squamous metaplasia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["treatment", "morphine"], ["drug", "morphine"], ["effect", "Acute generalized exanthematous pustulosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "experienced", "type": "adverse event", "roles": [["subject", "the patient"], ["treatment", "Eleven days after initiation of therapy with amiodarone"], ["drug", "amiodarone"], ["duration", "Eleven days"], ["time elapsed", "Eleven days"], ["effect", "syncope and was noted to have recurrent episodes of polymorphous ventricular tachycardia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "patients with ET"], ["subject disorder", "ET"], ["treatment", "Prolonged used of hydroxyurea"], ["drug", "hydroxyurea"], ["treatment disorder", "ET"], ["effect", "acute leukemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "BCG vaccination"], ["drug", "BCG"], ["route", "vaccination"], ["effect", "Metastatic osteomyelitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "valproic acid"], ["drug", "valproic acid"], ["effect", "coma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "two patients"], ["population", "two"], ["treatment", "methotrexate"], ["drug", "methotrexate"], ["effect", "painful erosions of their psoriasis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Methysergide"], ["drug", "Methysergide"], ["effect", "retroperitoneal fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "suffered", "type": "adverse event", "roles": [["subject", "2 children with cerebral palsy"], ["age", "children"], ["population", "2"], ["subject disorder", "cerebral palsy"], ["treatment", "immediately after treatment with hyperbaric oxygen"], ["drug", "hyperbaric oxygen"], ["treatment disorder", "cerebral palsy"], ["effect", "morbidity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A patient is described with polycythemia vera"], ["subject disorder", "polycythemia vera"], ["treatment", "anticoagulants"], ["drug", "anticoagulants"], ["treatment disorder", "polycythemia vera"], ["effect", "spontaneous retropharyngeal hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "side effects", "type": "adverse event", "roles": [["treatment", "fludarabine phosphate therapy"], ["drug", "fludarabine phosphate"], ["effect", "CD4 T - lymphocyte depletion , myelosuppression , and subsequent severe infections"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Penicillin"], ["drug", "Penicillin"], ["effect", "Jarisch - Herxheimer reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "increase", "type": "adverse event", "roles": [["subject", "patients with schizophrenia"], ["subject disorder", "schizophrenia"], ["treatment", "risperidone"], ["drug", "risperidone"], ["treatment disorder", "schizophrenia"], ["effect", "affect"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["subject", "a patient with progressive renal impairment"], ["subject disorder", "progressive renal impairment"], ["treatment", "chronic cibenzoline"], ["drug", "cibenzoline"], ["treatment disorder", "progressive renal impairment"], ["effect", "blurred vision , QRS broadening and cardiac failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["subject", "a postoperative patient with pre - existent myasthenia gravis"], ["subject disorder", "pre - existent myasthenia gravis"], ["treatment", "oral verapamil"], ["drug", "verapamil"], ["route", "oral"], ["treatment disorder", "pre - existent myasthenia gravis"], ["effect", "exacerbation in myasthenic weakness"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["subject", "patient"], ["treatment", "penicillin"], ["drug", "penicillin"], ["effect", "JHR"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "acquired", "type": "adverse event", "roles": [["subject", "A 34 - year - old man"], ["age", "34 - year - old"], ["gender", "man"], ["subject disorder", "diabetic macular edema"], ["treatment", "intravitreal injection of triamcinolone"], ["drug", "triamcinolone"], ["route", "intravitreal injection"], ["treatment disorder", "diabetic macular edema"], ["effect", "visual field defects and severe vision loss in both eyes"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resulting", "type": "adverse event", "roles": [["treatment", "Simvastatin - amiodarone interaction"], ["drug", "Simvastatin"], ["drug", "amiodarone"], ["combination drug", "Simvastatin"], ["combination drug", "amiodarone"], ["effect", "rhabdomyolysis , azotemia , and possible hepatotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 73 - year - old woman"], ["age", "73 - year - old"], ["gender", "woman"], ["subject disorder", "bipolar disorder"], ["treatment", "high - dosage olanzapine"], ["drug", "olanzapine"], ["dosage", "high - dosage"], ["treatment disorder", "bipolar disorder"], ["effect", "parkinsonism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "paclitaxel"], ["drug", "paclitaxel"], ["effect", "Fatal pulmonary fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Raltegravir"], ["drug", "Raltegravir"], ["effect", "Eosinophilia and Systemic Symptoms ( DRESS ) syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "manifested", "type": "adverse event", "roles": [["subject", "A 10 - year - old boy with osteosarcoma and normal renal function"], ["age", "10 - year - old"], ["gender", "boy"], ["subject disorder", "osteosarcoma"], ["treatment", "4 - hour infusion of high - dose methotrexate ( MTX ) ( 12 g / m2 )"], ["drug", "methotrexate"], ["dosage", "high - dose"], ["route", "infusion"], ["time elapsed", "2 hours"], ["treatment disorder", "osteosarcoma"], ["effect", "acute renal failure with life - threatening hyperkalemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "three depressed patients"], ["population", "three"], ["subject disorder", "depressed"], ["treatment", "trazodone"], ["drug", "trazodone"], ["treatment disorder", "depressed"], ["effect", "hypomanic symptoms"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "praziquantel therapy"], ["drug", "praziquantel"], ["effect", "disseminated muscular cysticercosis followed by myositis ( fever , diffuse myalgia , weakness of the lower limbs , and inflammatory reaction around dying cysticerci )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["subject", "patients who have unexplained high temperatures"], ["subject disorder", "unexplained high temperatures"], ["treatment", "diltiazem therapy"], ["drug", "diltiazem"], ["effect", "fever"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["treatment", "ifosfamide"], ["drug", "ifosfamide"], ["effect", "neurotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "appeared", "type": "adverse event", "roles": [["treatment", "the 55th day of amphotericin B treatment"], ["drug", "amphotericin B"], ["duration", "55th day"], ["time elapsed", "55th day"], ["effect", "Palpable purpuric skin lesions on the anterior surface of both legs"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "cisplatinum , vinblastine , and bleomycin"], ["drug", "cisplatinum"], ["drug", "vinblastine"], ["drug", "bleomycin"], ["treatment disorder", "testicular carcinoma"], ["combination drug", "cisplatinum"], ["combination drug", "vinblastine"], ["combination drug", "bleomycin"], ["effect", "Transient left homonymous hemianopsia and encephalopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a 46 - yr - old woman with ovarian carcinoma"], ["age", "46 - yr - old"], ["gender", "woman"], ["subject disorder", "ovarian carcinoma"], ["treatment", "undergoing treatment with cisplatin and cyclophosphamide"], ["drug", "cisplatin"], ["drug", "cyclophosphamide"], ["treatment disorder", "ovarian carcinoma"], ["combination drug", "cisplatin"], ["combination drug", "cyclophosphamide"], ["effect", "porphyria cutanea tarda"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resulted", "type": "adverse event", "roles": [["subject", "one child"], ["age", "child"], ["population", "one"], ["treatment", "a second course of carbamazepine"], ["drug", "carbamazepine"], ["effect", "return of the dystonia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "increase", "type": "adverse event", "roles": [["treatment", "acyclovir"], ["drug", "acyclovir"], ["effect", "serum lithium levels"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "revisited", "type": "adverse event", "roles": [["treatment", "Sulfadiazine"], ["drug", "Sulfadiazine"], ["effect", "crystalluria"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induce", "type": "adverse event", "roles": [["subject", "subarachnoid haemorrhage ( SAH ) patients , misdiagnosed as migraine patients"], ["subject disorder", "subarachnoid haemorrhage"], ["subject disorder", "misdiagnosed as migraine"], ["treatment", "Administration of sumatriptan"], ["drug", "sumatriptan"], ["treatment disorder", "subarachnoid haemorrhage"], ["effect", "symptomatic cerebral vasospasm"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "development", "type": "adverse event", "roles": [["subject", "Six of 13 outpatients with schizophrenia"], ["population", "Six of 13"], ["subject disorder", "schizophrenia"], ["treatment", "a ten - week open trial of risperidone"], ["drug", "risperidone"], ["treatment disorder", "schizophrenia"], ["effect", "intolerable affect , including feelings of agitation and depression and periods of crying and insomnia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["subject", "a patient with pulmonary hypertension and limited scleroderma"], ["subject disorder", "pulmonary hypertension"], ["subject disorder", "limited scleroderma"], ["treatment", "acute infusion of epoprostenol"], ["drug", "epoprostenol"], ["route", "acute infusion"], ["treatment disorder", "pulmonary hypertension"], ["effect", "Pulmonary edema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "cisplatin"], ["drug", "cisplatin"], ["effect", "vomiting"]]}, {"trigger": "antiemetic", "type": "potential therapeutic event", "roles": [["treatment", "Decadron ( dexamethasone ; Merck Sharp &amp; Dohme , West Point , Pa )"], ["drug", "Decadron"], ["treatment disorder", "vomiting"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "long - term treatment with the dopamine agonist pergolide"], ["drug", "dopamine agonist pergolide"], ["treatment disorder", "Parkinson Disease"], ["effect", "Pleuropulmonary fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurring", "type": "adverse event", "roles": [["subject", "An infertile patient with amenorrhea - galactorrhea syndrome"], ["subject disorder", "infertile"], ["subject disorder", "amenorrhea - galactorrhea syndrome"], ["treatment", "Bromocryptine treatment"], ["drug", "Bromocryptine"], ["treatment disorder", "amenorrhea - galactorrhea syndrome"], ["effect", "lost vision during a pregnancy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["treatment", "a delay of 24 to 48 hours after acyclovir peak serum concentrations"], ["drug", "acyclovir"], ["duration", "24 to 48 hours"], ["time elapsed", "24 to 48 hours"], ["effect", "neurotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "Two cases"], ["population", "Two"], ["treatment", "mequitazine"], ["drug", "mequitazine"], ["effect", "photosensitivity reactions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "a patient with decreased calcium - dependent potassium permeability of cell membranes"], ["subject disorder", "decreased calcium - dependent potassium permeability of cell membranes"], ["treatment", "clozapine treatment"], ["drug", "clozapine"], ["treatment disorder", "decreased calcium - dependent potassium permeability of cell membranes"], ["effect", "Rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 47 year - old woman"], ["age", "47 year - old"], ["gender", "woman"], ["treatment", "intramuscular pentazocine injections in the lower extremities"], ["drug", "pentazocine"], ["route", "intramuscular"], ["route", "injections"], ["effect", "gradual stiffness and weakness of the lower extremities"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["subject", "a patient with water intoxication"], ["subject disorder", "water intoxication"], ["treatment", "massive ingestion of caffeine - containing beverages"], ["drug", "caffeine"], ["route", "ingestion"], ["treatment disorder", "water intoxication"], ["effect", "severe rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 25 - year - old postpartum white woman"], ["age", "25 - year - old"], ["gender", "woman"], ["race", "white"], ["subject disorder", "postpartum white"], ["subject disorder", "bacterial vaginosis"], ["treatment", "on day 6 of therapy with clindamycin vaginal cream"], ["drug", "clindamycin"], ["route", "vaginal cream"], ["treatment disorder", "bacterial vaginosis"], ["effect", "multiple watery stools and abdominal cramping"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "three case"], ["population", "three"], ["treatment", "Dose - dependent olanzapine"], ["drug", "olanzapine"], ["effect", "leukopenia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "became", "type": "adverse event", "roles": [["subject", "He"], ["gender", "He"], ["treatment", "2 weeks after administration of levodopa"], ["drug", "levodopa"], ["duration", "2 weeks"], ["time elapsed", "2 weeks"], ["effect", "completely premorbid"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "a case"], ["treatment", "darifenacin"], ["drug", "darifenacin"], ["effect", "interstitial granulomatous dermatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induce", "type": "adverse event", "roles": [["subject", "this patient"], ["gender", "she"], ["treatment", "Amiodarone"], ["drug", "Amiodarone"], ["effect", "AVT"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A young diamond dealer"], ["age", "young"], ["subject disorder", "diamond dealer"], ["subject disorder", "nausea"], ["treatment", "four courses of intermittent Decadron used as part of a five - drug antiemetic regimen for cisplatin - associated nausea"], ["drug", "Decadron"], ["frequency", "four courses"], ["treatment disorder", "cisplatin - associated nausea"], ["effect", "visual impairment attributed to bilateral posterior subcapsular cataracts"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "losartan administration"], ["drug", "losartan"], ["effect", "angioedema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "3 months after the transurethral injection of calcium hydroxylapatite"], ["drug", "calcium hydroxylapatite"], ["route", "transurethral injection"], ["time elapsed", "3 months"], ["effect", "granulomatous reaction leading to urethral prolapse"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "a patient with rheumatoid arthritis"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "methotrexate and rofecoxib"], ["drug", "methotrexate"], ["drug", "rofecoxib"], ["treatment disorder", "rheumatoid arthritis"], ["combination drug", "methotrexate"], ["combination drug", "rofecoxib"], ["effect", "Epstein - Barr virus - associated lymphoproliferative disorder"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "promoted", "type": "adverse event", "roles": [["treatment", "aspirin"], ["drug", "aspirin"], ["treatment disorder", "meningioma"], ["effect", "enlargement of spontaneous hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "increased", "type": "adverse event", "roles": [["treatment", "omeprazole"], ["drug", "omeprazole"], ["effect", "diarrhea"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "Treatment", "type": "potential therapeutic event", "roles": [["subject", "a patient with severe digitoxin intoxication"], ["subject disorder", "severe digitoxin intoxication"], ["treatment", "Fab fragments of anti - digitalis antibodies"], ["drug", "Fab fragments of anti - digitalis antibodies"], ["treatment disorder", "severe digitoxin intoxication"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "Development", "type": "adverse event", "roles": [["treatment", "cyclophosphamide"], ["drug", "cyclophosphamide"], ["effect", "porphyria cutanea tarda"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "a premature infant"], ["age", "premature"], ["treatment", "intraventricular administration of nafcillin"], ["drug", "nafcillin"], ["route", "intraventricular"], ["effect", "seizures"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "single case"], ["population", "single"], ["treatment", "zuclopenthixol"], ["drug", "zuclopenthixol"], ["effect", "priapism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurring", "type": "adverse event", "roles": [["subject", "a case"], ["subject disorder", "locally advanced pancreatic cancer"], ["treatment", "gemcitabine monotherapy"], ["treatment", "five months after completing chemoradiation"], ["drug", "gemcitabine"], ["duration", "five months"], ["time elapsed", "five months"], ["treatment disorder", "locally advanced pancreatic cancer"], ["effect", "radiation recall dermatitis and myositis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "gold sodium thiomalate"], ["drug", "gold sodium thiomalate"], ["effect", "Stroke - like syndrome"], ["effect", "vasomotor reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "MTX"], ["drug", "MTX"], ["treatment disorder", "leukemia , gestational disease"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "hepatic injury and liver enzyme elevations"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "fluoxetine"], ["drug", "fluoxetine"], ["effect", "adverse drug reaction ( ADR )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["treatment", "etanercept"], ["drug", "etanercept"], ["treatment disorder", "active ankylosing spondylitis"], ["effect", "Crohn 's disease"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "long - term pulse itraconazole treatment"], ["drug", "itraconazole"], ["route", "long - term pulse"], ["treatment disorder", "onychomycosis"], ["effect", "Fatal hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "outcome", "type": "adverse event", "roles": [["treatment", "intravesical formalin instillation"], ["drug", "formalin"], ["route", "intravesical"], ["effect", "changes mimicking renal tuberculosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["treatment", "anti - emetic drug"], ["drug", "anti - emetic"], ["effect", "Both reactions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "in", "type": "adverse event", "roles": [["treatment", "cyclosporine"], ["drug", "cyclosporine"], ["treatment disorder", "systemic lupus erythematosus with thrombocytopenia"], ["effect", "Reversible posterior leukoencephalopathy syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "reduced", "type": "potential therapeutic event", "roles": [["subject", "Among patients"], ["population", "Among"], ["treatment", "aspirin and clopidogrel"], ["drug", "aspirin"], ["drug", "clopidogrel"], ["combination drug", "aspirin"], ["combination drug", "clopidogrel"], ["effect", "upper gastrointestinal bleeding"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "enteropathy", "type": "adverse event", "roles": [["subject", "a pediatric bone marrow transplant recipient"], ["age", "pediatric"], ["subject disorder", "bone marrow transplant"], ["treatment", "Clofazimine"], ["drug", "Clofazimine"], ["effect", "enteropathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "from", "type": "adverse event", "roles": [["treatment", "transdermal scopolamine"], ["drug", "scopolamine"], ["route", "transdermal"], ["effect", "Anisocoria"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "he"], ["gender", "he"], ["subject disorder", "fever"], ["treatment", "chloroquine"], ["drug", "chloroquine"], ["treatment disorder", "fever"], ["effect", "symptoms consistent with those of chloroquine toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 36 - year - old man"], ["age", "36 - year - old"], ["gender", "man"], ["subject disorder", "testicular carcinoma"], ["treatment", "cisplatinum , vinblastine , and bleomycin"], ["drug", "cisplatinum"], ["drug", "vinblastine"], ["drug", "bleomycin"], ["treatment disorder", "testicular carcinoma"], ["combination drug", "cisplatinum"], ["combination drug", "vinblastine"], ["combination drug", "bleomycin"], ["effect", "a dense left homonymous hemianopsia , encephalopathy , and a partial nondominant parietal lobe syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "a statin and a protease inhibitor"], ["drug", "statin"], ["drug", "protease inhibitor"], ["combination drug", "statin"], ["combination drug", "protease inhibitor"], ["effect", "death"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "MTX - treated RA patients"], ["subject disorder", "RA"], ["treatment", "Methotrexate ( MTX )"], ["drug", "Methotrexate"], ["treatment disorder", "RA"], ["effect", "Epstein - Barr virus ( EBV) - associated polyclonal B cell lymphoproliferative disorder"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "azathioprine"], ["treatment", "warfarin"], ["drug", "azathioprine"], ["drug", "warfarin"], ["combination drug", "warfarin"], ["combination drug", "azathioprine"], ["effect", "warfarin resistance"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complication", "type": "adverse event", "roles": [["treatment", "paclitaxel therapy"], ["drug", "paclitaxel"], ["effect", "Pulmonary fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "potential therapeutic event", "roles": [["subject", "Two patients with adrenal carcinoma"], ["population", "Two"], ["subject disorder", "adrenal carcinoma"], ["treatment", "2,2 - bis ( 2 - chlorophenyl - 4 - chlorophenyl) - 1,1 - dichloroethane ( o , p' - DDD )"], ["drug", "2,2 - bis ( 2 - chlorophenyl - 4 - chlorophenyl) - 1,1 - dichloroethane"], ["treatment disorder", "adrenal carcinoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a patient with severe acyclovir overdose"], ["treatment", "severe acyclovir overdose"], ["drug", "acyclovir"], ["dosage", "overdose"], ["effect", "coma and nonoliguric renal failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "An 8 - year - old girl"], ["age", "8 - year - old"], ["gender", "girl"], ["treatment", "7 months later"], ["drug", "BCG"], ["duration", "7 months"], ["time elapsed", "7 months"], ["effect", "osteomyelitis in the left calcaneus"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "persisted", "type": "adverse event", "roles": [["treatment", "FAB"], ["drug", "FAB"], ["effect", "cardiac DGTX toxicity ( total AV - block )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "in", "type": "adverse event", "roles": [["treatment", "quinine"], ["drug", "quinine"], ["treatment disorder", "amblyopia"], ["effect", "Abnormalities of the pupil and visual - evoked potential"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resulted", "type": "adverse event", "roles": [["subject", "A case"], ["subject disorder", "pregnancy"], ["subject disorder", "toxemia of pregnancy"], ["treatment", "therapeutic use of magnesium sulfate"], ["drug", "magnesium sulfate"], ["treatment disorder", "toxemia of pregnancy"], ["effect", "hypocalcemia , with a low plasma parathyroid hormone ( PTH ) concentration"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "side - effect", "type": "adverse event", "roles": [["treatment", "low - dose methotrexate therapy during rheumatoid arthritis"], ["drug", "methotrexate"], ["dosage", "low - dose"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "acute megaloblastic anaemia and pneumonitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "risk", "type": "adverse event", "roles": [["treatment", "dexamethasone"], ["drug", "dexamethasone"], ["effect", "osteonecrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a patient with inoperable pancreatic cancer"], ["subject disorder", "inoperable pancreatic cancer"], ["treatment", "radiation - recall related to gemcitabine"], ["drug", "gemcitabine"], ["treatment disorder", "inoperable pancreatic cancer"], ["effect", "gastrointestinal bleeding"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "adverse event", "roles": [["subject", "a 14 - year - old male with nephrotic syndrome"], ["age", "14 - year - old"], ["gender", "male"], ["subject disorder", "nephrotic syndrome"], ["treatment", "oral prednisolone for 6 weeks"], ["drug", "prednisolone"], ["route", "oral"], ["duration", "6 weeks"], ["time elapsed", "6 weeks"], ["treatment disorder", "nephrotic syndrome"], ["effect", "SJS"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 45 - year - old woman with thyrotoxicosis"], ["age", "45 - year - old"], ["gender", "woman"], ["subject disorder", "thyrotoxicosis"], ["treatment", "propylthiouracil"], ["drug", "propylthiouracil"], ["treatment disorder", "thyrotoxicosis"], ["effect", "agranulocytosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "side effects", "type": "adverse event", "roles": [["treatment", "prolonged ACTH therapy"], ["drug", "ACTH"], ["effect", "hyperkalemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complicating", "type": "adverse event", "roles": [["treatment", "long - term mitomycin C and 5 - fluorouracil therapy"], ["drug", "mitomycin C"], ["drug", "5 - fluorouracil"], ["treatment disorder", "gastric carcinoma"], ["combination drug", "mitomycin C"], ["combination drug", "5 - fluorouracil"], ["effect", "Haemolytic - uraemic syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "adverse interaction", "type": "adverse event", "roles": [["treatment", "selective serotonin reuptake inhibitors ( SSRI ) and fentanyl"], ["drug", "selective serotonin reuptake inhibitors"], ["drug", "fentanyl"], ["combination drug", "selective serotonin reuptake inhibitors"], ["combination drug", "fentanyl"], ["effect", "serotonin syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "a 61 - year - old diabetic patient who presented wit hypoglycaemic coma"], ["age", "61 - year - old"], ["subject disorder", "diabetic"], ["treatment", "glibenclamide therapy"], ["drug", "glibenclamide"], ["treatment disorder", "diabetic"], ["effect", "Intrahepatic cholestasis and cutaneous bullae"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "responsible", "type": "adverse event", "roles": [["treatment", "cloxacillin"], ["drug", "cloxacillin"], ["effect", "increased INR"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "sumatriptan"], ["drug", "sumatriptan"], ["effect", "Cardiac arrest"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "one patient"], ["population", "one"], ["treatment", "receiving continuous bladder irrigations with alum"], ["drug", "aluminum"], ["effect", "seizures"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "Nine azotemic patients"], ["population", "Nine"], ["subject disorder", "azotemic"], ["treatment", "cephalosporin or moxalactam antibiotics"], ["drug", "cephalosporin"], ["drug", "moxalactam antibiotics"], ["treatment disorder", "azotemic"], ["effect", "coagulopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "exposed", "type": "adverse event", "roles": [["subject", "fetuses"], ["age", "fetuses"], ["treatment", "disulfiram"], ["drug", "disulfiram"], ["effect", "poor prognosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "injured", "type": "adverse event", "roles": [["treatment", "caffeine"], ["drug", "caffeine"], ["effect", "muscle cells , which were fragile due to the potassium depletion induced by the coexisting hyponatremia , to result in unusually severe rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "an 81 - year - old - man"], ["age", "81 - year - old"], ["gender", "man"], ["treatment", "erlotinib"], ["drug", "erlotinib"], ["effect", "rosaceiform eruption"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "An 11 - year - old boy"], ["age", "11 - year - old"], ["gender", "boy"], ["subject disorder", "graft - versus - host disease"], ["treatment", "2 years after initiation of clofazimine treatment"], ["drug", "clofazimine"], ["duration", "2 years"], ["time elapsed", "2 years"], ["treatment disorder", "graft - versus - host disease"], ["effect", "severe enteropathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "experience", "type": "adverse event", "roles": [["subject", "patients"], ["treatment", "high doses of oral niacin"], ["drug", "niacin"], ["dosage", "high doses"], ["route", "oral"], ["effect", "visual symptoms"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "under", "type": "adverse event", "roles": [["subject", "renal transplanted patients"], ["subject disorder", "renal transplanted"], ["treatment", "immunosuppression with tacrolimus"], ["drug", "tacrolimus"], ["treatment disorder", "renal transplanted"], ["effect", "Reflex sympathetic dystrophy syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["subject", "an 11 - year - old female treated for mediastinal T - cell lymphoma"], ["age", "11 - year - old"], ["gender", "female"], ["subject disorder", "mediastinal T - cell lymphoma"], ["treatment", "the second cycle of high - dose methotrexate ( HDMTX )"], ["drug", "methotrexate"], ["dosage", "high - dose"], ["treatment disorder", "mediastinal T - cell lymphoma"], ["effect", "renal failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "three cases of patients"], ["population", "three"], ["treatment", "olanzapine treatment"], ["drug", "olanzapine"], ["effect", "leukopenia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "the combined use of simvastatin and colchicine"], ["drug", "simvastatin"], ["drug", "colchicine"], ["combination drug", "simvastatin"], ["combination drug", "colchicine"], ["effect", "Rapid onset of muscle weakness ( rhabdomyolysis )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 35 - year - old man with seropositive rheumatoid arthritis"], ["age", "35 - year - old"], ["gender", "man"], ["subject disorder", "seropositive rheumatoid arthritis"], ["treatment", "fenclofenac"], ["drug", "fenclofenac"], ["treatment disorder", "seropositive rheumatoid arthritis"], ["effect", "selective IgA deficiency"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "demonstrated", "type": "adverse event", "roles": [["subject", "two newborns with congenital heart anomalies"], ["age", "newborns"], ["population", "two"], ["subject disorder", "congenital heart anomalies"], ["treatment", "the dose of systemic prostaglandin E1"], ["drug", "prostaglandin E1"], ["dosage", "the dose"], ["treatment disorder", "congenital heart anomalies"], ["effect", "harlequin color change"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "described", "type": "adverse event", "roles": [["subject", "infants of women"], ["age", "infants"], ["gender", "women"], ["treatment", "disulfiram in the first trimester of their pregnancies"], ["drug", "disulfiram"], ["time elapsed", "first trimester"], ["effect", "Nonspecific but significant abnormalities"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "triggered", "type": "adverse event", "roles": [["treatment", "infliximab"], ["drug", "infliximab"], ["effect", "production of granulocyte and neutrophil autoantibodies with resultant autoimmune agranulocytosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "arising", "type": "adverse event", "roles": [["subject", "a postmenopausal woman"], ["gender", "woman"], ["subject disorder", "postmenopausal"], ["subject disorder", "breast cancer"], ["treatment", "tamoxifen therapy"], ["drug", "tamoxifen"], ["treatment disorder", "breast cancer"], ["effect", "Ovarian endometrioid adenocarcinoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Tacrolimus"], ["drug", "Tacrolimus"], ["effect", "acute renal failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a woman with cryptococcal meningitis and no previous cardiac disease"], ["gender", "woman"], ["subject disorder", "cryptococcal meningitis"], ["treatment", "an acute overdose of amphotericin B"], ["drug", "amphotericin B"], ["dosage", "an acute overdose"], ["treatment disorder", "cryptococcal meningitis"], ["effect", "fatal cardiac arrhythmia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["treatment", "intake of captopril"], ["drug", "captopril"], ["effect", "bullous lichenoid eruption"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "overcome", "type": "potential therapeutic event", "roles": [["treatment", "increasing steroid replacement therapy"], ["drug", "steroid"], ["effect", "hypoadrenalism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Interferon alpha - 2b"], ["drug", "Interferon alpha - 2b"], ["effect", "cardiomyopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "systemic tissue plasminogen activator"], ["drug", "systemic tissue plasminogen activator"], ["effect", "Choroidal hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a patient with chronic schizophrenia with suicidal tendencies"], ["subject disorder", "chronic schizophrenia"], ["treatment", "Clozapine"], ["drug", "Clozapine"], ["treatment disorder", "chronic schizophrenia"], ["effect", "eosinophilia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "propafenone"], ["treatment", "long - term therapy with the addition of citalopram"], ["drug", "propafenone"], ["drug", "citalopram"], ["combination drug", "propafenone"], ["combination drug", "citalopram"], ["effect", "Adverse effects"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "an adult"], ["age", "adult"], ["treatment", "exposure to cimetidine"], ["drug", "cimetidine"], ["effect", "hepatic dysfunction and an impaired macrophage migration"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "4 patients"], ["population", "4"], ["treatment", "within 2 weeks of starting treatment with a statin drug"], ["drug", "statin"], ["duration", "2 weeks"], ["time elapsed", "2 weeks"], ["effect", "symptoms of myasthenia gravis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "decreased", "type": "potential therapeutic event", "roles": [["subject", "patient 's"], ["treatment", "After only the third dose of pentamidine"], ["drug", "pentamidine"], ["dosage", "the third dose"], ["effect", "heart rate had decreased to 48 beats / minute"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "A 44 - year - old woman"], ["age", "44 - year - old"], ["gender", "woman"], ["treatment", "amiodarone , disopyramide , and quinidine"], ["drug", "amiodarone"], ["drug", "disopyramide"], ["drug", "quinidine"], ["combination drug", "amiodarone"], ["combination drug", "disopyramide"], ["combination drug", "quinidine"], ["effect", "atypical ventricular tachycardia ( AVT , torsade de pointes )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "causative", "type": "adverse event", "roles": [["treatment", "Azathioprine"], ["drug", "Azathioprine"], ["effect", "warfarin resistance"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "used", "type": "potential therapeutic event", "roles": [["subject", "patients with a history of alcohol abuse"], ["subject disorder", "alcohol abuse"], ["treatment", "Disulfiram"], ["drug", "Disulfiram"], ["treatment disorder", "alcohol abuse"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["subject", "human immunodeficiency virus ( HIV) - infected patients"], ["subject disorder", "human immunodeficiency virus ( HIV)"], ["treatment", "Nevirapine is a non - nucleoside reverse transcriptase inhibitor"], ["drug", "Nevirapine"], ["treatment disorder", "human immunodeficiency virus ( HIV)"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "ergotamine"], ["drug", "ergotamine"], ["effect", "Vasospasm"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "she"], ["gender", "she"], ["treatment", "a six - week course of low - dose cyclosporine A"], ["drug", "cyclosporine A"], ["dosage", "low - dose"], ["effect", "severe but reversible loss of glomerular filtration rate and effective renal plasma flow"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "simvastatin"], ["treatment", "addition of amiodarone to previously well - tolerated chronic statin therapy"], ["drug", "simvastatin"], ["drug", "amiodarone"], ["combination drug", "amiodarone"], ["combination drug", "simvastatin"], ["effect", "rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["subject", "a 50 - year - old transgender female with HIV infection and recurrent deep vein thrombosis"], ["age", "50 - year - old"], ["gender", "female"], ["subject disorder", "HIV infection"], ["subject disorder", "recurrent deep vein thrombosis"], ["treatment", "TRIO study regimen"], ["drug", "TRIO"], ["treatment disorder", "HIV infection"], ["treatment disorder", "recurrent deep vein thrombosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "by", "type": "adverse event", "roles": [["treatment", "zafirlukast"], ["drug", "zafirlukast"], ["effect", "In vitro inhibition of CYP2C9"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "attribute", "type": "adverse event", "roles": [["subject", "patients who have asymptomatic meningioma"], ["subject disorder", "asymptomatic meningioma"], ["treatment", "aspirin"], ["drug", "aspirin"], ["treatment disorder", "asymptomatic meningioma"], ["effect", "intratumoral hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "IVTA injection"], ["drug", "IVTA"], ["route", "injection"], ["effect", "fundus picture"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "of", "type": "adverse event", "roles": [["treatment", "amiodarone"], ["drug", "amiodarone"], ["effect", "proarrhythmic action"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["subject", "two cases"], ["population", "two"], ["subject disorder", "psoriasis"], ["treatment", "NMSC treatment with imiquimod in the context of infliximab"], ["drug", "imiquimod"], ["drug", "infliximab"], ["treatment disorder", "psoriasis"], ["combination drug", "imiquimod"], ["combination drug", "infliximab"], ["effect", "severe , atypical ASRs"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complicated", "type": "adverse event", "roles": [["treatment", "propranolol overdose"], ["treatment", "relieved by intravenous glucagon"], ["drug", "propranolol"], ["dosage", "overdose"], ["effect", "esophageal spasm"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Fenclofenac"], ["drug", "Fenclofenac"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "selective IgA deficiency"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "pediatric population"], ["age", "pediatric"], ["treatment", "Naproxen"], ["drug", "Naproxen"], ["effect", "a dimorphic clinical pattern : a PCT - like presentation and one simulating erythropoietic protoporphyria"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treat", "type": "potential therapeutic event", "roles": [["treatment", "Zafirlukast"], ["drug", "Zafirlukast"], ["treatment disorder", "allergic and exercise - induced asthma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["treatment", "olanzapine"], ["drug", "olanzapine"], ["effect", "hyperglycemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "diagnosed", "type": "potential therapeutic event", "roles": [["subject", "a 61 - year - old man with a 30 - year history of fistulizing CD"], ["age", "61 - year - old"], ["gender", "man"], ["subject disorder", "fistulizing CD"], ["treatment", "9 months after treatment with infliximab"], ["drug", "infliximab"], ["duration", "9 months"], ["time elapsed", "9 months"], ["treatment disorder", "fistulizing CD"], ["effect", "B - cell non - Hodgkin 's lymphoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "pediatric oncology patients"], ["age", "pediatric"], ["subject disorder", "oncology"], ["treatment", "ifosfamide"], ["drug", "ifosfamide"], ["treatment disorder", "oncology"], ["effect", "Fanconi syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a patient with chronic renal failure and ischemic heart disease"], ["subject disorder", "chronic renal failure"], ["subject disorder", "ischemic heart disease"], ["treatment", "an axillary block with bupivacaine and additional injection of lidocaine in the operative field"], ["drug", "bupivacaine"], ["drug", "lidocaine"], ["route", "axillary block"], ["treatment disorder", "chronic renal failure"], ["treatment disorder", "ischemic heart disease"], ["effect", "methemoglobinemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Amikacin"], ["drug", "Amikacin"], ["effect", "type 5 Bartter - like syndrome with severe hypocalcemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "L - asparaginase"], ["drug", "L - asparaginase"], ["effect", "severe necrotizing pancreatitis"]]}, {"trigger": "treated", "type": "potential therapeutic event", "roles": [["treatment", "percutaneous drainage"], ["drug", "percutaneous drainage"], ["treatment disorder", "severe necrotizing pancreatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a patient without underlying heart disease"], ["treatment", "insulin"], ["drug", "insulin"], ["effect", "cardiac failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "frequency", "type": "adverse event", "roles": [["subject", "patients"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "leflunomide"], ["drug", "leflunomide"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "weight loss"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "INH"], ["drug", "INH"], ["effect", "drug eruptions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "immediate instillations of epirubicin"], ["drug", "epirubicin"], ["route", "immediate instillations"], ["treatment disorder", "superficial urothelial tumours"], ["effect", "primary and secondary perforation of the bladder"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "Ofloxacin"], ["drug", "Ofloxacin"], ["effect", "toxic epidermal necrolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["subject", "a 62 - year - old woman"], ["age", "62 - year - old"], ["gender", "woman"], ["subject disorder", "advanced ovarian cancer"], ["treatment", "six cycles of paclitaxel and carboplatin as combination chemotherapy"], ["drug", "paclitaxel"], ["drug", "carboplatin"], ["frequency", "six cycles"], ["treatment disorder", "advanced ovarian cancer"], ["combination drug", "paclitaxel"], ["combination drug", "carboplatin"], ["effect", "Fatal lung fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 21 - year - old patient"], ["age", "21 - year - old"], ["subject disorder", "drug - resistant schizophrenia"], ["treatment", "his nineteenth week of treatment with clozapine"], ["drug", "clozapine"], ["duration", "nineteenth week"], ["time elapsed", "nineteenth week"], ["treatment disorder", "drug - resistant schizophrenia"], ["effect", "rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a patient with neuroendocrine tumor of the cervix"], ["subject disorder", "neuroendocrine tumor of the cervix"], ["treatment", "Cisplatin"], ["drug", "Cisplatin"], ["treatment disorder", "neuroendocrine tumor of the cervix"], ["effect", "syndrome of inappropriate antidiuretic hormone ( SIADH )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "intravenous vasopressin infusion"], ["drug", "vasopressin"], ["route", "intravenous"], ["effect", "Myoglobinuria and acute renal failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "pegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and ribavirin"], ["drug", "pegylated interferon alpha - 2a"], ["drug", "ribavirin"], ["treatment disorder", "hepatitis C"], ["combination drug", "pegylated interferon alpha - 2a"], ["combination drug", "ribavirin"], ["effect", "fulminant adult respiratory distress syndrome ( ARDS )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "disulfiram therapy"], ["drug", "disulfiram"], ["effect", "Catatonia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developing", "type": "adverse event", "roles": [["treatment", "imiquimod"], ["drug", "imiquimod"], ["effect", "exaggerated ASRs"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Losartan"], ["drug", "Losartan"], ["effect", "angioedema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "mequitazine or other phenothiazine - derivative drugs"], ["drug", "mequitazine"], ["effect", "photosensitivity reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "improved", "type": "potential therapeutic event", "roles": [["treatment", "Oxycodone - gabapentin"], ["drug", "Oxycodone"], ["drug", "gabapentin"], ["combination drug", "Oxycodone"], ["combination drug", "gabapentin"], ["effect", "pain relief"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "contributed", "type": "adverse event", "roles": [["subject", "2 of the 3 cases"], ["population", "2 of the 3"], ["treatment", "lithium carbonate and beta - blockers"], ["drug", "lithium carbonate"], ["drug", "beta - blockers"], ["effect", "incontinence"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "bis - chloronitrosourea ( BCNU ) therapy"], ["drug", "bis - chloronitrosourea"], ["effect", "Pulmonary fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "died", "type": "adverse event", "roles": [["subject", "a 26 - year - old female with diffuse large B - cell lymphoma"], ["age", "26 - year - old"], ["gender", "female"], ["subject disorder", "diffuse large B - cell lymphoma"], ["treatment", "81 days after the administration of high - dose BCNU ( 600 mg / m2 )"], ["drug", "BCNU"], ["dosage", "high - dose"], ["duration", "81 days"], ["time elapsed", "81 days"], ["treatment disorder", "diffuse large B - cell lymphoma"], ["effect", "severe pulmonary fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["subject", "The patient"], ["treatment", "methimazole instead of propylthiouracil"], ["drug", "methimazole"], ["drug", "propylthiouracil"], ["duration", "10 weeks"], ["time elapsed", "10 weeks"], ["effect", "agranulocytosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "experienced", "type": "adverse event", "roles": [["subject", "she"], ["gender", "she"], ["treatment", "Three months after starting citalopram"], ["drug", "citalopram"], ["duration", "Three months"], ["time elapsed", "Three months"], ["effect", "chest tightness and dizziness"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["subject", "a small number of patients"], ["population", "small number"], ["treatment", "vincristine"], ["drug", "vincristine"], ["effect", "severe visual loss"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induce", "type": "adverse event", "roles": [["treatment", "glatiramer acetate"], ["drug", "glatiramer acetate"], ["effect", "skin necrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "increase", "type": "adverse event", "roles": [["treatment", "SSRI - drugs"], ["drug", "SSRI"], ["effect", "serotonin concentrations"], ["effect", "pruritus and other dermal side effects"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "increased", "type": "adverse event", "roles": [["subject", "patients"], ["treatment", "Dabigatran etexilate and concomitant use of non - steroidal anti - inflammatory drugs or acetylsalicylic acid"], ["drug", "Dabigatran etexilate"], ["drug", "non - steroidal anti - inflammatory drugs or acetylsalicylic acid"], ["combination drug", "Dabigatran etexilate"], ["combination drug", "non - steroidal anti - inflammatory drugs or acetylsalicylic acid"], ["effect", "bleeding"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "receiving", "type": "adverse event", "roles": [["subject", "six cases of MS patients"], ["population", "six"], ["subject disorder", "MS"], ["treatment", "IFN - beta"], ["drug", "IFN - beta"], ["treatment disorder", "MS"], ["effect", "inflammatory arthritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["treatment", "24 hours following an increase in the dose of disopyramide from 300 to 600 mg / day"], ["drug", "disopyramide"], ["dosage", "300 to 600 mg / day"], ["effect", "AVT with syncope"]]}, {"trigger": "abolished", "type": "potential therapeutic event", "roles": [["treatment", "isoproterenol"], ["drug", "isoproterenol"], ["treatment disorder", "arrhythmia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "The patient"], ["treatment", "initially treated with hydration and furosemide"], ["drug", "hydration"], ["drug", "furosemide"], ["effect", "congestive heart failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "having", "type": "adverse event", "roles": [["subject", "an HIV - positive woman"], ["gender", "woman"], ["subject disorder", "HIV"], ["treatment", "antiretroviral therapy"], ["drug", "Implanon"], ["treatment disorder", "HIV"], ["effect", "tubal pregnancies"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "COX - 2 inhibitor"], ["drug", "COX - 2 inhibitor"], ["effect", "enhanced hematopoietic toxicity and immunosuppression causing the EBV - associated lymphoproliferative disease"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Temsirolimus"], ["drug", "Temsirolimus"], ["effect", "glomerulopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["effect", "linear immunoglobulin ( Ig ) A bullous dermatosis ( LABD )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "This patient"], ["treatment", "5 days after the second course of HD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with leucovorin rescue"], ["drug", "HD - MTX"], ["dosage", "8 gm / m2"], ["duration", "5 days"], ["time elapsed", "5 days"], ["effect", "sequential symptoms including alternative hemiparesis , dysarthria and altered consciousness"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "dependent", "type": "adverse event", "roles": [["subject", "Adult and adolescent patients ( = or = 12 years old ; n = 141 )"], ["age", "Adult and adolescent"], ["population", "n = 141"], ["subject disorder", "asthma"], ["treatment", "steroid ( prednisone)"], ["drug", "prednisone"], ["route", "oral"], ["treatment disorder", "asthma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "produce", "type": "adverse event", "roles": [["subject", "children and in adults with preexisting cardiac disease"], ["age", "children"], ["subject disorder", "preexisting cardiac disease"], ["treatment", "Amphotericin B deoxycholate"], ["drug", "Amphotericin B deoxycholate"], ["effect", "significant cardiac toxicity , with ventricular arrhythmias and bradycardia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a male 60 yrs of age , who was treated with oxaliplatinum and 5 - fluorouracil"], ["age", "60 yrs of age"], ["gender", "male"], ["subject disorder", "unresectable rectum carcinoma"], ["treatment", "oxaliplatinum and 5 - fluorouracil"], ["drug", "oxaliplatinum"], ["drug", "5 - fluorouracil"], ["treatment disorder", "unresectable rectum carcinoma"], ["effect", "Diarrhoea , T - CD4 + lymphopenia and bilateral patchy pulmonary infiltrates"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["treatment", "piperacillin and cefotiam"], ["drug", "piperacillin"], ["drug", "cefotiam"], ["effect", "tardive seizures"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 55 - yr - old man"], ["age", "55 - yr - old"], ["gender", "man"], ["treatment", "a course of thiabendazole therapy"], ["drug", "thiabendazole"], ["effect", "prolonged jaundice and sicca complex"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "Methylphenidate ( Ritalin)"], ["drug", "Methylphenidate"], ["effect", "cataract and glaucoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "implicated", "type": "adverse event", "roles": [["treatment", "Simvastatin - nelfinavir interaction"], ["drug", "Simvastatin"], ["drug", "nelfinavir"], ["combination drug", "Simvastatin"], ["combination drug", "nelfinavir"], ["effect", "rhabdomyolysis and death"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "oxcarbazepine"], ["drug", "oxcarbazepine"], ["effect", "Uncontrolled headache"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "adverse event", "roles": [["subject", "kidney transplant recipients"], ["population", "four"], ["subject disorder", "kidney transplant"], ["treatment", "tacrolimus"], ["drug", "tacrolimus"], ["treatment disorder", "kidney transplant"], ["effect", "RSDS"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "chemotherapy of high - dose methotrexate"], ["drug", "methotrexate"], ["dosage", "high - dose"], ["treatment disorder", "osteogenic sarcoma"], ["effect", "Transient neurological disturbances"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "safety", "type": "potential therapeutic event", "roles": [["subject", "patients with uncontrolled partial - onset seizures"], ["subject disorder", "uncontrolled partial - onset seizures"], ["treatment", "adjunctive lacosamide"], ["drug", "lacosamide"], ["treatment disorder", "uncontrolled partial - onset seizures"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "develop", "type": "adverse event", "roles": [["subject", "patients with underlying Tourette 's syndrome or other movement disorders"], ["age", "adults"], ["age", "children"], ["subject disorder", "Tourette 's syndrome"], ["subject disorder", "other movement disorders"], ["treatment", "carbamazepine ( CBZ ) therapy"], ["drug", "carbamazepine"], ["treatment disorder", "Tourette 's syndrome"], ["effect", "tics"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["subject", "he"], ["gender", "he"], ["subject disorder", "bladder cancer"], ["treatment", "the third of six serial weekly BCG bladder instillations"], ["drug", "BCG"], ["frequency", "weekly"], ["route", "bladder instillations"], ["treatment disorder", "bladder cancer"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "received", "type": "potential therapeutic event", "roles": [["subject", "she"], ["gender", "she"], ["treatment", "quinidine , 1.2 g / day , without interruption for 17 years"], ["drug", "quinidine"], ["dosage", "1.2 g / day"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "intrabiliary infusion of monooctanoin"], ["drug", "monooctanoin"], ["route", "intrabiliary infusion"], ["effect", "noncardiogenic pulmonary edema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "Mitomycin - C"], ["drug", "Mitomycin - C"], ["effect", "hemolytic uremic syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "an adult patient without a history of metabolic disease"], ["age", "adult"], ["treatment", "Valproic acid"], ["drug", "Valproic acid"], ["effect", "coma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "Three patients with no history of asthma or allergy"], ["population", "Three"], ["subject disorder", "asthma"], ["subject disorder", "allergy"], ["subject disorder", "hypertension"], ["treatment", "propranolol"], ["drug", "propranolol"], ["treatment disorder", "hypertension"], ["effect", "bronchospasm"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resulted", "type": "adverse event", "roles": [["subject", "two cases"], ["population", "two"], ["treatment", "warfarin therapy"], ["treatment", "the addition of tolterodine"], ["drug", "warfarin"], ["drug", "tolterodine"], ["combination drug", "warfarin"], ["combination drug", "tolterodine"], ["effect", "prolonged international normalized ratios ( INRs )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "observed", "type": "adverse event", "roles": [["treatment", "mequitazine directly after UV exposure"], ["drug", "mequitazine"], ["effect", "immediate erythematous macule"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "accelerated", "type": "adverse event", "roles": [["treatment", "Acetazolamide"], ["drug", "Acetazolamide"], ["effect", "osteomalacia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "Both patients"], ["population", "Both"], ["treatment", "injection of chymopapain into a disk"], ["drug", "chymopapain"], ["route", "injection"], ["effect", "hypotensive"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "Large dose of methylphenidate"], ["drug", "methylphenidate"], ["dosage", "Large dose"], ["effect", "cataract and glaucoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a 54 - year - old man"], ["age", "54 - year - old"], ["gender", "man"], ["subject disorder", "leg cramps"], ["treatment", "the use of quinine sulfate"], ["drug", "quinine sulfate"], ["treatment disorder", "leg cramps"], ["effect", "Total blindness with a transient tonic pupillary response , denervation supersensitivity , and abnormal visual - evoked potentials"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Carbamazepine"], ["drug", "Carbamazepine"], ["effect", "tics"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "Three patients"], ["population", "Three"], ["treatment", "BCNU infusion"], ["drug", "BCNU"], ["route", "infusion"], ["effect", "myocardial ischemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["treatment", "ranolazine"], ["treatment", "drug interaction with clarithromycin"], ["drug", "clarithromycin"], ["drug", "ranolazine"], ["combination drug", "clarithromycin"], ["combination drug", "ranolazine"], ["effect", "debilitating neurological adverse effect"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "intra - articular hyaluronate injection"], ["drug", "hyaluronate"], ["route", "intra - articular injection"], ["effect", "Septic knee arthritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "concomitant use , however , of colchicine and statin"], ["drug", "colchicine"], ["drug", "statin"], ["combination drug", "colchicine"], ["combination drug", "statin"], ["effect", "muscle weakness"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["subject", "a patient with propylthiouracil - induced acute hepatic failure"], ["subject disorder", "propylthiouracil - induced acute hepatic failure"], ["subject disorder", "hyperthyroidism"], ["treatment", "amiodarone"], ["drug", "amiodarone"], ["treatment disorder", "hyperthyroidism"], ["effect", "acute hepatic failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Olanzapine"], ["drug", "Olanzapine"], ["effect", "parkinsonism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "experienced", "type": "adverse event", "roles": [["subject", "an 11 - year old male with Budd - Chiari syndrome"], ["age", "11 - year old"], ["gender", "male"], ["subject disorder", "Budd - Chiari syndrome"], ["treatment", "immunosuppressive therapy was changed from tacrolimus to sirolimus"], ["drug", "tacrolimus"], ["drug", "sirolimus"], ["treatment disorder", "Budd - Chiari syndrome"], ["effect", "profound worsening of chronic aphthous ulcers"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "two patients"], ["population", "two"], ["treatment", "taking riluzole at the recommended dose ( 100 mg daily ) for 7 and 4 weeks , respectively"], ["drug", "riluzole"], ["dosage", "100 mg"], ["frequency", "daily"], ["duration", "7 and 4 weeks"], ["time elapsed", "7 and 4 weeks"], ["effect", "acute hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resulting", "type": "adverse event", "roles": [["treatment", "interaction between levodopa and enteral nutrition"], ["drug", "levodopa"], ["route", "enteral nutrition"], ["effect", "neuroleptic malignant - like syndrome and prolonged ICU stay"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "interaction", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "tolterodine therapy"], ["treatment", "maintained on warfarin therapy"], ["drug", "tolterodine"], ["drug", "warfarin"], ["combination drug", "tolterodine"], ["combination drug", "warfarin"], ["effect", "drug interaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "potential therapeutic event", "roles": [["subject", "patient"], ["treatment", "clemastine"], ["drug", "clemastine"], ["treatment disorder", "The itch spread to the arms , abdomen and legs"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "causing", "type": "adverse event", "roles": [["subject", "a 36 - year - old woman"], ["age", "36 - year - old"], ["gender", "woman"], ["treatment", "erythromycin and ergotamine at normal doses"], ["drug", "erythromycin"], ["drug", "ergotamine"], ["dosage", "normal doses"], ["combination drug", "erythromycin"], ["combination drug", "ergotamine"], ["effect", "lower extremity ischemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occur", "type": "adverse event", "roles": [["treatment", "phenothiazines and clozapine"], ["drug", "phenothiazines"], ["drug", "clozapine"], ["combination drug", "phenothiazines"], ["combination drug", "clozapine"], ["effect", "Neutropenia and agranulocytosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "admission", "type": "potential therapeutic event", "roles": [["subject", "She"], ["gender", "She"], ["subject disorder", "acid - fast bacilli"], ["treatment", "rifampin"], ["drug", "rifampin"], ["treatment disorder", "acid - fast bacilli"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "pathogenesis", "type": "adverse event", "roles": [["treatment", "CCNU"], ["drug", "CCNU"], ["effect", "pulmonary fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "taking", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "raloxifene"], ["drug", "raloxifene"], ["effect", "Malignant mixed mullerian tumor of the uterus"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "quetiapine"], ["drug", "quetiapine"], ["effect", "Fatal overdoses"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Gemcitabine"], ["drug", "Gemcitabine"], ["effect", "rectus abdominus radiation recall"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "presented", "type": "adverse event", "roles": [["subject", "a severely depressed 55 - year - old woman"], ["age", "55 - year - old"], ["gender", "woman"], ["subject disorder", "severely depressed"], ["treatment", "combination treatment with antidepressants , atypical antipsychotic drugs , the mood stabilizer lithium and the lipid - lowering drug pravastatin"], ["drug", "lithium"], ["drug", "pravastatin"], ["treatment disorder", "severely depressed"], ["combination drug", "lithium"], ["combination drug", "atypical antipsychotic drugs , the mood stabilizer lithium"], ["combination drug", "pravastatin"], ["effect", "erythematous pigmented skin rash on the whole body"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a 20 - year - old woman with Basedow - Graves ' disease"], ["age", "20 - year - old"], ["gender", "woman"], ["subject disorder", "Basedow - Graves ' disease"], ["treatment", "PTU"], ["drug", "PTU"], ["treatment disorder", "Basedow - Graves ' disease"], ["effect", "fulminant hepatitis , which progressed to acute hepatic failure with grade III hepatic encephalopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "reduce", "type": "potential therapeutic event", "roles": [["subject", "children with increased - risk acute lymphoblastic leukemia ( ALL ) or stage III and IV lymphoblastic lymphoma"], ["age", "children"], ["subject disorder", "increased - risk acute lymphoblastic leukemia ( ALL ) or stage III and IV lymphoblastic lymphoma"], ["treatment", "high - dose ( HD ) intravenous ( IV ) cytarabine ( Ara - C ) added to HD IV methotrexate ( MTX )"], ["treatment disorder", "increased - risk acute lymphoblastic leukemia ( ALL )"], ["effect", "CNS and systemic relapses"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occur", "type": "adverse event", "roles": [["treatment", "lithium"], ["drug", "lithium"], ["effect", "neuroleptic malignant extrapyramidal syndrome"], ["effect", "a lithium toxicity that occurs in combination with phenothiazines , primarily thioridazine"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["treatment", "Trans - catheter hepatic arterial injection of lipiodol soluble anti - cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia"], ["drug", "lipiodol"], ["route", "Trans - catheter hepatic arterial injection"], ["treatment disorder", "hepatocellular carcinoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "theophylline"], ["drug", "theophylline"], ["effect", "Gynecomastia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "in", "type": "adverse event", "roles": [["subject", "multiple sclerosis patients"], ["subject disorder", "multiple sclerosis"], ["treatment", "interferon - beta"], ["drug", "interferon - beta"], ["treatment disorder", "multiple sclerosis"], ["effect", "Arthritis and bursitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "diltiazem hydrochloride"], ["drug", "diltiazem hydrochloride"], ["effect", "fever"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "heparin"], ["drug", "heparin"], ["effect", "thrombocytopenia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "potential therapeutic event", "roles": [["subject", "a 41 yr old leprosy patient"], ["age", "41 yr old"], ["subject disorder", "leprosy"], ["treatment", "10 yrs with clofazimine"], ["drug", "clofazimine"], ["treatment disorder", "leprosy"], ["effect", "severe abdominal pain"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "side effect", "type": "adverse event", "roles": [["treatment", "antiemetic treatment with dexamethasone"], ["drug", "dexamethasone"], ["effect", "Osteonecrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "development", "type": "adverse event", "roles": [["subject", "a patient with acute promyleocytic leukemia ( APL )"], ["subject disorder", "acute promyleocytic leukemia"], ["treatment", "within 10 days of treatment with ATRA at a dose of 40 mg orally twice daily"], ["drug", "ATRA"], ["dosage", "40 mg"], ["frequency", "twice daily"], ["duration", "10 days"], ["time elapsed", "10 days"], ["treatment disorder", "acute promyleocytic leukemia"], ["effect", "scrotal ulcer"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "increased", "type": "potential therapeutic event", "roles": [["treatment", "initiation of topical vitamin D3 ointment ( 20 micro g / g of tacalcitol ) 10 g / day"], ["drug", "vitamin D3"], ["dosage", "20 micro g / g"], ["route", "topical"], ["treatment disorder", "skin lesions"], ["effect", "serum level of calcium and urinary excretion of calcium increased gradually"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "Vancomycin"], ["drug", "Vancomycin"], ["effect", "LABD"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "methylprednisolone"], ["drug", "methylprednisolone"], ["effect", "Vision declined"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "showed", "type": "adverse event", "roles": [["subject", "he"], ["gender", "he"], ["treatment", "Eight days after the end of interferon treatment"], ["drug", "interferon"], ["duration", "Eight days"], ["time elapsed", "Eight days"], ["effect", "inability to sit still for ten seconds and walked around constantly"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "infliximab"], ["drug", "infliximab"], ["treatment disorder", "enteropathic spondyloarthropathy"], ["effect", "agranulocytosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Aripiprazole"], ["drug", "Aripiprazole"], ["effect", "hiccups"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "normalized", "type": "potential therapeutic event", "roles": [["treatment", "discontinuation of pegvisomant"], ["drug", "pegvisomant"], ["effect", "hepatic enzyme disturbances normalized"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a 58 - year - old female patient with Graves ' disease"], ["age", "58 - year - old"], ["gender", "female"], ["subject disorder", "Graves ' disease"], ["treatment", "third exposure to methimazole ( MMI )"], ["drug", "methimazole"], ["treatment disorder", "Graves ' disease"], ["effect", "AA"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["effect", "radiation recall in rectus abdominus muscles"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "admitted", "type": "potential therapeutic event", "roles": [["subject", "an 80 - year - old woman"], ["age", "80 - year - old"], ["gender", "woman"], ["subject disorder", "Staphylococcus aureus knee arthritis"], ["treatment", "several intraarticular injections of sodium hyaluronate and corticosteroids"], ["drug", "sodium hyaluronate"], ["drug", "corticosteroids"], ["route", "intraarticular injections"], ["treatment disorder", "Staphylococcus aureus knee arthritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "Association", "type": "adverse event", "roles": [["treatment", "zomepirac administration"], ["drug", "zomepirac"], ["effect", "renal cortical necrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "gold sodium thiomalate"], ["drug", "gold sodium thiomalate"], ["effect", "Vasomotor reactions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["treatment", "Moxifloxacin - acetaminophen - warfarin interaction"], ["drug", "Moxifloxacin"], ["drug", "acetaminophen"], ["drug", "warfarin"], ["treatment disorder", "bladder cancer"], ["combination drug", "Moxifloxacin"], ["combination drug", "acetaminophen"], ["combination drug", "warfarin"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["subject", "four patients"], ["population", "four"], ["subject disorder", "severe hepatic veno - occlusive disease ( HVOD )"], ["treatment", "intensive chemotherapy containing busulfan"], ["drug", "busulfan"], ["route", "chemotherapy"], ["time elapsed", "2 - 45 days"], ["treatment disorder", "severe hepatic veno - occlusive disease ( HVOD )"], ["effect", "thrombosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "An adolescent male"], ["age", "adolescent"], ["gender", "male"], ["treatment", "16 weeks after cessation of intramuscular L - asparaginase"], ["drug", "L - asparaginase"], ["route", "intramuscular"], ["duration", "16 weeks"], ["time elapsed", "16 weeks"], ["effect", "acute pancreatitis and pseudocyst of the pancreas"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "potentiator", "type": "potential therapeutic event", "roles": [["subject", "patients with cystic fibrosis and the G551D mutation"], ["subject disorder", "cystic fibrosis"], ["subject disorder", "G551D mutation"], ["treatment", "A CFTR potentiator"], ["drug", "CFTR"], ["treatment disorder", "cystic fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "lead", "type": "adverse event", "roles": [["treatment", "Quinapril"], ["drug", "Quinapril"], ["effect", "prolonged hypotension and , less frequently , transient renal impairment"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developing", "type": "adverse event", "roles": [["subject", "a renal transplant recipient"], ["subject disorder", "renal transplant"], ["treatment", "maintained on cyclosporine and prednisone"], ["drug", "cyclosporine"], ["drug", "prednisone"], ["treatment disorder", "renal transplant"], ["combination drug", "cyclosporine"], ["combination drug", "prednisone"], ["effect", "Nocardia Asteroides brain abscess"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "control", "type": "potential therapeutic event", "roles": [["subject", "a patient with PTU - induced fulminant hepatitis"], ["subject disorder", "hyperthyroidism"], ["subject disorder", "fulminant hepatitis"], ["treatment", "amiodarone"], ["drug", "amiodarone"], ["treatment disorder", "hyperthyroidism"], ["treatment disorder", "fulminant hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "patient 's mother"], ["gender", "mother"], ["treatment", "metamizole"], ["drug", "metamizole"], ["effect", "overwhelming sepsis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "infection", "type": "adverse event", "roles": [["subject", "a patient with a long - standing history of refractory CLL"], ["subject disorder", "refractory CLL"], ["treatment", "fludarabine phosphate"], ["drug", "fludarabine phosphate"], ["treatment disorder", "refractory CLL"], ["effect", "respiratory syncytial virus ( RSV ) infection"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "presented", "type": "adverse event", "roles": [["subject", "A 77 - year - old woman with no history of epilepsy"], ["age", "77 - year - old"], ["gender", "woman"], ["subject disorder", "back pain relating to vertebral metastasis of a malignant lymphoma"], ["treatment", "receiving continuous intravenous morphine"], ["drug", "morphine"], ["route", "intravenous"], ["treatment disorder", "back pain relating to vertebral metastasis of a malignant lymphoma"], ["effect", "nonconvulsive status epilepticus"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "Oral corticosteroids ( OCS )"], ["drug", "Oral corticosteroids"], ["effect", "systemic adverse events ( AEs )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "Development", "type": "adverse event", "roles": [["treatment", "long - term colchicine treatment"], ["drug", "colchicine"], ["effect", "Peyronie 's disease"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "5 - FU"], ["drug", "5 - FU"], ["effect", "neurologic symptoms such as encephalopathy and coma"]]}, {"trigger": "reverse", "type": "potential therapeutic event", "roles": [["subject", "DPD - deficient patients with severe acute 5 - FU reactions"], ["subject disorder", "DPD - deficient"], ["subject disorder", "severe acute 5 - FU reactions"], ["treatment", "the administration of thymidine"], ["drug", "thymidine"], ["treatment disorder", "severe acute 5 - FU reactions"], ["effect", "neurologic symptoms such as encephalopathy and coma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a patient"], ["subject disorder", "asthma"], ["treatment", "aspirin"], ["treatment", "zafirlukast"], ["drug", "aspirin"], ["effect", "asthma"]]}, {"trigger": "treated", "type": "potential therapeutic event", "roles": [["treatment", "zafirlukast"], ["drug", "zafirlukast"], ["treatment disorder", "asthma"], ["effect", "Adverse reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a patient"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "therapy with gold"], ["drug", "gold"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "nephrotic syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complications", "type": "adverse event", "roles": [["treatment", "nonsteroidal anti - inflammatory agents"], ["drug", "zomepirac"], ["effect", "renal complications"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resolved", "type": "potential therapeutic event", "roles": [["treatment", "discontinuation of metronidazole"], ["drug", "metronidazole"], ["effect", "Clinical , spectroscopic , and imaging abnormalities resolved"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "started", "type": "potential therapeutic event", "roles": [["subject", "two other patients ( one after OLTX and one with Crohn 's disease )"], ["population", "two"], ["subject disorder", "Crohn 's disease"], ["subject disorder", "HIV"], ["treatment", "a raltegravir - based HIV therapy"], ["treatment", "1 or 2 mg of tacrolimus twice daily"], ["drug", "raltegravir"], ["dosage", "1 or 2 mg"], ["frequency", "twice daily"], ["treatment disorder", "HIV"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["treatment", "interferon alpha"], ["drug", "interferon alpha"], ["effect", "Reversible cardiomyopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "Metipranolol"], ["drug", "Metipranolol"], ["effect", "granulomatous anterior uveitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "increase", "type": "adverse event", "roles": [["treatment", "tifacogin"], ["drug", "tifacogin"], ["effect", "bleeding"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "timolol"], ["drug", "timolol"], ["effect", "ocular pemphigoid"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "A 70 - year - old man"], ["age", "70 - year - old"], ["gender", "man"], ["subject disorder", "itching"], ["treatment", "antihistaminic agent ( homochlorcyclizine hydrochloride )"], ["drug", "homochlorcyclizine hydrochloride"], ["treatment disorder", "itching"], ["effect", "dyspnea"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "withdrawal", "type": "adverse event", "roles": [["treatment", "Methadone"], ["treatment", "starting an antiretroviral regimen including nevirapine"], ["drug", "Methadone"], ["drug", "nevirapine"], ["combination drug", "Methadone"], ["combination drug", "nevirapine"], ["effect", "Methadone withdrawal"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["treatment", "zonisamide"], ["drug", "zonisamide"], ["effect", "oligohidrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["treatment disorder", "lung and breast cancer"], ["effect", "Radiation recall"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "risk", "type": "adverse event", "roles": [["treatment", "clozapine"], ["drug", "clozapine"], ["effect", "neutropenia and agranulocytosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["treatment", "Vicriviroc ( SCH 417690 )"], ["drug", "Vicriviroc"], ["treatment disorder", "human immunodeficiency virus infection"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "development", "type": "adverse event", "roles": [["subject", "Children"], ["age", "Children"], ["treatment", "zonisamide"], ["drug", "zonisamide"], ["effect", "neurological symptoms associated with an elevation of body temperature"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "experienced", "type": "adverse event", "roles": [["subject", "2 male patients"], ["gender", "male"], ["population", "2"], ["treatment", "venlafaxine"], ["drug", "venlafaxine"], ["effect", "incontinence"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "treatment with ethambutol and rifampicin"], ["drug", "ethambutol"], ["drug", "rifampicin"], ["combination drug", "ethambutol"], ["combination drug", "rifampicin"], ["effect", "Polyarthritis , hepatitis and anti - native DNA antibodies"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "an HIV - infected woman"], ["gender", "woman"], ["subject disorder", "HIV"], ["treatment", "nevirapine"], ["drug", "nevirapine"], ["treatment disorder", "HIV"], ["effect", "mild leukopenia"], ["effect", "skin and hepatic toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["subject", "a geriatric patient"], ["age", "geriatric"], ["treatment", "3 days after treatment with olanzapine"], ["drug", "olanzapine"], ["duration", "3 days"], ["time elapsed", "3 days"], ["effect", "rapidly occurring hyperglycemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "Tifacogin administration"], ["drug", "Tifacogin"], ["effect", "increase in risk of bleeding"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "two epileptic patients"], ["population", "two"], ["subject disorder", "epileptic"], ["treatment", "addition of oral fluoresone 750 mg daily to the phenobarbital and phenytoin"], ["drug", "fluoresone"], ["drug", "phenobarbital"], ["drug", "phenytoin"], ["frequency", "daily"], ["route", "oral"], ["treatment disorder", "epileptic"], ["combination drug", "fluoresone"], ["combination drug", "phenobarbital"], ["combination drug", "phenytoin"], ["effect", "Gynecomastia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "development", "type": "adverse event", "roles": [["treatment", "combined lithium and haloperidol"], ["drug", "lithium"], ["drug", "haloperidol"], ["combination drug", "lithium"], ["combination drug", "haloperidol"], ["effect", "hyperpyrexia , severe rigidity , mutism , and development of irreversible tardive dyskinesia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["treatment", "clozapine"], ["drug", "clozapine"], ["effect", "agranulocytosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "reported", "type": "adverse event", "roles": [["subject", "three women and one man"], ["gender", "women"], ["population", "three"], ["treatment", "intravenous L - asparaginase"], ["drug", "L - asparaginase"], ["route", "intravenous"], ["effect", "pseudocyst of the pancreas"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "Ritalin"], ["drug", "Ritalin"], ["effect", "cataract and glaucoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "short - term therapy with Amikacin"], ["drug", "Amikacin"], ["effect", "renal tubular dysfunction"], ["effect", "refractory hypokalemia , hypocalcemia , hypomagnesemia , metabolic alkalosis , and polyuria"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["treatment", "BCNU"], ["drug", "BCNU"], ["effect", "Cardiac toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "chemotherapy"], ["treatment", "when added to conventional therapy with a corticosteroid and a 5 - hydroxytryptamine(3 ) ( 5 - HT(3 ) antagonist"], ["drug", "a corticosteroid"], ["drug", "5 - hydroxytryptamine(3 ) ( 5 - HT(3 ) antagonist"], ["combination drug", "a corticosteroid"], ["combination drug", "5 - hydroxytryptamine(3 )"], ["effect", "nausea and vomiting"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "tacrolimus"], ["drug", "tacrolimus"], ["effect", "HUS"], ["effect", "ARF"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "receiving", "type": "adverse event", "roles": [["subject", "patients"], ["treatment", "pentamidine"], ["drug", "pentamidine"], ["effect", "cardiotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "vitamin D3 ointment and thiazide simultaneously"], ["drug", "vitamin D3"], ["drug", "thiazide"], ["route", "ointment"], ["combination drug", "vitamin D3"], ["combination drug", "thiazide"], ["effect", "hypercalcemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "adverse event", "type": "adverse event", "roles": [["subject", "patients with rheumatoid arthritis"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "leflunomide"], ["drug", "leflunomide"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "Significant weight loss"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "a man with classic rheumatoid arthritis"], ["gender", "man"], ["subject disorder", "classic rheumatoid arthritis"], ["treatment", "gold or penicillamine therapy"], ["drug", "gold"], ["treatment disorder", "classic rheumatoid arthritis"], ["effect", "membranous nephropathy associated with nephrotic syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "potential therapeutic event", "roles": [["subject", "HIV - infected patients"], ["subject disorder", "HIV"], ["subject disorder", "tuberculosis"], ["treatment", "concomitantly treated with rifampin for tuberculosis"], ["drug", "etravirine"], ["drug", "rifampin"], ["treatment disorder", "tuberculosis"], ["combination drug", "etravirine"], ["combination drug", "rifampin"], ["treatment disorder", "tuberculosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "development", "type": "adverse event", "roles": [["treatment", "an excessive dose of AZ"], ["drug", "AZ"], ["dosage", "excessive dose"], ["treatment disorder", "bone marrow disorder"], ["effect", "hemorrhagic gastritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Acyclovir"], ["drug", "Acyclovir"], ["effect", "neurotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "a patient with rheumatoid arthritis"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "sulphasalazine therapy"], ["drug", "sulphasalazine"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "Psoriasis - like skin reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "diagnosed", "type": "adverse event", "roles": [["subject", "2 patients with Crohn 's disease ( CD )"], ["population", "2"], ["subject disorder", "Crohn 's disease"], ["treatment", "infliximab"], ["drug", "infliximab"], ["treatment disorder", "Crohn 's disease"], ["effect", "lymphoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "used", "type": "potential therapeutic event", "roles": [["treatment", "Valproic acid"], ["drug", "Valproic acid"], ["treatment disorder", "idiopathic generalized epilepsies , including juvenile absence epilepsy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "manifesting", "type": "adverse event", "roles": [["treatment", "intrathecal methotrexate"], ["drug", "methotrexate"], ["route", "intrathecal"], ["effect", "neurotoxicity manifesting as left arm weakness and aphasia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "relationship", "type": "adverse event", "roles": [["treatment", "warfarin - cloxacillin interaction"], ["drug", "warfarin"], ["drug", "cloxacillin"], ["combination drug", "warfarin"], ["combination drug", "cloxacillin"], ["effect", "increased INR value"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "two female patients diagnosed with relapsing - remitting multiple sclerosis ( RRMS )"], ["gender", "female"], ["population", "two"], ["subject disorder", "relapsing - remitting multiple sclerosis"], ["treatment", "IFN - beta therapy"], ["drug", "IFN - beta"], ["treatment disorder", "relapsing - remitting multiple sclerosis"], ["effect", "inflammatory musculoskeletal manifestations"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "brain - damaged children"], ["age", "children"], ["subject disorder", "brain - damaged"], ["treatment", "carbamazepine administration"], ["drug", "carbamazepine"], ["treatment disorder", "brain - damaged"], ["effect", "Dystonia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "had", "type": "adverse event", "roles": [["subject", "51 patients"], ["population", "51"], ["treatment", "omeprazole"], ["drug", "omeprazole"], ["effect", "gastrointestinal event"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "secondary", "type": "adverse event", "roles": [["treatment", "pamidronate"], ["drug", "pamidronate"], ["treatment disorder", "acute vitamin D poisoning"], ["effect", "hypercalcemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "in", "type": "potential therapeutic event", "roles": [["treatment", "Clopidogrel with or without omeprazole"], ["drug", "Clopidogrel"], ["drug", "omeprazole"], ["treatment disorder", "coronary artery disease"], ["combination drug", "Clopidogrel"], ["combination drug", "omeprazole"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "contribute", "type": "adverse event", "roles": [["subject", "elderly patients"], ["age", "elderly"], ["subject disorder", "dementia"], ["treatment", "risperidone"], ["drug", "risperidone"], ["effect", "dystonia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["treatment", "ciprofloxacin"], ["drug", "ciprofloxacin"], ["effect", "prolonged ECT seizure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resolved", "type": "potential therapeutic event", "roles": [["subject", "his"], ["gender", "his"], ["subject disorder", "delirium"], ["treatment", "abstinence from oolong tea"], ["drug", "oolong tea"], ["treatment disorder", "delirium"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "to", "type": "adverse event", "roles": [["treatment", "intrathecal diamorphine"], ["drug", "diamorphine"], ["route", "intrathecal"], ["effect", "Anaphylaxis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "result", "type": "adverse event", "roles": [["treatment", "acyclovir when given intravenously in doses of 10 mg / kg"], ["drug", "acyclovir"], ["dosage", "10 mg / kg"], ["route", "intravenously"], ["effect", "increased serum lithium concentrations"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "he"], ["gender", "he"], ["treatment", "sertraline treatment"], ["drug", "sertraline"], ["duration", "two weeks"], ["time elapsed", "two weeks"], ["effect", "intense itching sensation in his scalp"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "side effects", "type": "adverse event", "roles": [["treatment", "cytostatic chemotherapeutic agents"], ["drug", "cytostatic chemotherapeutic agents"], ["effect", "Pigmentary aberrations"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "causing", "type": "adverse event", "roles": [["treatment", "Atovaquone"], ["drug", "Atovaquone"], ["effect", "vortex keratopathy involving the corneal epithelium"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["treatment", "a few minutes after injection of the morphine antagonist naloxone"], ["drug", "morphine"], ["drug", "naloxone"], ["route", "injection"], ["time elapsed", "a few minutes"], ["effect", "generalized tonic - clonic seizure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "consequence", "type": "adverse event", "roles": [["treatment", "progestin therapy"], ["drug", "progestin"], ["effect", "Squamous metaplasia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "adverse event", "roles": [["treatment", "vasopressin"], ["drug", "vasopressin"], ["effect", "gastrointestinal hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "regressed", "type": "potential therapeutic event", "roles": [["treatment", "theophylline"], ["drug", "theophylline"], ["treatment disorder", "gynecomastia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["subject", "this patient"], ["treatment", "erroneous intake of 1 g doxycycline"], ["drug", "doxycycline"], ["dosage", "1 g"], ["effect", "Renal hypophosphatemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "the patient"], ["subject disorder", "meningeal tumor"], ["treatment", "in the third week of MTX treatment"], ["drug", "MTX"], ["duration", "third week"], ["time elapsed", "third week"], ["treatment disorder", "meningeal tumor"], ["effect", "progressive visual loss and loss of consciousness"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a nine - year - old boy"], ["age", "nine - year - old"], ["gender", "boy"], ["subject disorder", "suspected tuberculosis"], ["treatment", "seven months ' continuous treatment for suspected tuberculosis with rifampicin and ethambutol"], ["drug", "rifampicin"], ["drug", "ethambutol"], ["duration", "seven months"], ["time elapsed", "seven months"], ["treatment disorder", "suspected tuberculosis"], ["combination drug", "rifampicin"], ["combination drug", "ethambutol"], ["effect", "polyarthritis , rash and hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "statin treatment"], ["drug", "statin"], ["effect", "myasthenic syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "safe and effective", "type": "potential therapeutic event", "roles": [["treatment", "Topical imiquimod and tumor necrosis factor ( TNF) - alpha inhibitors"], ["drug", "imiquimod"], ["route", "Topical"], ["treatment disorder", "non - melanoma skin cancer ( NMSC )"], ["treatment disorder", "moderate to severe psoriasis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "zomepirac"], ["drug", "zomepirac"], ["effect", "Focal renal cortical necrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "2 cases"], ["population", "2"], ["subject disorder", "dermatologic problems"], ["treatment", "mequitazine"], ["drug", "mequitazine"], ["treatment disorder", "dermatologic problems"], ["effect", "photosensitivity reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "episodes", "type": "adverse event", "roles": [["treatment", "Carboplatin"], ["treatment", "cisplatin"], ["drug", "Carboplatin"], ["drug", "cisplatin"], ["effect", "SIADH"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "intravitreal injection of triamcinolone acetonide"], ["drug", "triamcinolone acetonide"], ["route", "intravitreal injection"], ["effect", "glaucoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "progression", "type": "adverse event", "roles": [["treatment", "rituximab"], ["drug", "rituximab"], ["treatment disorder", "CD20 - negative T - cell - rich B - cell lymphoma"], ["treatment disorder", "nodular lymphocyte - predominant Hodgkin 's lymphoma"], ["effect", "CD20 - negative T - cell - rich B - cell lymphoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "presented", "type": "adverse event", "roles": [["subject", "an adult patient with acute lymphoblastic leukemia"], ["age", "adult"], ["subject disorder", "acute lymphoblastic leukemia"], ["treatment", "consolidation treatment with L - asparaginase"], ["drug", "L - asparaginase"], ["treatment disorder", "acute lymphoblastic leukemia"], ["effect", "repeated transient ischemic attacks followed by a seizure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["subject", "a patient with pancreatic cancer"], ["subject disorder", "pancreatic cancer"], ["treatment", "Gemcitabine"], ["drug", "Gemcitabine"], ["treatment disorder", "pancreatic cancer"], ["effect", "radiation recall"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "continued", "type": "potential therapeutic event", "roles": [["treatment", "CBZ"], ["drug", "CBZ"], ["treatment disorder", "development of the tics"], ["effect", "the tics abated and then ceased spontaneously <unk> or = 6 months"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurring", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "olanzapine"], ["drug", "olanzapine"], ["effect", "neutropenia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "3 AS patients"], ["population", "3"], ["subject disorder", "active AS"], ["treatment", "etanercept"], ["drug", "etanercept"], ["treatment disorder", "active AS"], ["effect", "CD"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["treatment", "chemotherapy"], ["drug", "oxaliplatinum"], ["drug", "5 - fluorouracil"], ["route", "chemotherapy"], ["combination drug", "5 - fluorouracil"], ["combination drug", "oxaliplatinum"], ["effect", "pulmonary adverse reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "colchicine"], ["drug", "colchicine"], ["effect", "rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "responded", "type": "potential therapeutic event", "roles": [["treatment", "atropine"], ["drug", "atropine"], ["treatment disorder", "a recurrence of paroxysmal atrial fibrillation"], ["effect", "AVT with syncope"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "emerged", "type": "adverse event", "roles": [["subject", "Three male patients aged 78 - 83 years"], ["age", "78 - 83 years"], ["gender", "male"], ["population", "Three"], ["treatment", "CPA administration"], ["drug", "CPA"], ["effect", "severe hepatotoxic reactions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["treatment", "the administration of the antitumor antibiotics actinomycin - D ( NSC - 3053 ) and mithramycin ( NSC - 24559 )"], ["drug", "actinomycin - D"], ["drug", "mithramycin"], ["effect", "Exacerbations of the heart failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "a patient with rheumatoid arthritis"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "leflunomide therapy"], ["drug", "leflunomide"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "Diffuse alveolar hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["subject", "a 64 - year - old man with secondary adrenocortical insufficiency"], ["age", "64 - year - old"], ["gender", "man"], ["subject disorder", "secondary adrenocortical insufficiency"], ["subject disorder", "sciatic pain syndrome"], ["treatment", "chronic transdermal fentanyl treatment"], ["drug", "fentanyl"], ["route", "transdermal"], ["treatment disorder", "secondary adrenocortical insufficiency"], ["treatment disorder", "sciatic pain syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 52 - year - old , white female"], ["age", "52 - year - old"], ["gender", "female"], ["race", "white"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "8 weeks treatment with sodium aurothiomalate"], ["drug", "sodium aurothiomalate"], ["duration", "8 weeks"], ["time elapsed", "8 weeks"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "low - grade fever , cough , and dyspnea"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["treatment", "3 weeks after initiating treatment with SASP"], ["drug", "SASP"], ["duration", "3 weeks"], ["time elapsed", "3 weeks"], ["effect", "high fever , skin rash , liver dysfunction and atypical lymphocytosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "toxicity", "type": "adverse event", "roles": [["treatment", "chloroquine"], ["treatment", "high - grade chloroquine - resistant Plasmodium vivax"], ["drug", "chloroquine"], ["drug", "Plasmodium vivax"], ["combination drug", "chloroquine"], ["combination drug", "Plasmodium vivax"], ["effect", "severe chloroquine toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "All cases"], ["population", "All"], ["treatment", "previous use of rifabutin"], ["drug", "rifabutin"], ["effect", "corneal endothelial deposits"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "Two infants"], ["age", "infants"], ["population", "Two"], ["subject disorder", "infantile spasms"], ["treatment", "cessation of prolonged ACTH therapy"], ["drug", "ACTH"], ["treatment disorder", "infantile spasms"], ["effect", "hyperkalemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "cyclosporine"], ["drug", "cyclosporine"], ["effect", "CIPS"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "intravitreal triamcinolone acetonide injection"], ["drug", "triamcinolone acetonide"], ["route", "intravitreal"], ["route", "injection"], ["effect", "Acute syphilitic posterior placoid chorioretinitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complication", "type": "adverse event", "roles": [["treatment", "intramuscular L - asparaginase"], ["drug", "L - asparaginase"], ["route", "intramuscular"], ["effect", "Delayed pseudocyst of the pancreas"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "experienced", "type": "adverse event", "roles": [["subject", "a 35 - year - old woman with occult coronary artery disease"], ["age", "35 - year - old"], ["gender", "woman"], ["subject disorder", "occult coronary artery disease"], ["subject disorder", "migraine"], ["treatment", "receiving a first - time dose of subcutaneous sumatriptan"], ["drug", "sumatriptan"], ["route", "subcutaneous"], ["treatment disorder", "migraine"], ["effect", "cardiac arrest"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["treatment", "Epoprostenol ( prostacyclin )"], ["drug", "Epoprostenol"], ["treatment disorder", "primary pulmonary hypertension"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "adverse event", "roles": [["subject", "a man"], ["gender", "man"], ["subject disorder", "epididymitis"], ["treatment", "oral ofloxacin"], ["drug", "ofloxacin"], ["route", "oral"], ["treatment disorder", "epididymitis"], ["effect", "toxic epidermal necrolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "late - onset heparin"], ["drug", "heparin"], ["effect", "Massive pulmonary embolism"], ["effect", "thrombocytopenia"]]}, {"trigger": "treatment", "type": "potential therapeutic event", "roles": [["treatment", "lepirudin"], ["drug", "lepirudin"], ["treatment disorder", "coronary artery bypass graft surgery"], ["effect", "Massive pulmonary embolism"], ["effect", "thrombocytopenia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "Value", "type": "potential therapeutic event", "roles": [["subject", "increased - risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma"], ["age", "children"], ["subject disorder", "acute lymphoblastic leukemia"], ["subject disorder", "lymphoblastic lymphoma"], ["treatment", "high - dose cytarabine during interval therapy of a Berlin - Frankfurt - Munster - based protocol"], ["drug", "cytarabine"], ["dosage", "high - dose"], ["treatment disorder", "acute lymphoblastic leukemia"], ["treatment disorder", "lymphoblastic lymphoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "didanosine and masquerading as a surgical abdomen"], ["drug", "didanosine"], ["effect", "fulminant hepatic failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["treatment", "an amiodarone - simvastatin interaction"], ["drug", "amiodarone"], ["drug", "simvastatin"], ["combination drug", "amiodarone"], ["combination drug", "simvastatin"], ["effect", "rhabdomyolysis , renal failure , and possibly hepatotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "from", "type": "adverse event", "roles": [["treatment", "hydroquinone cream"], ["drug", "hydroquinone"], ["route", "cream"], ["effect", "Nail staining"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "development", "type": "adverse event", "roles": [["subject", "an epilepsy patient"], ["subject disorder", "epilepsy"], ["treatment", "diphenylhydantoin ( DILANTIN ) therapy for 20 years"], ["drug", "diphenylhydantoin"], ["duration", "20 years"], ["time elapsed", "20 years"], ["treatment disorder", "epilepsy"], ["effect", "IgG lambda - type monoclonal gammopathy and subsequent multiple myeloma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "characterized", "type": "adverse event", "roles": [["treatment", "Ibuprofen overdose"], ["drug", "Ibuprofen"], ["dosage", "overdose"], ["effect", "GI upset , dizziness , and mild sedation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "administered", "type": "potential therapeutic event", "roles": [["treatment", "PD medications ( pramipexole , entacapone , and immediate - release levodopa / carbidopa 100 mg/25 mg , 1.5 tablets 4 times daily )"], ["drug", "pramipexole"], ["drug", "entacapone"], ["drug", "levodopa"], ["drug", "carbidopa"], ["dosage", "100 mg/25 mg"], ["frequency", "4 times daily"], ["treatment disorder", "PD"], ["combination drug", "pramipexole"], ["combination drug", "entacapone"], ["combination drug", "levodopa"], ["combination drug", "carbidopa"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["treatment", "propafenone"], ["treatment", "interaction between propafenone and citalopram"], ["drug", "propafenone"], ["drug", "citalopram"], ["combination drug", "propafenone"], ["combination drug", "citalopram"], ["effect", "propafenone adverse effects ( eg , dizziness , falls ) and mimicked coronary artery disease"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "presented", "type": "adverse event", "roles": [["subject", "a young healthy woman"], ["age", "young"], ["gender", "woman"], ["subject disorder", "thromboembolic episode"], ["treatment", "acenocoumarol"], ["drug", "acenocoumarol"], ["treatment disorder", "thromboembolic episode"], ["effect", "early overanticoagulation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "A patient"], ["treatment", "parenteral amiodarone administration"], ["drug", "amiodarone"], ["route", "parenteral"], ["effect", "acute changes suggesting acute hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "he"], ["gender", "he"], ["treatment", "olanzapine was stopped and recurred ( fasting blood glucose 150 mg / dL ) after 2 days of rechallenge with olanzapine 2.5 mg twice daily"], ["drug", "olanzapine"], ["dosage", "2.5 mg"], ["frequency", "twice daily"], ["effect", "hyperglycemia ( fasting blood glucose 138 mg / dL )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "on", "type": "adverse event", "roles": [["subject", "HIV - infected patients"], ["subject disorder", "HIV"], ["treatment", "didanosine therapy"], ["drug", "didanosine"], ["treatment disorder", "HIV"], ["effect", "Fulminant hepatitis with severe lactate acidosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "intravitreal ranibizumab"], ["drug", "ranibizumab"], ["route", "intravitreal"], ["effect", "Persisent ocular hypertension"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["subject", "a 31 - year - old woman"], ["age", "31 - year - old"], ["gender", "woman"], ["treatment", "intrathecal administration of doxorubicin"], ["drug", "doxorubicin"], ["route", "intrathecal"], ["effect", "toxic myelopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "potential therapeutic event", "roles": [["subject", "The patient had a background of obsessive compulsive disorder"], ["subject disorder", "obsessive compulsive disorder"], ["treatment", "paroxetine"], ["drug", "paroxetine"], ["treatment disorder", "obsessive compulsive disorder"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["subject", "patients with defective calcium - activated K+ channels"], ["subject disorder", "defective calcium - activated K+ channels"], ["treatment", "Clozapine"], ["drug", "Clozapine"], ["treatment disorder", "defective calcium - activated K+ channels"], ["effect", "rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["effect", "LABD"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "two cases"], ["population", "two"], ["treatment", "Nitrofurantoin"], ["drug", "Nitrofurantoin"], ["effect", "lung disease"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Trazodone"], ["drug", "Trazodone"], ["effect", "transient hypomanic symptoms"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "continuous intravesical alum irrigation"], ["drug", "alum"], ["route", "irrigation"], ["treatment disorder", "hemorrhagic cystitis"], ["effect", "Acute aluminum toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Amphotericin B"], ["drug", "Amphotericin B"], ["effect", "cutaneous leucocytoclastic vasculitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "increased", "type": "adverse event", "roles": [["treatment", "acyclovir therapy"], ["drug", "acyclovir"], ["effect", "lithium level had increased 4 - fold"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "interaction", "type": "potential therapeutic event", "roles": [["subject", "a kidney transplanted woman , suffering from pulmonary infection sustained by a bacterial pathogen , in particular Hemophilus Influenzae"], ["gender", "woman"], ["subject disorder", "kidney transplanted"], ["subject disorder", "pulmonary infection"], ["treatment", "clarithromycin and sirolimus"], ["drug", "clarithromycin"], ["drug", "sirolimus"], ["treatment disorder", "pulmonary infection"], ["combination drug", "clarithromycin"], ["combination drug", "sirolimus"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "A 25 - year - old man with a history of mid - borderline ( BB ) Hansen 's disease"], ["age", "25 - year - old"], ["gender", "man"], ["subject disorder", "mid - borderline ( BB ) Hansen 's disease"], ["treatment", "starting dapsone and rifampin therapy"], ["drug", "dapsone"], ["drug", "rifampin"], ["treatment disorder", "mid - borderline ( BB ) Hansen 's disease"], ["combination drug", "dapsone"], ["combination drug", "rifampin"], ["effect", "reversal reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "quetiapine overdose"], ["drug", "quetiapine"], ["dosage", "overdose"], ["effect", "death"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induce", "type": "adverse event", "roles": [["treatment", "antiepileptic drugs"], ["drug", "antiepileptic"], ["effect", "seizure types or exacerbate existing ones"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a pregnant patient with myotonic dystrophy"], ["subject disorder", "myotonic dystrophy"], ["treatment", "ritodrine - hydrochloride"], ["drug", "ritodrine - hydrochloride"], ["treatment disorder", "myotonic dystrophy"], ["effect", "rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurring", "type": "adverse event", "roles": [["treatment", "progestin therapy of hyperplasia"], ["drug", "progestin"], ["treatment disorder", "hyperplasia"], ["effect", "squamous metaplasia within endometrial glands"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "experienced", "type": "adverse event", "roles": [["subject", "DPD - deficient patients with cancer"], ["subject disorder", "DPD - deficient"], ["subject disorder", "cancer"], ["treatment", "5 - FU therapy"], ["drug", "5 - FU"], ["treatment disorder", "cancer"], ["effect", "potentially lethal risks , and traumatic psychosocial stresses"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["treatment", "Methotrexate"], ["drug", "Methotrexate"], ["treatment disorder", "psoriasis"], ["effect", "toxic"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["treatment", "11 , 12 , and 26 months after start of etanercept therapy"], ["drug", "etanercept"], ["duration", "11 , 12 , and 26 months"], ["time elapsed", "11 , 12 , and 26 months"], ["treatment disorder", "active CD"], ["effect", "Typical symptoms of active CD"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "he"], ["gender", "he"], ["subject disorder", "neck pain"], ["treatment", "aspirin"], ["drug", "aspirin"], ["treatment disorder", "neck pain"], ["effect", "tracheal compression with stridor"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "use of clindamycin phosphate vaginal cream"], ["drug", "clindamycin phosphate"], ["route", "vaginal cream"], ["effect", "colitis ( CDIC )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "vancomycin"], ["drug", "vancomycin"], ["effect", "anaphylactic reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "received", "type": "potential therapeutic event", "roles": [["subject", "a 74 - year - old female patient"], ["age", "74 - year - old"], ["gender", "female"], ["subject disorder", "depression"], ["treatment", "amitriptyline"], ["drug", "amitriptyline"], ["treatment disorder", "depression"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complication", "type": "adverse event", "roles": [["treatment", "tocolytic therapy with ritodrine hydrochloride"], ["drug", "ritodrine hydrochloride"], ["effect", "Rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "Voriconazole ( VRC )"], ["drug", "Voriconazole"], ["effect", "angio - oedema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "Tamoxifen"], ["drug", "Tamoxifen"], ["effect", "malignant transformation of endometriosis through atypical endometriosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "potential therapeutic event", "roles": [["subject", "One patient"], ["population", "One"], ["subject disorder", "prostatitis"], ["treatment", "levofloxacin immediately prior to tolterodine initiation"], ["drug", "levofloxacin"], ["treatment disorder", "prostatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "The first patient"], ["population", "The first"], ["treatment", "2 weeks after initiation of IFN - beta"], ["drug", "IFN - beta"], ["duration", "2 weeks"], ["time elapsed", "2 weeks"], ["effect", "monoarthritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "interferon - alpha"], ["drug", "interferon - alpha"], ["effect", "refractory akathisia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "erlotinib"], ["drug", "erlotinib"], ["effect", "Rosaceiform eruption"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "oral - verapamil"], ["treatment", "concomitant beta - adrenergic blockade by the oral route"], ["drug", "verapamil"], ["drug", "beta - adrenergic blockade"], ["route", "oral"], ["combination drug", "beta - adrenergic blockade"], ["combination drug", "verapamil"], ["effect", "hypotension"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "signs", "type": "adverse event", "roles": [["subject", "patients"], ["treatment", "intravenous acyclovir is administered concurrently with lithium"], ["drug", "acyclovir"], ["drug", "lithium"], ["route", "intravenous"], ["combination drug", "acyclovir"], ["combination drug", "lithium"], ["effect", "lithium toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "decrease", "type": "potential therapeutic event", "roles": [["treatment", "HD Ara - C added to HD MTX"], ["drug", "HD Ara - C"], ["drug", "HD MTX"], ["combination drug", "HD Ara - C"], ["combination drug", "HD MTX"], ["effect", "CNS relapse"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "viloxazine"], ["drug", "viloxazine"], ["effect", "Theophylline intoxication"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "impaired", "type": "adverse event", "roles": [["treatment", "25000 microg / l or higher"], ["treatment", "at lower concentrations only zinc"], ["drug", "zinc"], ["dosage", "25000 microg / l"], ["effect", "Cercarial encystment"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "effect", "type": "adverse event", "roles": [["treatment", "brimonidine"], ["drug", "brimonidine"], ["effect", "paradoxical effect"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "a child homozygous for MTHFR C677 T polymorphism"], ["age", "child"], ["subject disorder", "MTHFR C677 T polymorphism"], ["treatment", "high - dose methotrexate"], ["drug", "methotrexate"], ["dosage", "high - dose"], ["treatment disorder", "MTHFR C677 T polymorphism"], ["effect", "Renal failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "present", "type": "adverse event", "roles": [["treatment", "high - dose leucovorin , hemodialysis , charcoal hemoperfusion , and carboxypeptidase G2"], ["drug", "leucovorin"], ["dosage", "high - dose"], ["route", "infusion"], ["effect", "renal function recovered completely"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "develop", "type": "adverse event", "roles": [["subject", "Ten to 15 % of patients"], ["population", "Ten to 15 %"], ["treatment", "ifosfamide"], ["drug", "ifosfamide"], ["effect", "encephalopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["subject", "35 rheumatologists at the Robert Breck Brigham Arthritis Center"], ["population", "35"], ["treatment", "leflunomide between November 1998 and January 2000"], ["drug", "leflunomide"], ["effect", "weight loss"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurring", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "disulfiram treatment"], ["drug", "disulfiram"], ["effect", "catatonic syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "high - flux hemodiafiltration"], ["drug", "high - flux hemodiafiltration"], ["treatment disorder", "vancomycin toxicity"], ["effect", "hypophosphatemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resulted", "type": "adverse event", "roles": [["treatment", "Two weeks following rechallenge with alendronate sodium"], ["drug", "alendronate sodium"], ["duration", "Two weeks"], ["time elapsed", "Two weeks"], ["effect", "recurrence of his scleritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "causing", "type": "adverse event", "roles": [["treatment", "intrathecal diamorphine"], ["drug", "diamorphine"], ["route", "intrathecal"], ["effect", "anaphylaxis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "cerivastatin"], ["drug", "cerivastatin"], ["effect", "rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "inducer", "type": "adverse event", "roles": [["treatment", "azathioprine"], ["drug", "azathioprine"], ["effect", "warfarin resistance"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "alendronate sodium"], ["drug", "alendronate sodium"], ["effect", "nodular scleritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "Most cardiac surgical patients"], ["subject disorder", "cardiac surgical"], ["treatment", "heparin"], ["drug", "heparin"], ["effect", "thrombocytopenia ( HIT ) postoperatively"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "a case"], ["treatment", "atovaquone"], ["drug", "atovaquone"], ["effect", "vortex keratopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "she"], ["gender", "she"], ["treatment", "a maximal dose of phenylephrine"], ["drug", "phenylephrine"], ["effect", "prominent positive U waves"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "Two patients with ocular inflammation of unknown origin"], ["population", "Two"], ["subject disorder", "ocular inflammation of unknown origin"], ["treatment", "IVTA injection"], ["drug", "IVTA"], ["route", "injection"], ["treatment disorder", "ocular inflammation of unknown origin"], ["effect", "severe chorioretinitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "started", "type": "potential therapeutic event", "roles": [["treatment", "Disopyramide"], ["drug", "Disopyramide"], ["treatment disorder", "supraventricular tachycardia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 50 - year - old woman with a history of migraine without aura , predominantly occurring around her menstrual periods"], ["age", "50 - year - old"], ["gender", "woman"], ["subject disorder", "migraine without aura"], ["subject disorder", "predominantly occurring around her menstrual periods"], ["treatment", "the use of zolmitriptan"], ["drug", "zolmitriptan"], ["treatment disorder", "migraine without aura"], ["effect", "spinal cord lesion"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["treatment", "olanzapine"], ["drug", "olanzapine"], ["effect", "skin rash effect"]]}, {"trigger": "triggered", "type": "adverse event", "roles": [["treatment", "pravastatin , a 3 - hydoxy - 3 - methylglutaryl - coenzyme A - (HMG - CoA) - reductase inhibitor , and lithium medication"], ["drug", "pravastatin"], ["drug", "lithium medication"], ["combination drug", "pravastatin"], ["combination drug", "lithium medication"], ["effect", "skin rash effect"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complicate", "type": "adverse event", "roles": [["treatment", "interferon alfa"], ["drug", "interferon alfa"], ["effect", "Anterior ischemic optic neuropathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["subject", "she"], ["gender", "she"], ["treatment", "After 5 weeks of therapy"], ["drug", "pantoprazole"], ["duration", "5 weeks"], ["time elapsed", "5 weeks"], ["effect", "general malaise"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "secondary", "type": "adverse event", "roles": [["treatment", "iatrogenic vitamin D poisoning"], ["drug", "iatrogenic vitamin D poisoning"], ["effect", "acute , severe hypercalcemia"]]}, {"trigger": "use", "type": "potential therapeutic event", "roles": [["treatment", "pamidronate"], ["drug", "pamidronate"], ["treatment disorder", "acute , severe hypercalcemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "relationship", "type": "adverse event", "roles": [["subject", "our patient"], ["treatment", "gemcitabine treatment"], ["drug", "gemcitabine"], ["effect", "cutaneous eruption"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "administered", "type": "potential therapeutic event", "roles": [["subject", "a 58 - yr - old woman"], ["age", "58 - yr - old"], ["gender", "woman"], ["subject disorder", "parathyroidectomy"], ["treatment", "Methylene blue"], ["drug", "Methylene blue"], ["treatment disorder", "parathyroidectomy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["subject", "veterans with PTSD"], ["population", "two"], ["subject disorder", "PTSD"], ["treatment", "lithium"], ["drug", "lithium"], ["treatment disorder", "PTSD"], ["effect", "serious problems with irritability or angry outbursts"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "result", "type": "adverse event", "roles": [["treatment", "flucloxacillin"], ["drug", "flucloxacillin"], ["effect", "fatal hepatic injury"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "hepatic artery infusion HAI"], ["drug", "HAI"], ["route", "hepatic artery infusion"], ["effect", "Neurologic toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "side effect", "type": "adverse event", "roles": [["subject", "infantile spasms"], ["age", "infantile"], ["subject disorder", "infantile spasms"], ["treatment", "prolonged adrenocorticotropic hormone therapy"], ["drug", "adrenocorticotropic hormone"], ["treatment disorder", "infantile spasms"], ["effect", "Hyperkalemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["subject", "two cases"], ["population", "two"], ["treatment", "naproxen and oxaprozin"], ["drug", "naproxen"], ["drug", "oxaprozin"], ["combination drug", "naproxen"], ["combination drug", "oxaprozin"], ["effect", "pseudoporphyria"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "potential therapeutic event", "roles": [["subject", "She"], ["gender", "She"], ["treatment", "an average weekly warfarin dose of 39 mg ( 5.5 mg daily )"], ["drug", "warfarin"], ["dosage", "39 mg"], ["frequency", "weekly"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "because", "type": "adverse event", "roles": [["treatment", "conventional amphotericin B"], ["drug", "amphotericin B"], ["effect", "severe side effects"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "diltiazem"], ["drug", "diltiazem"], ["effect", "Widespread cutaneous vasculitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "4 weeks after starting gemfibrozil"], ["drug", "warfarin"], ["drug", "gemfibrozil"], ["duration", "4 weeks"], ["time elapsed", "4 weeks"], ["effect", "severe hypoprothrombinemia and bleeding"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a 40 - year - old woman"], ["age", "40 - year - old"], ["gender", "woman"], ["treatment", "a course of oral flucloxacillin"], ["drug", "flucloxacillin"], ["route", "oral"], ["effect", "fulminant hepatic failure and aplastic anaemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "development", "type": "adverse event", "roles": [["treatment", "Capecitabine therapy"], ["drug", "Capecitabine"], ["effect", "acute coronary syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "lithium"], ["drug", "lithium"], ["effect", "biochemical hyperparathyroidism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "relationship", "type": "adverse event", "roles": [["treatment", "infliximab"], ["drug", "infliximab"], ["treatment disorder", "Crohn 's disease"], ["effect", "lymphoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "development", "type": "adverse event", "roles": [["treatment", "raloxifene"], ["drug", "raloxifene"], ["effect", "malignant mixed mesodermal tumor"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "recognition", "type": "adverse event", "roles": [["treatment", "high - dose methotrexate therapy"], ["drug", "methotrexate"], ["dosage", "high - dose"], ["effect", "renal toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developing", "type": "adverse event", "roles": [["subject", "patients with rheumatoid arthritis"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "methotrexate therapy"], ["drug", "methotrexate"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "lymphoproliferative diseases"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "secondary", "type": "adverse event", "roles": [["treatment", "intrathecal methotrexate"], ["drug", "methotrexate"], ["route", "intrathecal"], ["effect", "cytotoxic edema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "causes", "type": "adverse event", "roles": [["treatment", "Morphine"], ["drug", "Morphine"], ["effect", "hyperhidrosis and facial flushing"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "oral calcineurin and mTOR inhibitors"], ["drug", "calcineurin"], ["drug", "mTOR inhibitors"], ["route", "oral"], ["combination drug", "calcineurin"], ["combination drug", "mTOR inhibitors"], ["effect", "Severe aphthous stomatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "hospitalized", "type": "adverse event", "roles": [["subject", "A 79 - year - old man with ischemic heart disease , chronic atrial fibrillation , chronic renal failure , hypothyroidism , and gout arthritis"], ["age", "79 - year - old"], ["gender", "man"], ["subject disorder", "chronic atrial fibrillation"], ["subject disorder", "chronic renal failure"], ["subject disorder", "hypothyroidism"], ["subject disorder", "gout arthritis"], ["subject disorder", "ischemic heart disease , chronic atrial fibrillation , chronic renal failure , hypothyroidism , and gout arthritis"], ["treatment", "colchicine"], ["drug", "colchicine"], ["treatment disorder", "ischemic heart disease , chronic atrial fibrillation , chronic renal failure , hypothyroidism"], ["treatment disorder", "gout arthritis"], ["effect", "fatigue , myalgia , and leg weakness"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a child with juvenile absence epilepsy"], ["age", "child"], ["subject disorder", "juvenile absence epilepsy"], ["treatment", "intravenous valproic acid"], ["drug", "valproic acid"], ["route", "intravenous"], ["treatment disorder", "juvenile absence epilepsy"], ["effect", "seizure exacerbation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "She"], ["gender", "She"], ["treatment", "acyclovir"], ["drug", "acyclovir"], ["effect", "VZV antigen - positive zoster"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["subject", "3 cases"], ["population", "3"], ["treatment", "rifabutin"], ["drug", "rifabutin"], ["effect", "corneal endothelial deposits"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "promethazine"], ["drug", "promethazine"], ["effect", "coma"]]}, {"trigger": "Response", "type": "potential therapeutic event", "roles": [["treatment", "flumazenil"], ["drug", "flumazenil"], ["treatment disorder", "promethazine - induced coma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["subject", "41 anecdotic cases"], ["population", "41"], ["treatment", "olanzapine ( Zyprexa )"], ["drug", "olanzapine"], ["effect", "neutropenia or agranulocytosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "patients with vitamin B12 deficiency"], ["subject disorder", "vitamin B12 deficiency"], ["treatment", "nitrous oxide anesthesia"], ["drug", "nitrous oxide"], ["treatment disorder", "vitamin B12 deficiency"], ["effect", "Neurologic degeneration"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resulted", "type": "adverse event", "roles": [["treatment", "antiarrhythmics"], ["drug", "antiarrhythmics"], ["treatment disorder", "arrhythmia"], ["effect", "intolerable adverse effects or no effect on the arrhythmia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "to", "type": "adverse event", "roles": [["treatment", "compound tincture of benzoin"], ["drug", "benzoin"], ["effect", "Allergic contact dermatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "a 67 - year - old man"], ["age", "67 - year - old"], ["gender", "man"], ["subject disorder", "myocardial infarction"], ["treatment", "administration of tissue plasminogen activator"], ["drug", "tissue plasminogen activator"], ["treatment disorder", "myocardial infarction"], ["effect", "spontaneous choroidal hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "she"], ["gender", "she"], ["treatment", "Forty - one days later"], ["treatment", "drug - drug interaction between triamcinolone and her boosted protease inhibitor therapy"], ["drug", "triamcinolone"], ["drug", "her boosted protease inhibitor therapy"], ["effect", "severe iatrogenic Cushing 's syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "five female patients"], ["gender", "female"], ["population", "five"], ["subject disorder", "peptic acid diseases"], ["treatment", "taking proton pump inhibitors omeprazole , lansoprazole , or pantoprazole for 7 - 15 days for peptic acid diseases"], ["drug", "omeprazole"], ["drug", "lansoprazole"], ["drug", "pantoprazole"], ["duration", "7 - 15 days"], ["time elapsed", "7 - 15 days"], ["treatment disorder", "peptic acid diseases"], ["effect", "Pheripheral edema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "experienced", "type": "adverse event", "roles": [["subject", "a child with metastatic osteosarcoma"], ["age", "child"], ["subject disorder", "metastatic osteosarcoma"], ["treatment", "methotrexate"], ["drug", "methotrexate"], ["treatment disorder", "metastatic osteosarcoma"], ["effect", "anaphylactic / anaphylactoid reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "involved", "type": "adverse event", "roles": [["treatment", "interferon alpha"], ["drug", "interferon alpha"], ["effect", "lichen nitidus"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "led", "type": "adverse event", "roles": [["treatment", "Alendronate"], ["drug", "Alendronate"], ["effect", "nodular scleritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "intoxication", "type": "adverse event", "roles": [["subject", "a 36 - year - old man ( 35 mg DGTX )"], ["age", "36 - year - old"], ["gender", "man"], ["treatment", "prolonged and repeated i.v. - infusions of Fab fragments of anti - digitalis antibodies ( FAB )"], ["drug", "digitoxin ( DGTX )"], ["dosage", "35 mg"], ["route", "i.v. - infusions"], ["effect", "A massive digitoxin ( DGTX ) intoxication"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "result", "type": "adverse event", "roles": [["treatment", "Gold - salt therapy"], ["drug", "Gold - salt"], ["effect", "damage to proximal tubules that leak renal tubular antigens , which in turn complex with autoantibody and produce an autoimmune membranous nephropathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "to", "type": "adverse event", "roles": [["subject", "three more cases of children with recalcitrant atopic dermatitis"], ["age", "children"], ["population", "three"], ["subject disorder", "recalcitrant atopic dermatitis"], ["subject disorder", "atopic dermatitis"], ["treatment", "bisabolol"], ["drug", "bisabolol"], ["treatment disorder", "atopic dermatitis"], ["effect", "allergic contact dermatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "Rituximab therapy"], ["drug", "Rituximab"], ["effect", "CD20 - negative tumors"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 48 - year - old woman"], ["age", "48 - year - old"], ["gender", "woman"], ["subject disorder", "thyrotoxicosis"], ["treatment", "methimazole"], ["drug", "methimazole"], ["treatment disorder", "thyrotoxicosis"], ["effect", "agranulocytosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "ifosfamide"], ["drug", "ifosfamide"], ["effect", "encephalopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "diagnosed", "type": "adverse event", "roles": [["subject", "a woman"], ["gender", "women"], ["treatment", "raloxifene"], ["drug", "raloxifene"], ["effect", "malignant mixed mesodermal tumor"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "result", "type": "adverse event", "roles": [["treatment", "Interactions between warfarin and cloxacillin"], ["drug", "warfarin"], ["drug", "cloxacillin"], ["combination drug", "warfarin"], ["combination drug", "cloxacillin"], ["effect", "serious adverse reactions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "three cases"], ["population", "three"], ["treatment", "ofloxacin"], ["drug", "ofloxacin"], ["effect", "Stevens - Johnson syndrome or toxic epidermal necrolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "accelerated", "type": "adverse event", "roles": [["treatment", "Acetazolamide"], ["drug", "Acetazolamide"], ["effect", "osteomalacia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complication", "type": "adverse event", "roles": [["subject", "patients"], ["treatment", "either anticalcineurinic drug ( CyA or tacrolimus )"], ["treatment", "under monotherapy or with a low steroid dose"], ["drug", "CyA"], ["drug", "tacrolimus"], ["dosage", "low steroid dose"], ["effect", "osteoarticular complication"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "omeprazole"], ["drug", "omeprazole"], ["effect", "AIN"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "result", "type": "adverse event", "roles": [["subject", "patients"], ["treatment", "warfarin"], ["drug", "warfarin"], ["effect", "bleeding risk"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Adriamycin"], ["drug", "Adriamycin"], ["effect", "cardiomyopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "admitted", "type": "adverse event", "roles": [["subject", "An 11 - year - old boy"], ["age", "11 - year - old"], ["gender", "boy"], ["subject disorder", "respiratory distress syndrome"], ["treatment", "a relatively high dose of methotrimeprazine meleate ( Levemepromazine ) a phenothiazine antipsychotic drug"], ["drug", "methotrimeprazine meleate"], ["dosage", "a relatively high dose"], ["treatment disorder", "respiratory distress syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "presented", "type": "adverse event", "roles": [["subject", "An adult male"], ["age", "adult"], ["gender", "male"], ["treatment", "ingesting methanol"], ["drug", "methanol"], ["effect", "central blindness"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "All"], ["population", "All"], ["subject disorder", "RA"], ["treatment", "within 20 weeks of beginning i m gold therapy"], ["drug", "i m gold"], ["duration", "20 weeks"], ["time elapsed", "20 weeks"], ["treatment disorder", "RA"], ["effect", "mucocutaneous side effects"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "Two children , 1 with idiopathic nephrotic syndrome and 1 with endo - extracapillary glomerulonephritis"], ["age", "children"], ["population", "Two"], ["subject disorder", "endo - extracapillary glomerulonephritis"], ["subject disorder", "idiopathic nephrotic syndrome"], ["treatment", "i.v . pulse methylprednisolone ( IVPMP )"], ["drug", "methylprednisolone"], ["route", "i.v . pulse"], ["treatment disorder", "idiopathic nephrotic syndrome"], ["effect", "seizures and transient blindness"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["subject", "a boy with nephrotic syndrome"], ["age", "boy"], ["gender", "boy"], ["subject disorder", "nephrotic syndrome"], ["treatment", "prednisolone therapy"], ["drug", "prednisolone"], ["treatment disorder", "nephrotic syndrome"], ["effect", "Stevens - Johnson syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "VRC"], ["drug", "VRC"], ["effect", "angio - oedema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Insulin"], ["drug", "Insulin"], ["effect", "cardiac failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "disappeared", "type": "potential therapeutic event", "roles": [["treatment", "clemastine and betametasone treatment"], ["drug", "clemastine"], ["drug", "betametasone"], ["treatment disorder", "symptoms"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "ofloxacin"], ["drug", "ofloxacin"], ["effect", "toxic epidermal necrolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["treatment", "lithium therapy"], ["drug", "lithium"], ["effect", "renal failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 56 - year - old male parkinsonian patient"], ["age", "56 - year - old"], ["gender", "male"], ["subject disorder", "parkinsonian"], ["treatment", "oral administration of cinepazide"], ["drug", "cinepazide"], ["route", "oral"], ["treatment disorder", "parkinsonian"], ["effect", "unique behavioral change"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "production", "type": "adverse event", "roles": [["treatment", "carbamazepine"], ["drug", "carbamazepine"], ["effect", "dystonia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "risk", "type": "adverse event", "roles": [["treatment", "Metamizole"], ["drug", "Metamizole"], ["effect", "agranulocytosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "thionamide"], ["drug", "thionamide"], ["effect", "hematologic adverse reactions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "adverse event", "roles": [["subject", "patients with open angle glaucoma"], ["population", "Two"], ["subject disorder", "open angle glaucoma"], ["treatment", "metripranolol 0.6 % eye drops"], ["drug", "metripranolol"], ["route", "eye drops"], ["treatment disorder", "open angle glaucoma"], ["effect", "bilateral granulomatous anterior uveitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complication", "type": "adverse event", "roles": [["treatment", "propranolol"], ["drug", "propranolol"], ["effect", "life - threatening bronchospasm"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "2 female patients"], ["gender", "female"], ["population", "2"], ["treatment", "paroxetine and sertraline"], ["drug", "paroxetine"], ["drug", "sertraline"], ["effect", "incontinence"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a woman with classical rheumatoid arthritis"], ["gender", "woman"], ["subject disorder", "classical rheumatoid arthritis"], ["treatment", "introduction of sulphasalazine ( SASP ) therapy"], ["drug", "sulphasalazine"], ["treatment disorder", "classical rheumatoid arthritis"], ["effect", "severe and lasting psoriasis - like skin reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "darifenacin"], ["drug", "darifenacin"], ["effect", "Interstitial granulomatous dermatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "methanol"], ["drug", "methanol"], ["effect", "visual impairment"]]}, {"trigger": "Reversal", "type": "potential therapeutic event", "roles": [["treatment", "fomepizole"], ["drug", "fomepizole"], ["treatment disorder", "severe methanol - induced visual impairment"], ["effect", "no evidence of retinal toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "decrease", "type": "potential therapeutic event", "roles": [["subject", "patients"], ["treatment", "Proton - pump inhibitors ( PPIs )"], ["treatment", "receiving dual antiplatelet therapy"], ["drug", "Proton - pump inhibitors"], ["drug", "antiplatelet"], ["combination drug", "Proton - pump inhibitors"], ["combination drug", "antiplatelet"], ["effect", "decrease the risk of such complications"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "responsible", "type": "adverse event", "roles": [["treatment", "caffeine"], ["drug", "caffeine"], ["effect", "rhabdomyolysis as well as the delirium"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "achieved", "type": "potential therapeutic event", "roles": [["subject", "children with increased - risk ALL or stage III and IV lymphoblastic lymphoma"], ["age", "children"], ["subject disorder", "increased - risk ALL or stage III and IV lymphoblastic lymphoma"], ["treatment", "HD IV MTX and intrathecal injections of MTX"], ["drug", "HD IV MTX"], ["route", "intrathecal injections"], ["treatment disorder", "increased - risk ALL or stage III and IV lymphoblastic lymphoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "interferon alpha"], ["drug", "interferon alpha"], ["effect", "Generalized lichen nitidus with involvement of the palms"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "of", "type": "adverse event", "roles": [["treatment", "cyclophosphamide therapy"], ["drug", "cyclophosphamide"], ["effect", "Hemorrhagic cystitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "in", "type": "adverse event", "roles": [["subject", "certain patients with lithium nephrotoxicity"], ["subject disorder", "lithium nephrotoxicity"], ["treatment", "lithium"], ["drug", "lithium"], ["treatment disorder", "lithium nephrotoxicity"], ["effect", "Secondary hyperparathyroidism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["subject", "a case"], ["subject disorder", "an asymptomatic falx meningioma"], ["treatment", "the internal use of low - dose aspirin for 16 months"], ["drug", "aspirin"], ["dosage", "low - dose"], ["route", "internal"], ["treatment disorder", "an asymptomatic falx meningioma"], ["effect", "hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "noted", "type": "adverse event", "roles": [["subject", "five out of six patients"], ["population", "five out of six"], ["treatment", "not receiving a cardiac glycoside and four out of six who were receiving ouabain , and none of the 16 who were receiving digoxin"], ["drug", "ouabain"], ["drug", "digoxin"], ["effect", "Minor electrocardiographical changes"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "develop", "type": "adverse event", "roles": [["treatment", "co - administration of pravastatin"], ["drug", "pravastatin"], ["effect", "allergic reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "cyclophosphamide"], ["drug", "cyclophosphamide"], ["effect", "hepatic angiosarcoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "an expression", "type": "adverse event", "roles": [["treatment", "5 - FU"], ["drug", "5 - FU"], ["effect", "ocular motor disturbances"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "Complications", "type": "adverse event", "roles": [["subject", "an eight - year old boy"], ["age", "eight - year old"], ["gender", "boy"], ["subject disorder", "synovial sarcoma"], ["treatment", "chemotherapy for a synovial sarcoma"], ["drug", "cisplatinum"], ["drug", "adriamycin"], ["route", "chemotherapy"], ["treatment disorder", "synovial sarcoma"], ["effect", "cisplatinum nephrotoxicity and adriamycin cardiotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurs", "type": "adverse event", "roles": [["subject", "renal transplant recipients"], ["subject disorder", "renal transplant"], ["treatment", "antimicrobial agents"], ["drug", "antimicrobial agents"], ["treatment disorder", "renal transplant"], ["effect", "Bacterial infection"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "reduces", "type": "potential therapeutic event", "roles": [["subject", "patients with severe , persistent asthma"], ["subject disorder", "severe , persistent asthma"], ["treatment", "ciclesonide"], ["drug", "ciclesonide"], ["treatment disorder", "severe , persistent asthma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "intrathecal administration of doxorubicin"], ["drug", "doxorubicin"], ["route", "intrathecal"], ["effect", "myelopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "secondary", "type": "adverse event", "roles": [["treatment", "alpha interferon"], ["drug", "alpha interferon"], ["effect", "Multiple sclerosis - like disease"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a patient with mild chronic renal insufficiency"], ["subject disorder", "mild chronic renal insufficiency"], ["subject disorder", "acute gouty bursitis"], ["treatment", "taking simvastatin for over a year"], ["treatment", "within 3 weeks after the start of treatment with colchicine for acute gouty bursitis"], ["drug", "simvastatin"], ["drug", "colchicine"], ["duration", "3 weeks"], ["time elapsed", "3 weeks"], ["treatment disorder", "acute gouty bursitis"], ["effect", "acute weakness"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "the patient"], ["treatment", "Shortly after chemotherapy and an injection of pegfilgrastim"], ["drug", "pegfilgrastim"], ["route", "chemotherapy"], ["route", "injection"], ["effect", "poorly defined , rapidly progressive erythema , edema , and pain in his right forearm"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "leading", "type": "adverse event", "roles": [["subject", "a polytrauma patient with Parkinson 's disease ( PD )"], ["subject disorder", "polytrauma"], ["subject disorder", "Parkinson 's disease"], ["treatment", "interaction between enteral feeds and levodopa"], ["drug", "levodopa"], ["route", "enteral"], ["treatment disorder", "polytrauma"], ["effect", "neuroleptic malignant - like syndrome ( NMLS )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "receiving", "type": "adverse event", "roles": [["subject", "a schizophrenia patient"], ["subject disorder", "schizophrenia"], ["treatment", "olanzapine and thiazide"], ["drug", "olanzapine"], ["drug", "thiazide"], ["treatment disorder", "schizophrenia"], ["combination drug", "olanzapine"], ["combination drug", "thiazide"], ["effect", "neutropenia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "imiquimod"], ["drug", "imiquimod"], ["effect", "mild to moderate application site reactions ( ASRs )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "to", "type": "adverse event", "roles": [["subject", "Nineteen cases"], ["population", "Nineteen"], ["treatment", "compound tincture of benzoin"], ["drug", "benzoin"], ["effect", "allergic contact dermatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "3 children with epilepsy"], ["age", "children"], ["population", "3"], ["subject disorder", "epilepsy"], ["subject disorder", "complex partial seizures"], ["treatment", "initiation of CBZ"], ["drug", "CBZ"], ["treatment disorder", "complex partial seizures"], ["effect", "facial motor tics"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "against", "type": "adverse event", "roles": [["treatment", "cadmium , zinc and cadmium / zinc mixtures at concentrations ranging from 1000 to 50000 microg / l"], ["drug", "cadmium"], ["drug", "zinc"], ["dosage", "1000 to 50000 microg / l"], ["effect", "cercariae and metacercariae of Parorchis acanthus"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "side - effect", "type": "adverse event", "roles": [["subject", "a 29 - year Nigerian female patient with generalized tonic - elonic seizures"], ["age", "29 - year"], ["gender", "female"], ["race", "Nigerian"], ["subject disorder", "generalized tonic - elonic seizures"], ["treatment", "carbamazepine administration"], ["drug", "carbamazepine"], ["treatment disorder", "generalized tonic - elonic seizures"], ["effect", "syndrome of inappropriate antidiuresis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "potential therapeutic event", "roles": [["subject", "A patient"], ["subject disorder", "atrial fibrillation"], ["treatment", "warfarin"], ["drug", "warfarin"], ["treatment disorder", "atrial fibrillation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "higher risk", "type": "adverse event", "roles": [["treatment", "Mood stabilizer therapy and pravastatin"], ["drug", "Mood stabilizer therapy"], ["drug", "pravastatin"], ["combination drug", "Mood stabilizer therapy"], ["combination drug", "pravastatin"], ["effect", "adverse skin reactions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "secondary", "type": "adverse event", "roles": [["treatment", "all - trans retinoic acid"], ["drug", "all - trans retinoic acid"], ["treatment disorder", "acute promyelocytic leukemia"], ["effect", "Pulmonary leukostasis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complained", "type": "adverse event", "roles": [["subject", "A 74 - year - old hypercholestrerolaemic woman"], ["age", "74 - year - old"], ["gender", "woman"], ["subject disorder", "hypercholestrerolaemic"], ["treatment", "cerivastatin ( 0.15 mg / day ) for 22 days"], ["drug", "cerivastatin"], ["dosage", "0.15 mg / day"], ["duration", "22 days"], ["time elapsed", "22 days"], ["treatment disorder", "hypercholestrerolaemic"], ["effect", "general muscle weakness and muscle pain"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "cimetidine"], ["drug", "cimetidine"], ["effect", "hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["treatment", "concomitant administration of viloxazine"], ["drug", "viloxazine"], ["effect", "theophylline intoxication"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "secondary", "type": "adverse event", "roles": [["treatment", "interferon alfa"], ["drug", "interferon alfa"], ["effect", "Anterior ischemic optic neuropathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["treatment", "recombinant and natural interferon alpha administration"], ["drug", "recombinant"], ["drug", "natural interferon alpha"], ["effect", "bilateral optic neuritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["treatment", "Rofecoxib"], ["drug", "Rofecoxib"], ["treatment disorder", "dysmenorrhea"], ["effect", "herpetiform fixed drug eruption predominantly involving the lips with classic clinical and histological findings in a red - brown lesion on the dorsal hand"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "4 cases"], ["population", "4"], ["treatment", "Statin"], ["drug", "Statin"], ["effect", "myasthenia gravis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "with", "type": "adverse event", "roles": [["treatment", "alcohol and imipramine"], ["drug", "alcohol"], ["drug", "imipramine"], ["effect", "spindle coma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "intermittent Decadron"], ["drug", "Decadron"], ["frequency", "intermittent"], ["effect", "Cataracts"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "present", "type": "adverse event", "roles": [["subject", "two epileptic patients"], ["population", "two"], ["subject disorder", "epileptic"], ["treatment", "long - term treatment with congeners of phenytoin , phenobarbital , and acetazolamide"], ["drug", "phenytoin"], ["drug", "phenobarbital"], ["drug", "acetazolamide"], ["treatment disorder", "epileptic"], ["combination drug", "phenytoin"], ["combination drug", "phenobarbital"], ["combination drug", "acetazolamide"], ["effect", "osteomalacia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "when", "type": "adverse event", "roles": [["treatment", "acetaminophen is prescribed with caffeine"], ["drug", "acetaminophen"], ["drug", "caffeine"], ["combination drug", "acetaminophen"], ["combination drug", "caffeine"], ["effect", "hepatotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "toxicity", "type": "adverse event", "roles": [["treatment", "methotrexate"], ["drug", "methotrexate"], ["effect", "Erosion of psoriatic plaques"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["treatment", "transdermal scopolamine patch"], ["drug", "scopolamine"], ["route", "transdermal"], ["effect", "anisocoria"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "Efficacy", "type": "potential therapeutic event", "roles": [["treatment", "tifacogin ( recombinant tissue factor pathway inhibitor )"], ["drug", "tifacogin"], ["treatment disorder", "severe sepsis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "diagnosed", "type": "adverse event", "roles": [["subject", "a 64 - year - old woman with a bicornuate uterus"], ["age", "64 - year - old"], ["gender", "woman"], ["subject disorder", "bicornuate uterus"], ["subject disorder", "osteoporosis"], ["treatment", "taking raloxifene"], ["drug", "raloxifene"], ["treatment disorder", "osteoporosis"], ["effect", "malignant mixed mesodermal tumor"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "pegvisomant"], ["drug", "pegvisomant"], ["effect", "hepatic enzyme disturbances"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "adjunctive therapy", "type": "potential therapeutic event", "roles": [["subject", "patients with uncontrolled partial - onset seizures"], ["subject disorder", "uncontrolled partial - onset seizures"], ["treatment", "one to three concomitant antiepileptic drugs ( AEDs )"], ["drug", "lacosamide"], ["treatment disorder", "uncontrolled partial - onset seizures"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "potential therapeutic event", "roles": [["treatment", "discontinuation of hydroxychloroquine therapy"], ["drug", "hydroxychloroquine"], ["treatment disorder", "nephrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developing", "type": "adverse event", "roles": [["subject", "elderly patients"], ["age", "elderly"], ["treatment", "olanzapine"], ["drug", "olanzapine"], ["effect", "hyperglycemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "recovery", "type": "potential therapeutic event", "roles": [["subject", "a patient with collapsing focal glomeruloesclerosis ( collapsing FGS )"], ["subject disorder", "collapsing focal glomeruloesclerosis"], ["treatment", "withdrawal of cyclosporine ( CSA )"], ["drug", "cyclosporine"], ["treatment disorder", "collapsing focal glomeruloesclerosis"], ["effect", "PRES"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["subject", "patient"], ["treatment", "zuclopenthixol"], ["drug", "zuclopenthixol"], ["effect", "priapism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurring", "type": "adverse event", "roles": [["treatment", "cyclophosphamide therapy"], ["drug", "cyclophosphamide"], ["effect", "Hepatic angiosarcoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "receive", "type": "potential therapeutic event", "roles": [["subject", "children with increased - risk ( risk factor = 0.8 or T - lineage ) ALL or stage III and IV lymphoblastic lymphoma"], ["age", "children"], ["subject disorder", "increased - risk ( risk factor = 0.8 or T - lineage ) ALL"], ["subject disorder", "stage III and IV lymphoblastic lymphoma"], ["treatment", "four courses of HD MTX ( 5 g / m(2 ) over 24 hours every 2 weeks ) and four intrathecal administrations of MTX"], ["treatment disorder", "increased - risk ( risk factor = 0.8 or T - lineage ) ALL"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "toxicity", "type": "adverse event", "roles": [["treatment", "KW - 2149"], ["drug", "KW - 2149"], ["effect", "pulmonary toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Flucloxacillin"], ["drug", "Flucloxacillin"], ["effect", "aplastic anaemia and liver failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "patients with cancer"], ["subject disorder", "cancer"], ["treatment", "methotrexate"], ["drug", "methotrexate"], ["treatment disorder", "cancer"], ["effect", "anaphylaxis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["treatment", "BCNU"], ["drug", "BCNU"], ["effect", "pulmonary fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "sulfonamide"], ["drug", "sulfonamide"], ["effect", "injury to the urinary tract"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "Brimonidine"], ["drug", "Brimonidine"], ["effect", "IOP elevation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "an HIV carrier"], ["subject disorder", "HIV"], ["treatment", "nevirapine"], ["drug", "nevirapine"], ["treatment disorder", "HIV"], ["effect", "Severe leukopenia associated with mild hepatotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "evaluated", "type": "potential therapeutic event", "roles": [["subject", "20 patients with hepatocellular carcinoma ( HCC ) associated with cirrhosis of the liver"], ["population", "20"], ["subject disorder", "hepatocellular carcinoma ( HCC ) associated with cirrhosis of the liver"], ["treatment", "Lp - TAE alone and combined with radiofrequency ( RF ) capacitive hyperthermia ( HT )"], ["drug", "Lp - TAE"], ["frequency", "radiofrequency ( RF )"], ["treatment disorder", "hepatocellular carcinoma ( HCC ) associated with cirrhosis of the liver"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "intracavernous injection of phentolamine / papaverine"], ["drug", "phentolamine"], ["drug", "papaverine"], ["route", "intracavernous injection"], ["combination drug", "phentolamine"], ["combination drug", "papaverine"], ["effect", "Fibrosis of corpus cavernosum"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["subject", "three children"], ["age", "children"], ["population", "three"], ["treatment", "carbamazepine"], ["drug", "carbamazepine"], ["effect", "dystonia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "exacerbated", "type": "adverse event", "roles": [["treatment", "valproic acid"], ["drug", "valproic acid"], ["effect", "Juvenile absence epilepsy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "result", "type": "adverse event", "roles": [["subject", "These cases"], ["population", "These"], ["treatment", "suicidal ingestion of drugs in which quetiapine was considered a significant factor"], ["drug", "quetiapine"], ["route", "ingestion"], ["effect", "deaths"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["treatment", "zafirlukast therapy"], ["drug", "zafirlukast"], ["effect", "hypereosinophilia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "patients"], ["treatment", "methotrexate"], ["drug", "methotrexate"], ["effect", "anaphylaxis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Pentazocine"], ["drug", "Pentazocine"], ["effect", "fibrous myopathy and localized neuropathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "toxicity", "type": "adverse event", "roles": [["treatment", "vancomycin"], ["drug", "vancomycin"], ["effect", "toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "a patient with hepatitis C"], ["subject disorder", "hepatitis C"], ["treatment", "systemic treatment with interferon alpha and ribavirin"], ["drug", "interferon alpha"], ["drug", "ribavirin"], ["treatment disorder", "hepatitis C"], ["effect", "generalized lichen nitidus with involvement of the palms"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "experienced", "type": "adverse event", "roles": [["subject", "a woman with chronic schizophrenia"], ["gender", "woman"], ["subject disorder", "chronic schizophrenia"], ["treatment", "addition of propranolol to her neuroleptic regimen"], ["drug", "propranolol"], ["treatment disorder", "chronic schizophrenia"], ["effect", "delirium , grand mal seizure , and photosensitivity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "an infant with complex congenital heart disease"], ["age", "infant"], ["subject disorder", "complex congenital heart disease"], ["treatment", "captopril for afterload reduction following cardiac surgery"], ["drug", "captopril"], ["treatment disorder", "complex congenital heart disease"], ["effect", "pulmonary infiltrates with eosinophilia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "valproic acid"], ["drug", "valproic acid"], ["effect", "hyperammonemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "pharmacokinetic and pharmacodynamic interactions between three different selective serotonin - reuptake inhibitors ( SSRI ) and possibly ciprofloxacin"], ["drug", "ciprofloxacin"], ["drug", "selective serotonin - reuptake inhibitors"], ["effect", "serotonin syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "cyclosporin a withdrawal"], ["treatment", "etanercept"], ["drug", "cyclosporin"], ["drug", "etanercept"], ["effect", "Generalised pustular psoriasis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "became", "type": "adverse event", "roles": [["subject", "36 - y - o patient with schizophrenia"], ["age", "36 - y - o"], ["subject disorder", "schizophrenia"], ["treatment", "consumed gradually increasing quantities of oolong tea that eventually reached 15 L each day"], ["drug", "oolong tea"], ["dosage", "15 L"], ["frequency", "each day"], ["treatment disorder", "schizophrenia"], ["effect", "delirious"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a neonate"], ["age", "neonate"], ["treatment", "Intraventricular nafcillin"], ["drug", "nafcillin"], ["route", "Intraventricular"], ["effect", "seizures"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "cephalosporin"], ["drug", "cephalosporin"], ["effect", "coagulopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "thiabendazole"], ["drug", "thiabendazole"], ["effect", "Intrahepatic cholestasis and sicca complex"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "development", "type": "adverse event", "roles": [["subject", "patients"], ["treatment", "diphenylhydantoin"], ["drug", "diphenylhydantoin"], ["effect", "monoclonal gammopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "Moxalactam"], ["drug", "Moxalactam"], ["effect", "platelet dysfunction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "responsible", "type": "adverse event", "roles": [["subject", "all three AIDS patients"], ["population", "three"], ["subject disorder", "AIDS"], ["treatment", "ddI"], ["drug", "ddI"], ["treatment disorder", "AIDS"], ["effect", "fulminant hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "Two patients , each receiving warfarin for stroke prophylaxis in association with chronic atrial fibrillation"], ["population", "Two"], ["subject disorder", "stroke prophylaxis in association with chronic atrial fibrillation"], ["treatment", "initiation of tolterodine for urinary disorders"], ["drug", "tolterodine"], ["treatment disorder", "urinary disorders"], ["effect", "adverse effects"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "presented", "type": "adverse event", "roles": [["subject", "A 45 - year - old HIV - positive man ( CD4 + count 450 cells / mm(3 ) and history of AIDS - defining illness )"], ["age", "45 - year - old"], ["gender", "man"], ["subject disorder", "HIV - positive"], ["subject disorder", "presumed neurosyphilis"], ["treatment", "an initial intravenous dose of penicillin G"], ["drug", "penicillin G"], ["dosage", "an initial intravenous dose"], ["treatment disorder", "presumed neurosyphilis"], ["effect", "JHR"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "The second patient"], ["population", "second"], ["treatment", "50 months of IFN - beta therapy"], ["drug", "IFN - beta"], ["duration", "50 months"], ["time elapsed", "50 months"], ["effect", "autoimmune thyroid disease and a refractory pre - patellar bursitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "had", "type": "adverse event", "roles": [["subject", "the patient"], ["treatment", "isotretinoin"], ["drug", "isotretinoin"], ["effect", "agenesis of the cerebellar vermis , multiple leptomeningeal neuroglial heterotopias , hydrocephalus , and abnormalities of the corticospinal tracts"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["treatment", "long - term oral isotretinoin therapy"], ["drug", "isotretinoin"], ["route", "oral"], ["effect", "Reversible sclerotic changes of lumbar spine and femur"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "trazodone"], ["drug", "trazodone"], ["effect", "priapism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "infliximab infusion"], ["drug", "infliximab"], ["route", "infusion"], ["treatment disorder", "Crohn 's disease"], ["effect", "Severe adenovirus pneumonia ( AVP )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "theophylline"], ["drug", "theophylline"], ["effect", "gynecomastia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a patient with an underlying vascular malformation"], ["subject disorder", "underlying vascular malformation"], ["treatment", "pseudoephedrine"], ["drug", "pseudoephedrine"], ["effect", "intracerebral hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 58 - year - old woman"], ["age", "58 - year - old"], ["gender", "woman"], ["treatment", "four days after the application of a patch of transdermal scopolamine delivery system ( TRANSDERM - V )"], ["drug", "scopolamine"], ["route", "patch"], ["duration", "four days"], ["time elapsed", "four days"], ["effect", "unilateral acute angle - closure glaucoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a 50 - year - old male patient with a 15 - year history of psoriasis including mutilating psoriatic arthritis"], ["age", "50 - year - old"], ["gender", "male"], ["subject disorder", "mutilating psoriatic arthritis"], ["subject disorder", "psoriasis"], ["treatment", "withdrawal of cyclosporin A"], ["drug", "cyclosporin A"], ["treatment disorder", "psoriasis"], ["effect", "generalised pustular exacerbation and a aggravation of the joint condition"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "exhibited", "type": "adverse event", "roles": [["subject", "she"], ["gender", "she"], ["treatment", "Six days after starting acyclovir"], ["drug", "acyclovir"], ["duration", "Six days"], ["time elapsed", "Six days"], ["effect", "lithium toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "Toxicity", "type": "adverse event", "roles": [["treatment", "cadmium and zinc"], ["drug", "cadmium"], ["drug", "zinc"], ["treatment disorder", "Parorchis acanthus ( Digenea : Philophthalmidae )"], ["combination drug", "cadmium"], ["combination drug", "zinc"], ["effect", "Toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "effectuated", "type": "adverse event", "roles": [["treatment", "lithium"], ["drug", "lithium"], ["effect", "neurotoxicity ( SILENT )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "One patient"], ["population", "One"], ["treatment", "ouabain"], ["drug", "ouabain"], ["effect", "cardiomyopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "involved", "type": "adverse event", "roles": [["treatment", "tamoxifen"], ["drug", "tamoxifen"], ["effect", "pathogenesis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "glibenclamide therapy"], ["drug", "glibenclamide"], ["effect", "Intrahepatic cholestasis and cutaneous bullae"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "enhances", "type": "potential therapeutic event", "roles": [["subject", "painful diabetic neuropathy patients"], ["subject disorder", "painful diabetic neuropathy"], ["treatment", "Prolonged - release oxycodone"], ["treatment", "existing gabapentin therapy"], ["drug", "Prolonged - release oxycodone"], ["treatment disorder", "painful diabetic neuropathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["treatment", "pantoprazole"], ["drug", "pantoprazole"], ["effect", "acute interstitial nephritis ( AIN )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a patient of organic bipolar affective disorder"], ["subject disorder", "organic bipolar affective disorder"], ["treatment", "atypical antipsychotic aripiprazole"], ["drug", "aripiprazole"], ["treatment disorder", "organic bipolar affective disorder"], ["effect", "hiccups"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "administered", "type": "potential therapeutic event", "roles": [["subject", "A 28 year - old man with chronic hepatitis B"], ["age", "28 year - old"], ["gender", "man"], ["subject disorder", "chronic hepatitis B"], ["treatment", "interferon - alpha ( 5 x 10(6 ) IU ) intramuscularly once a day for 28 days"], ["drug", "interferon - alpha"], ["frequency", "once a day"], ["duration", "28 days"], ["treatment disorder", "chronic hepatitis B"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "experienced", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "high - dosage olanzapine"], ["drug", "olanzapine"], ["dosage", "high - dosage"], ["effect", "parkinsonism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 65 - year - old woman with bipolar disorder and complicated cardiovascular disease"], ["age", "65 - year - old"], ["gender", "woman"], ["subject disorder", "bipolar disorder"], ["subject disorder", "complicated cardiovascular disease"], ["subject disorder", "acute depression"], ["treatment", "high doses of trazodone"], ["drug", "trazodone"], ["dosage", "high doses"], ["treatment disorder", "acute depression"], ["effect", "movement disorder"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complication", "type": "adverse event", "roles": [["treatment", "warfarin"], ["drug", "warfarin"], ["effect", "adverse bleeding"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["subject", "a case"], ["subject disorder", "parathyroidectomy"], ["treatment", "methylene blue infusion"], ["drug", "methylene blue"], ["route", "infusion"], ["treatment disorder", "parathyroidectomy"], ["effect", "autonomic , neurological and neuromuscular instability"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "children"], ["age", "children"], ["treatment", "intensive chemotherapy containing busulfan"], ["drug", "busulfan"], ["route", "chemotherapy"], ["effect", "PVT"], ["effect", "HVOD"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "ofloxacin"], ["drug", "ofloxacin"], ["effect", "toxic epidermal necrolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resulting", "type": "adverse event", "roles": [["treatment", "Concomitant use of simvastatin and amiodarone"], ["drug", "simvastatin"], ["drug", "amiodarone"], ["combination drug", "simvastatin"], ["combination drug", "amiodarone"], ["effect", "severe rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "clindamycin phosphate vaginal cream"], ["drug", "clindamycin phosphate"], ["route", "vaginal cream"], ["effect", "CDIC"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "warfarin"], ["drug", "warfarin"], ["effect", "intercerebral hematoma"], ["effect", "coagulopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "a patient with spinal cord astrocytoma"], ["subject disorder", "spinal cord astrocytoma"], ["treatment", "a single dose of vincristine"], ["drug", "vincristine"], ["dosage", "single dose"], ["treatment disorder", "spinal cord astrocytoma"], ["effect", "Severe visual loss"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "ameliorate", "type": "potential therapeutic event", "roles": [["treatment", "Clonazepam , thioridazine , beta - blockers , anticholinergics , and bromocriptine"], ["drug", "Clonazepam"], ["drug", "thioridazine"], ["drug", "beta - blockers"], ["drug", "anticholinergics"], ["drug", "bromocriptine"], ["treatment disorder", "akathisia"], ["combination drug", "Clonazepam"], ["combination drug", "thioridazine"], ["combination drug", "beta - blockers"], ["combination drug", "anticholinergics"], ["combination drug", "bromocriptine"], ["effect", "akathisia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "adverse event", "roles": [["subject", "four of 44 children ( 9 % )"], ["age", "children"], ["population", "four of 44"], ["subject disorder", "relapsed Wilms ' tumors"], ["treatment", "ifosfamide , a derivative of cyclophosphamide"], ["drug", "ifosfamide"], ["treatment disorder", "relapsed Wilms ' tumors"], ["effect", "Musculoskeletal complaints"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "causing", "type": "adverse event", "roles": [["treatment", "warfarin - like anticoagulant"], ["drug", "warfarin"], ["effect", "intracerebral hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "Gemcitabine"], ["drug", "Gemcitabine"], ["effect", "radiation recall"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "effect", "type": "adverse event", "roles": [["treatment", "brimonidine"], ["drug", "brimonidine"], ["effect", "paradoxical ocular effect"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "eruption", "type": "adverse event", "roles": [["treatment", "rofecoxib"], ["drug", "rofecoxib"], ["effect", "Fixed drug eruption"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "documented", "type": "adverse event", "roles": [["subject", "patients"], ["subject disorder", "diarrhea"], ["subject disorder", "bacterial vaginosis"], ["treatment", "clindamycin vaginal cream"], ["drug", "clindamycin"], ["route", "vaginal cream"], ["treatment disorder", "bacterial vaginosis"], ["effect", "C. difficile toxin"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["treatment", "pantoprazole"], ["drug", "pantoprazole"], ["effect", "Acute interstitial nephritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "taxanes such as paclitaxel"], ["drug", "taxanes"], ["effect", "pneumonitis and lung fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "sustained", "type": "adverse event", "roles": [["subject", "Infant twins"], ["age", "Infant"], ["population", "twins"], ["subject disorder", "candidiasis"], ["treatment", "a concentrated solution of benzalkonium ( Zephiran ) chloride"], ["drug", "benzalkonium"], ["route", "concentrated solution"], ["treatment disorder", "candidiasis"], ["effect", "circumoral and pharyngeal burns"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "teratogenicity", "type": "adverse event", "roles": [["treatment", "Isotretinoin"], ["drug", "Isotretinoin"], ["effect", "teratogenicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "cimetidine administration"], ["drug", "cimetidine"], ["effect", "Hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "an 11 - month - old female infant with a depressed level of consciousness"], ["age", "11 - month - old"], ["gender", "female"], ["subject disorder", "depressed level of consciousness"], ["treatment", "ingestion of ibuprofen"], ["treatment", "administration of naloxone"], ["drug", "ibuprofen"], ["route", "ingestion"], ["effect", "mental status markedly improved"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resolution", "type": "potential therapeutic event", "roles": [["treatment", "discontinuation of colchicine"], ["drug", "colchicine"], ["treatment disorder", "rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 73 year - old patient with Wolff - Parkinson - White syndrome and paroxysmic supraventricular tachycardia"], ["age", "73 year - old"], ["subject disorder", "Wolff - Parkinson - White syndrome"], ["subject disorder", "paroxysmic supraventricular tachycardia"], ["treatment", "within 15 days of initiation of flecainide"], ["drug", "flecainide"], ["duration", "15 days"], ["time elapsed", "15 days"], ["treatment disorder", "Wolff - Parkinson - White syndrome"], ["effect", "acute reversible encephalopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "returned", "type": "potential therapeutic event", "roles": [["treatment", "sertraline medication"], ["drug", "sertraline"], ["treatment disorder", "depressive symptoms"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "association", "type": "adverse event", "roles": [["treatment", "CHOP chemotherapy"], ["drug", "CHOP"], ["route", "chemotherapy"], ["treatment disorder", "CD30 ( Ki - 1) - positive anaplastic large - cell lymphoma"], ["effect", "Supravenous hyperpigmentation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["subject", "A 33 - year - old male"], ["age", "33 - year - old"], ["gender", "male"], ["treatment", "4 % hydroquinone in sorbolene cream and 0.1 % tretinoin cream to the face intermittently for 9 months"], ["drug", "4 % hydroquinone"], ["drug", "sorbolene cream"], ["route", "cream"], ["duration", "9 months"], ["time elapsed", "9 months"], ["effect", "brown discolouration of the fingernails"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "patients with acquired immunodeficiency syndrome"], ["population", "two"], ["subject disorder", "acquired immunodeficiency syndrome"], ["treatment", "sulfadiazine"], ["drug", "sulfadiazine"], ["treatment disorder", "acquired immunodeficiency syndrome"], ["effect", "crystalluria and renal failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["treatment", "calcium stearate"], ["drug", "calcium stearate"], ["route", "oral"], ["effect", "Acute eosinophilic pneumonia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "by", "type": "adverse event", "roles": [["treatment", "olanzapine"], ["drug", "olanzapine"], ["effect", "acute intoxication"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "morphine - 6 - glucuronide"], ["drug", "morphine"], ["drug", "6 - glucuronide"], ["effect", "Long lasting respiratory depression"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "seven children , 5 years of age and younger"], ["age", "5 years of age"], ["population", "seven"], ["treatment", "antiemetic combination of pentobarbital and pyrilamine maleate"], ["drug", "pentobarbital"], ["drug", "pyrilamine maleate"], ["effect", "toxic encephalopathy characterized by depressed level of consciousness , marked irritability , and ataxia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "5 - fluorouracil chemotherapy"], ["drug", "5 - fluorouracil"], ["route", "chemotherapy"], ["effect", "Oculomotor disturbances"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "presented", "type": "adverse event", "roles": [["subject", "the patient"], ["treatment", "doxorubicin"], ["drug", "doxorubicin"], ["effect", "thoracic pain and breathing distress due to superior vena cava perforation by the central catheter and subsequent extravasation of the drug into the mediastinum"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "prophylaxis", "type": "potential therapeutic event", "roles": [["subject", "An 18 - year - old Japanese man weighing 53 kg with an anaplastic large cell lymphoma"], ["age", "18 - year - old"], ["gender", "man"], ["race", "Japanese"], ["subject disorder", "anaplastic large cell lymphoma"], ["treatment", "continuous IV administration of TAC"], ["drug", "TAC"], ["route", "IV"], ["treatment disorder", "graft - versus - host disease ( GVHD )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "ameliorated", "type": "potential therapeutic event", "roles": [["subject", "a refractory akathisia case"], ["subject disorder", "refractory akathisia"], ["treatment", "Intravenous administration of levodopa"], ["drug", "levodopa"], ["route", "Intravenous"], ["treatment disorder", "refractory akathisia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "development", "type": "adverse event", "roles": [["subject", "Patients with lymphoblastic lymphoma"], ["subject disorder", "lymphoblastic lymphoma"], ["treatment", "L - asparaginase and steroid"], ["drug", "L - asparaginase"], ["drug", "steroid"], ["treatment disorder", "lymphoblastic lymphoma"], ["combination drug", "L - asparaginase"], ["combination drug", "steroid"], ["effect", "cortical venous thrombosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["subject", "patients with significant risk factors for coronary artery disease"], ["subject disorder", "coronary artery disease"], ["treatment", "sumatriptan"], ["drug", "sumatriptan"], ["effect", "coronary artery vasospasm"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "prescribed", "type": "potential therapeutic event", "roles": [["subject", "a 25 - year - old man found dead at home"], ["age", "25 - year - old"], ["gender", "man"], ["subject disorder", "schizophrenia"], ["treatment", "olanzapine"], ["drug", "olanzapine"], ["treatment disorder", "schizophrenia"], ["effect", "dead"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 67 - year - old man"], ["age", "67 - year - old"], ["gender", "man"], ["treatment", "10 - day course of oral ampicillin"], ["drug", "ampicillin"], ["route", "oral"], ["effect", "diarrhea"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "appearing", "type": "adverse event", "roles": [["treatment", "high - dose intravenous phenylephrine"], ["drug", "phenylephrine"], ["dosage", "high - dose"], ["route", "intravenous"], ["effect", "Prominent positive U waves"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "taking", "type": "adverse event", "roles": [["subject", "patients"], ["treatment", "metformin"], ["drug", "metformin"], ["effect", "Severe acidosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["subject", "children with primary glomerulonephritis"], ["age", "children"], ["subject disorder", "primary glomerulonephritis"], ["treatment", "intravenous pulse methylprednisolone"], ["drug", "methylprednisolone"], ["route", "intravenous pulse"], ["treatment disorder", "primary glomerulonephritis"], ["effect", "Seizures and transient blindness"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a patient with acromegaly"], ["subject disorder", "acromegaly"], ["treatment", "combined treatment with the long - acting somatostatin - analog octreotide and the GH receptor antagonist pegvisomant"], ["drug", "octreotide"], ["drug", "pegvisomant"], ["treatment disorder", "acromegaly"], ["combination drug", "octreotide"], ["combination drug", "pegvisomant"], ["effect", "severe drug - induced hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "assigned", "type": "potential therapeutic event", "roles": [["subject", "1754 patients ( > or = 18 years ) with severe sepsis and a high INR ( + or = 1.2 )"], ["population", "1754"], ["subject disorder", "severe sepsis"], ["subject disorder", "high INR"], ["treatment", "intravenous infusion of either tifacogin ( 0.025 mg / kg per hour for 96 hours , n = 880 ) or placebo ( arginine citrate buffer , n = 874 )"], ["treatment disorder", "low INR"], ["treatment disorder", "high INR"], ["treatment disorder", "low INR"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a 23 - year - old man"], ["age", "23 - year - old"], ["gender", "man"], ["subject disorder", "methicillin - resistant Staphylococcus aureus infection"], ["treatment", "vancomycin"], ["drug", "vancomycin"], ["treatment disorder", "methicillin - resistant Staphylococcus aureus infection"], ["effect", "anaphylactic reaction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "Recovery", "type": "potential therapeutic event", "roles": [["treatment", "15 days following cessation of the offending drug , Amikacin"], ["drug", "Amikacin"], ["duration", "15 days"], ["time elapsed", "15 days"], ["treatment disorder", "tubular dysfunction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "L - asparaginase"], ["drug", "L - asparaginase"], ["effect", "pancreatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "BCNU"], ["drug", "BCNU"], ["effect", "pulmonary fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 58 - year - old man with advanced renal cell carcinoma"], ["age", "58 - year - old"], ["gender", "man"], ["subject disorder", "advanced renal cell carcinoma"], ["treatment", "five days after temsirolimus infusion"], ["drug", "temsirolimus"], ["route", "infusion"], ["time elapsed", "five days"], ["treatment disorder", "advanced renal cell carcinoma"], ["effect", "grade 3 proteinuria ( 8.5 g/24 h ) without microscopic hematuria or renal insufficiency"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["subject", "A 2 - year - old mentally retarded boy with frontal lobe epilepsy"], ["age", "2 - year - old"], ["gender", "boy"], ["subject disorder", "mentally retarded"], ["subject disorder", "frontal lobe epilepsy"], ["treatment", "administration of zonisamide"], ["drug", "zonisamide"], ["treatment disorder", "frontal lobe epilepsy"], ["effect", "episode that resembled heat stroke"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "methylene blue infusion during parathyroidectomy"], ["drug", "methylene blue"], ["route", "infusion"], ["effect", "Serotonin syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "Two patients"], ["population", "Two"], ["subject disorder", "disseminated adenocarcinoma of the colon"], ["treatment", "5 - fluorouracil ( 5 - FU )"], ["drug", "5 - fluorouracil"], ["treatment disorder", "disseminated adenocarcinoma of the colon"], ["effect", "cerebellar dysfunction typical of 5 - FU neurotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "achieved", "type": "potential therapeutic event", "roles": [["treatment", "corticosteroids"], ["drug", "corticosteroids"], ["effect", "complete remission of clinical and radiological abnormalities"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "praziquantel therapy"], ["drug", "praziquantel"], ["effect", "Disseminated muscular cysticercosis with myositis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "widely separated courses of adriamycin"], ["treatment", "exacerbated by actinomycin - D and mithramycin"], ["drug", "adriamycin"], ["drug", "actinomycin - D"], ["drug", "mithramycin"], ["effect", "Cardiomyopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["effect", "Linear immunoglobulin A bullous dermatosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "association", "type": "adverse event", "roles": [["subject", "both patients"], ["population", "both"], ["treatment", "tolterodine"], ["treatment", "course of tolterodine"], ["drug", "tolterodine"], ["effect", "elevated INR"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "association", "type": "adverse event", "roles": [["treatment", "prostaglandin E1"], ["drug", "prostaglandin E1"], ["effect", "harlequin color change"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "in", "type": "adverse event", "roles": [["subject", "a patient"], ["subject disorder", "refractory palmopustular psoriasis and psoriatic arthritis"], ["treatment", "Efalizumab and Etanercept"], ["drug", "Efalizumab"], ["drug", "Etanercept"], ["treatment disorder", "refractory palmopustular psoriasis and psoriatic arthritis"], ["combination drug", "Efalizumab"], ["combination drug", "Etanercept"], ["effect", "tuberculosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "development", "type": "adverse event", "roles": [["treatment", "the displacement of lidocaine from protein binding by bupivacaine , in combination with metabolic acidosis and treatment with other oxidants"], ["drug", "lidocaine"], ["drug", "bupivacaine"], ["combination drug", "lidocaine"], ["combination drug", "bupivacaine"], ["effect", "methemoglobinemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "in", "type": "adverse event", "roles": [["subject", "a tolmetin - treated patient"], ["treatment", "tolmetin"], ["drug", "tolmetin"], ["effect", "Nephrotic range pseudoproteinuria"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complained", "type": "adverse event", "roles": [["subject", "the patient"], ["treatment", "the first cyclosporine dose"], ["treatment", "during the cyclosporine infusion"], ["drug", "cyclosporine"], ["dosage", "first cyclosporine dose"], ["effect", "leg pain"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "cerivastatin"], ["drug", "cerivastatin"], ["effect", "acute rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurrence", "type": "adverse event", "roles": [["subject", "a patient suffering from rheumatoid arthritis"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "low - dose methotrexate"], ["drug", "methotrexate"], ["dosage", "low - dose"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "acute megaloblastic anaemia and a pneumonitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a 57 - year - old man with acral erythrocyanosis progressing to acute digital ischemia and gangrene"], ["age", "57 - year - old"], ["gender", "man"], ["subject disorder", "metastatic squamous cell carcinoma of the hypopharynx"], ["treatment", "combined chemotherapy ( bleomycin and methotrexate )"], ["drug", "bleomycin"], ["drug", "methotrexate"], ["route", "chemotherapy"], ["treatment disorder", "metastatic squamous cell carcinoma of the hypopharynx"], ["effect", "acute digital ischemia and gangrene"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["subject", "a 7 year old girl with haemolytic uraemic syndrome"], ["age", "7 year old"], ["gender", "girl"], ["subject disorder", "haemolytic uraemic syndrome"], ["treatment", "intravenous administration of morphine"], ["drug", "morphine"], ["route", "intravenous"], ["treatment disorder", "haemolytic uraemic syndrome"], ["effect", "long lasting respiratory depression"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "with", "type": "adverse event", "roles": [["treatment", "quetiapine"], ["drug", "quetiapine"], ["effect", "leucocytopenia and thrombocytopenia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["treatment", "intrabiliary infusion of mono - octanoin"], ["drug", "mono - octanoin"], ["route", "intrabiliary infusion"], ["effect", "Noncardiogenic pulmonary edema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "prevent", "type": "potential therapeutic event", "roles": [["treatment", "Cardiac glycosides"], ["treatment", "competitively inhibiting doxorubicin at its receptor sites"], ["drug", "Cardiac glycosides"], ["drug", "doxorubicin"], ["effect", "cardiomyopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "receiving", "type": "potential therapeutic event", "roles": [["subject", "Three hundred and thirty eight patients with moderate to severe painful diabetic neuropathy"], ["population", "Three hundred and thirty eight"], ["subject disorder", "moderate to severe painful diabetic neuropathy"], ["treatment", "oral prolonged - release oxycodone or placebo tablets added to their therapy for up to 12 weeks"], ["drug", "gabapentin"], ["dosage", "maximum tolerated dose"], ["route", "oral"], ["treatment disorder", "moderate to severe painful diabetic neuropathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "in", "type": "adverse event", "roles": [["subject", "patients"], ["treatment", "thromboprophylactic dabigatran etexilate , with and without concomitant NSAID or ASA"], ["drug", "dabigatran etexilate"], ["effect", "bleeding"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Dapsone"], ["drug", "Dapsone"], ["effect", "erythroderma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a patient with rheumatoid arthritis"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "Methotrexate"], ["drug", "Methotrexate"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "hepatic necrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "three cases"], ["population", "three"], ["treatment", "quetiapine"], ["drug", "quetiapine"], ["effect", "suicidal overdose deaths"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "Both patients"], ["population", "Both"], ["treatment", "o , p' - DDD and apparently adequate dexamethasone replacement therapy"], ["drug", "o , p' - DDD"], ["effect", "hypoadrenalism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["subject", "a 78 - year - old woman"], ["age", "78 - year - old"], ["gender", "woman"], ["treatment", "a single sodium hyaluronate injection"], ["drug", "sodium hyaluronate"], ["route", "injection"], ["effect", "Neisseria mucosa knee arthritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "failure", "type": "adverse event", "roles": [["subject", "an HIV - positive woman"], ["gender", "woman"], ["subject disorder", "HIV"], ["treatment", "antiretroviral therapy"], ["drug", "Implanon"], ["treatment disorder", "HIV"], ["effect", "two ectopic pregnancies"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "periurethral injection of calcium hydroxylapatite"], ["drug", "calcium hydroxylapatite"], ["route", "periurethral injection"], ["treatment disorder", "stress urinary incontinence"], ["effect", "Massive prolapse of the urethral mucosa"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "A 35 - year - old female with borderline lepromatous ( BL ) leprosy"], ["age", "35 - year - old"], ["gender", "female"], ["subject disorder", "borderline lepromatous ( BL ) leprosy"], ["treatment", "dapsone"], ["drug", "dapsone"], ["treatment disorder", "borderline lepromatous ( BL ) leprosy"], ["effect", "erythroderma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "include", "type": "adverse event", "roles": [["treatment", "methotrexate"], ["drug", "methotrexate"], ["effect", "bone marrow suppression and oral and gastrointestinal ulceration"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "internal use of low - dose aspirin"], ["drug", "aspirin"], ["dosage", "low - dose"], ["route", "internal"], ["treatment disorder", "falx meningioma"], ["effect", "Hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "infection", "type": "adverse event", "roles": [["subject", "a patient"], ["subject disorder", "chronic lymphocytic leukemia"], ["treatment", "fludarabine"], ["drug", "fludarabine"], ["treatment disorder", "chronic lymphocytic leukemia"], ["effect", "respiratory syncytial virus pulmonary infection"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["treatment", "amiodarone therapy"], ["drug", "amiodarone"], ["treatment disorder", "atrial fibrillation complicating cardiomyopathy"], ["effect", "Nonsustained polymorphous ventricular tachycardia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "in", "type": "adverse event", "roles": [["treatment", "low dosage clofazimine"], ["drug", "clofazimine"], ["dosage", "low dosage"], ["effect", "abdominal pain"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "clonazepam"], ["drug", "clonazepam"], ["effect", "agitation , aggression , hyperactivity , irritability , property destruction , and temper tantrums"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "cephalosporin or moxalactam antibiotics"], ["drug", "cephalosporin"], ["drug", "moxalactam antibiotics"], ["treatment disorder", "acute and chronic renal failure"], ["effect", "Coagulopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "secondary", "type": "adverse event", "roles": [["subject", "patients"], ["subject disorder", "acute vitamin D poisoning"], ["treatment", "Pamidronate therapy"], ["drug", "Pamidronate"], ["treatment disorder", "acute vitamin D poisoning"], ["effect", "hypercalcemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "relationship", "type": "adverse event", "roles": [["subject", "this patient"], ["treatment", "amphotericin B deoxycholate therapy"], ["drug", "amphotericin B deoxycholate"], ["effect", "cardiac toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "an infant with congenital heart disease"], ["age", "infant"], ["subject disorder", "congenital heart disease"], ["treatment", "Captopril"], ["drug", "Captopril"], ["treatment disorder", "congenital heart disease"], ["effect", "pulmonary infiltrates with eosinophilia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induces", "type": "adverse event", "roles": [["treatment", "Chronic fentanyl application"], ["drug", "fentanyl"], ["effect", "adrenocortical insufficiency"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "improved", "type": "potential therapeutic event", "roles": [["subject", "her"], ["gender", "her"], ["subject disorder", "symptomatology"], ["treatment", "discontinuing captopril and starting systemic steroids"], ["drug", "captopril"], ["drug", "steroids"], ["treatment disorder", "symptomatology"], ["effect", "her eosinophilia and radiographic abnormalities both resolved"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "suffering", "type": "adverse event", "roles": [["subject", "a woman schizophrenic patient"], ["gender", "woman"], ["subject disorder", "schizophrenic"], ["treatment", "clozapine"], ["drug", "clozapine"], ["treatment disorder", "schizophrenic"], ["effect", "EPS"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["subject", "this patient"], ["treatment", "calcium stearate"], ["drug", "calcium stearate"], ["effect", "pulmonary disease"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "man , dogs , and cats"], ["gender", "man"], ["population", "man"], ["treatment", "Benzocaine"], ["drug", "Benzocaine"], ["effect", "methemoglobinemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "adverse event", "roles": [["subject", "two cases of HIV - 1 - infected patients"], ["population", "two"], ["subject disorder", "HIV - 1 - infected"], ["treatment", "didanosine ( ddI )"], ["drug", "didanosine"], ["treatment disorder", "HIV - 1 - infected"], ["effect", "fulminant hepatic failure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "Leflunomide"], ["drug", "Leflunomide"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "weight loss"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Antiretroviral"], ["drug", "Antiretroviral"], ["effect", "hepatic steatosis and lactic acidosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A woman"], ["gender", "woman"], ["treatment", "phenelzine"], ["drug", "phenelzine"], ["effect", "delusional parasitosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "causing", "type": "adverse event", "roles": [["treatment", "Percutaneous absorption of warfarin"], ["drug", "warfarin"], ["route", "Percutaneous absorption"], ["effect", "coagulopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "two cases"], ["population", "two"], ["treatment", "nitrofurantoin"], ["drug", "nitrofurantoin"], ["effect", "pulmonary toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Colchicine"], ["drug", "Colchicine"], ["effect", "rhabdomyolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["subject", "a case"], ["subject disorder", "Crohn 's disease ( CD )"], ["treatment", "three weeks following the administration of infliximab"], ["drug", "infliximab"], ["duration", "three weeks"], ["time elapsed", "three weeks"], ["treatment disorder", "Crohn 's disease ( CD )"], ["effect", "severe AVP"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["subject", "each patient"], ["population", "each"], ["treatment", "tolterodine"], ["drug", "tolterodine"], ["effect", "a significant increase in the patient 's INR"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occur", "type": "adverse event", "roles": [["subject", "3 % or more of patients with cancer"], ["population", "3 % or more"], ["subject disorder", "cancer"], ["treatment", "standard doses of 5 - FU"], ["drug", "5 - FU"], ["dosage", "standard doses"], ["treatment disorder", "cancer"], ["effect", "diarrhea , stomatitis , mucositis , myelosuppression , neurotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "concomitant acetaminophen and moxifloxacin use"], ["drug", "acetaminophen"], ["drug", "moxifloxacin"], ["combination drug", "acetaminophen"], ["combination drug", "moxifloxacin"], ["effect", "supratherapeutic INRs"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "colchicine and statin therapy"], ["drug", "colchicine"], ["drug", "statin"], ["duration", "several months"], ["time elapsed", "several months"], ["combination drug", "colchicine"], ["combination drug", "statin"], ["effect", "myopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "Cephalosporins"], ["drug", "Cephalosporins"], ["effect", "Vitamin K deficiency"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "subcutaneous injection of glatiramer acetate"], ["drug", "glatiramer acetate"], ["route", "subcutaneous injection"], ["effect", "Embolia cutis medicamentosa"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a 21 - year - old man with epilepsy who had a 3 - year history of insidious progressive decline in global cognitive abilities"], ["age", "21 - year - old"], ["gender", "man"], ["subject disorder", "epilepsy"], ["treatment", "valproic acid"], ["drug", "valproic acid"], ["treatment disorder", "epilepsy"], ["effect", "dementia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a 50 - year - old woman with advanced non - small cell lung cancer"], ["age", "50 - year - old"], ["gender", "woman"], ["subject disorder", "advanced non - small cell lung cancer"], ["treatment", "receiving cisplatin and gemcitabine chemotherapy"], ["drug", "cisplatin"], ["drug", "gemcitabine"], ["route", "chemotherapy"], ["treatment disorder", "advanced non - small cell lung cancer"], ["effect", "status epilepticus"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "VRC therapy"], ["drug", "VRC"], ["effect", "angio - oedema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occur", "type": "adverse event", "roles": [["treatment", "thalidomide treatment"], ["drug", "thalidomide"], ["effect", "Multiple syncopal episodes"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "taking", "type": "adverse event", "roles": [["subject", "A 25 - year - old woman"], ["age", "25 - year - old"], ["gender", "woman"], ["treatment", "methysergide"], ["drug", "methysergide"], ["effect", "iliocaval manifestations of retroperitoneal fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "alendronate therapy"], ["drug", "alendronate"], ["effect", "Nodular scleritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "ineffective", "type": "potential therapeutic event", "roles": [["subject", "both patients"], ["population", "both"], ["treatment", "tolterodine"], ["drug", "tolterodine"], ["effect", "elevated INRs"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "increasing", "type": "adverse event", "roles": [["subject", "any patient who is purging"], ["subject disorder", "purging"], ["treatment", "lithium"], ["drug", "lithium"], ["effect", "cardiac toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "role", "type": "adverse event", "roles": [["treatment", "disulfiram"], ["drug", "disulfiram"], ["effect", "catatonia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "L - asparaginase"], ["drug", "L - asparaginase"], ["effect", "Sagittal sinus thrombosis associated with transient free protein S deficiency"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "association", "type": "adverse event", "roles": [["treatment", "fenclofenac as well as aurothiomalate and sulphasalazine"], ["drug", "fenclofenac"], ["drug", "aurothiomalate"], ["drug", "sulphasalazine"], ["treatment disorder", "rheumatoid arthritis"], ["combination drug", "fenclofenac"], ["combination drug", "aurothiomalate"], ["combination drug", "sulphasalazine"], ["effect", "selective IgA deficiency with remission in rheumatoid arthritis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "clinically meaningful effect", "type": "potential therapeutic event", "roles": [["treatment", "co - administration of prolonged - release oxycodone and existing gabapentin therapy"], ["drug", "oxycodone"], ["drug", "gabapentin"], ["treatment disorder", "painful diabetic neuropathy"], ["combination drug", "oxycodone"], ["combination drug", "gabapentin"], ["effect", "clinically meaningful effect"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "concomitant administration of clarithromycin and sirolimus"], ["drug", "clarithromycin"], ["drug", "sirolimus"], ["combination drug", "clarithromycin"], ["combination drug", "sirolimus"], ["effect", "acute impairment of renal function"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "followed", "type": "adverse event", "roles": [["subject", "one case"], ["population", "one"], ["treatment", "readministration of riluzole"], ["drug", "riluzole"], ["effect", "relapse of hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Pseudoephedrine"], ["drug", "Pseudoephedrine"], ["effect", "hemorrhage associated with a cerebral vascular malformation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a 34 - year - old man without a history of glaucoma"], ["age", "34 - year - old"], ["gender", "man"], ["treatment", "intravitreal injection of triamcinolone acetate"], ["drug", "triamcinolone acetate"], ["route", "intravitreal injection"], ["effect", "severe corticosteroid - induced glaucoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "in", "type": "adverse event", "roles": [["treatment", "quinine"], ["drug", "quinine"], ["effect", "transient tonic pupillary response , denervation supersensitivity , and abnormal visual - evoked potentials"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "led", "type": "adverse event", "roles": [["subject", "him"], ["gender", "him"], ["treatment", "Two days ' administration of levomepromazine 100 mg"], ["drug", "levomepromazine"], ["dosage", "100 mg"], ["duration", "2 days"], ["time elapsed", "2 days"], ["effect", "coma for 2 days"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Methimazole"], ["drug", "Methimazole"], ["effect", "aplastic anemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "two cases of acute syphilitic posterior placoid chorioretinitis ( ASPPC )"], ["population", "two"], ["treatment", "intravitreal triamcinolone acetonide ( IVTA ) injection"], ["drug", "triamcinolone acetonide"], ["route", "intravitreal"], ["route", "injection"], ["effect", "acute syphilitic posterior placoid chorioretinitis ( ASPPC )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "from", "type": "adverse event", "roles": [["treatment", "ganciclovir"], ["drug", "ganciclovir"], ["effect", "Skin rash and splinter hemorrhages"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "pediatric patient with leukemia and a severe , L - asparaginase - induced necrotizing pancreatitis"], ["age", "pediatric"], ["subject disorder", "leukemia"], ["subject disorder", "a severe , L - asparaginase - induced necrotizing pancreatitis"], ["treatment", "L - asparaginase"], ["drug", "L - asparaginase"], ["treatment disorder", "a severe , L - asparaginase - induced necrotizing pancreatitis"], ["effect", "necrotizing pancreatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "INH therapy"], ["drug", "INH"], ["effect", "anagen effluvium with lichenoid eruption"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "ifosfamide"], ["drug", "ifosfamide"], ["effect", "encephalopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["treatment", "low - dose carbamazepine therapy"], ["drug", "carbamazepine"], ["dosage", "low - dose"], ["effect", "Hyponatraemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "capecitabine therapy"], ["drug", "capecitabine"], ["effect", "Acute coronary syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["treatment", "a single dose of vincristine"], ["drug", "vincristine"], ["dosage", "single dose"], ["effect", "severe visual loss"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a young woman with SLE and thrombocytopenia"], ["age", "young"], ["gender", "woman"], ["subject disorder", "SLE"], ["subject disorder", "thrombocytopenia"], ["treatment", "cyclosporine"], ["drug", "cyclosporine"], ["treatment disorder", "SLE"], ["effect", "severe perspiration , headache , and seizure"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "secondary", "type": "adverse event", "roles": [["subject", "patient"], ["treatment", "gabapentin withdrawal"], ["drug", "gabapentin"], ["effect", "generalized seizures and status epilepticus"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complication", "type": "adverse event", "roles": [["treatment", "insulin therapy"], ["drug", "insulin"], ["effect", "Self - limited edema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "contributed", "type": "adverse event", "roles": [["subject", "these patients"], ["treatment", "dexamethasone"], ["drug", "dexamethasone"], ["effect", "osteonecrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "experienced", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "discontinuation of nefazodone"], ["drug", "nefazodone"], ["effect", "benzodiazepine withdrawal symptoms"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "have", "type": "adverse event", "roles": [["treatment", "Isotretinoin"], ["drug", "Isotretinoin"], ["treatment disorder", "acne"], ["effect", "teratogenic effects"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induce", "type": "adverse event", "roles": [["treatment", "zuclopenthixol"], ["drug", "zuclopenthixol"], ["effect", "priapism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "Two patients"], ["population", "Two"], ["subject disorder", "chronic myeloid leukemia"], ["treatment", "high doses of CCNU ( 1100 mg / m2 and 1240 mg / m2 , respectively )"], ["drug", "CCNU"], ["dosage", "high doses"], ["treatment disorder", "chronic myeloid leukemia"], ["effect", "pulmonary fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "ofloxacin"], ["drug", "ofloxacin"], ["effect", "toxic epidermal necrolysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "aspirin prophylaxis"], ["drug", "aspirin"], ["treatment disorder", "meningioma"], ["effect", "hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "axillary block with bupivacaine and additional injection of lidocaine"], ["drug", "bupivacaine"], ["drug", "lidocaine"], ["route", "axillary block"], ["combination drug", "bupivacaine"], ["combination drug", "lidocaine"], ["effect", "Methemoglobinemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "role", "type": "adverse event", "roles": [["treatment", "morphine"], ["drug", "morphine"], ["effect", "Nonconvulsive status epilepticus"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "evolving", "type": "adverse event", "roles": [["subject", "two patients"], ["population", "two"], ["treatment", "hydroxyurea"], ["drug", "hydroxyurea"], ["effect", "Acute myeloid leukemia evolving from essential thrombocythemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "of", "type": "adverse event", "roles": [["treatment", "an ibuprofen overdose"], ["treatment", "reversed by naloxone"], ["drug", "ibuprofen"], ["dosage", "overdose"], ["effect", "Central nervous system manifestations"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "complication", "type": "adverse event", "roles": [["treatment", "sirolimus therapy"], ["drug", "sirolimus"], ["effect", "Aphthous stomatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["treatment", "propafenone and citalopram"], ["drug", "propafenone"], ["drug", "citalopram"], ["combination drug", "propafenone"], ["combination drug", "citalopram"], ["effect", "propafenone adverse effects"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "observed", "type": "adverse event", "roles": [["subject", "one out of 23 patients"], ["population", "one out of 23"], ["subject disorder", "osteogenic sarcoma"], ["treatment", "chemotherapy with high - dose methotrexate ( HD - MTX )"], ["drug", "methotrexate"], ["dosage", "high - dose"], ["route", "chemotherapy"], ["treatment disorder", "osteogenic sarcoma"], ["effect", "Temporary neurologic abnormalities"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["treatment", "propafenone"], ["treatment", "interaction between propafenone and citalopram"], ["drug", "propafenone"], ["drug", "citalopram"], ["combination drug", "propafenone"], ["combination drug", "citalopram"], ["effect", "propafenone adverse effects ( eg , dizziness , falls ) and mimicked coronary artery disease"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "intraarterial vasopressin therapy"], ["drug", "vasopressin"], ["route", "intraarterial"], ["effect", "Spontaneous bacterial peritonitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "reduces", "type": "potential therapeutic event", "roles": [["subject", "adult patients with severe , persistent asthma"], ["age", "adult"], ["subject disorder", "severe , persistent asthma"], ["treatment", "Ciclesonide"], ["drug", "Ciclesonide"], ["treatment disorder", "severe , persistent asthma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "patients unsuspected of having vitamin B12 deficiency"], ["population", "five"], ["subject disorder", "vitamin B12 deficiency"], ["treatment", "nitrous oxide anesthesia"], ["drug", "nitrous oxide"], ["effect", "subacute combined degeneration of the spinal cord"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "a 31 - year - old patient hospitalized due to behavioral alterations"], ["age", "31 - year - old"], ["subject disorder", "behavioral alterations"], ["treatment", "oral zuclopenthixol"], ["drug", "zuclopenthixol"], ["route", "oral"], ["treatment disorder", "behavioral alterations"], ["effect", "acute , painful erection"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "receiving", "type": "adverse event", "roles": [["subject", "Three cases of acute renal toxicity"], ["population", "Three"], ["treatment", "long - term therapy with mitomycin C and 5 - fluorouracil"], ["drug", "mitomycin C"], ["drug", "5 - fluorouracil"], ["combination drug", "mitomycin C"], ["combination drug", "5 - fluorouracil"], ["effect", "acute renal toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A 40 - year - old man with a long standing history of rheumatoid arthritis"], ["age", "40 - year - old"], ["gender", "man"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "MTX over a 6 month period"], ["drug", "MTX"], ["duration", "6 month"], ["time elapsed", "6 month"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "overwhelming hepatic necrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resulted", "type": "adverse event", "roles": [["treatment", "a total daily dose of 25 mg sertraline , with nondetectable sertraline and desmethylsertraline blood levels"], ["drug", "sertraline"], ["dosage", "25 mg"], ["frequency", "daily"], ["effect", "doubling of the lamotrigine blood level with symptoms of toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["treatment", "propranolol"], ["drug", "propranolol"], ["effect", "bronchospasm"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "A depressed woman with no history of bipolar illness"], ["gender", "woman"], ["subject disorder", "depressed"], ["subject disorder", "bipolar illness"], ["treatment", "fluoxetine"], ["drug", "fluoxetine"], ["treatment disorder", "depressed"], ["effect", "manic episode"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "trazodone therapy"], ["drug", "trazodone"], ["effect", "Priapism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurrence", "type": "adverse event", "roles": [["treatment", "interferon alfa"], ["drug", "interferon alfa"], ["effect", "anterior ischemic optic neuropathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Mequitazine"], ["drug", "Mequitazine"], ["effect", "photosensitivity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "pentamidine"], ["drug", "pentamidine"], ["effect", "cardiotoxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "receiving", "type": "potential therapeutic event", "roles": [["subject", "patient"], ["treatment", "warfarin"], ["treatment", "emtricitabine monotherapy"], ["drug", "warfarin"], ["drug", "emtricitabine"], ["frequency", "weekly"], ["combination drug", "warfarin"], ["combination drug", "emtricitabine"], ["effect", "mean international normalized ratio ( INR ) of 2.8 ( 95 % CI 2.5 to 3.1 )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "intracavernous self - injection of a combination of phentolamine and papaverine"], ["drug", "phentolamine"], ["drug", "papaverine"], ["route", "intracavernous self - injection"], ["effect", "penile fibrosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "followed", "type": "adverse event", "roles": [["subject", "the same patient"], ["treatment", "propylthiouracil and methimazole"], ["drug", "propylthiouracil"], ["drug", "methimazole"], ["combination drug", "propylthiouracil"], ["combination drug", "methimazole"], ["effect", "agranulocytosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "from", "type": "adverse event", "roles": [["treatment", "fluoxetine and sertraline"], ["drug", "fluoxetine"], ["drug", "sertraline"], ["effect", "Itch and skin rash"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "Oxycodone - gabapentin co - administration"], ["drug", "Oxycodone"], ["drug", "gabapentin"], ["combination drug", "Oxycodone"], ["combination drug", "gabapentin"], ["effect", "less escape medication use ( P = 0.03 ) and fewer nights of disturbed sleep ( P <unk> 0.05 )"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "adverse event", "roles": [["subject", "two case reports"], ["population", "two"], ["subject disorder", "epileptics"], ["treatment", "phenobarbital , phenytoin and fluoresone"], ["drug", "phenobarbital"], ["drug", "phenytoin"], ["drug", "fluoresone"], ["treatment disorder", "epileptics"], ["combination drug", "phenobarbital"], ["combination drug", "phenytoin"], ["effect", "Gynecomastia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Captopril"], ["drug", "Captopril"], ["effect", "lichen planus pemphigoides with pemphigus - like features"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "thiabendazole"], ["drug", "thiabendazole"], ["effect", "cholestasis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "Use", "type": "potential therapeutic event", "roles": [["subject", "patients with mucocutaneous reactions"], ["subject disorder", "mucocutaneous reactions"], ["treatment", "very low dosage of gold"], ["drug", "gold"], ["dosage", "very low dosage"], ["treatment disorder", "mucocutaneous reactions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "relief", "type": "potential therapeutic event", "roles": [["subject", "A 55 - year - old HIV - positive African woman"], ["age", "55 - year - old"], ["gender", "woman"], ["race", "African"], ["subject disorder", "HIV - positive"], ["subject disorder", "postherpetic neuralgia"], ["treatment", "single epidural triamcinolone injection"], ["drug", "triamcinolone"], ["route", "epidural"], ["treatment disorder", "postherpetic neuralgia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurred", "type": "adverse event", "roles": [["subject", "a patient"], ["subject disorder", "toothache"], ["treatment", "zomepirac sodium"], ["drug", "zomepirac sodium"], ["treatment disorder", "toothache"], ["effect", "Anaphylactoid shock , disseminated intravascular coagulation , and anuric renal failure requiring dialysis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "three of six young female volunteers"], ["age", "young"], ["gender", "female"], ["population", "three"], ["treatment", "intravenous proton pump inhibitors omeprazole and pantoprazole"], ["treatment", "high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid"], ["drug", "omeprazole"], ["drug", "pantoprazole"], ["dosage", "high doses"], ["route", "intravenous"], ["effect", "peripheral edema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "ameliorated", "type": "potential therapeutic event", "roles": [["treatment", "Intravenous levodopa 25 mg"], ["drug", "levodopa"], ["dosage", "25 mg"], ["route", "Intravenous"], ["treatment disorder", "akathisia symptoms"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a child"], ["age", "child"], ["treatment", "Cyclosporine"], ["treatment", "hematopoietic stem cell transplant"], ["drug", "Cyclosporine"], ["effect", "pain syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "a single small dose of vincristine"], ["drug", "vincristine"], ["dosage", "single small dose"], ["effect", "Visual loss"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "salazosulfapyridine"], ["drug", "salazosulfapyridine"], ["effect", "infectious mononucleosis - like syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "raltegravir"], ["drug", "raltegravir"], ["effect", "DRESS syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "cause", "type": "adverse event", "roles": [["treatment", "topical brimonidine"], ["drug", "brimonidine"], ["route", "topical"], ["effect", "paradoxical raised IOP"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "fatal", "type": "adverse event", "roles": [["treatment", "chloroquine overdose"], ["drug", "chloroquine"], ["dosage", "overdose"], ["effect", "chloroquine overdose"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["treatment", "use of a PPI"], ["drug", "clopidogrel"], ["drug", "omeprazole"], ["combination drug", "clopidogrel"], ["combination drug", "omeprazole"], ["effect", "cardiovascular events"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "reactions", "type": "adverse event", "roles": [["treatment", "methotrexate"], ["drug", "methotrexate"], ["effect", "Anaphylactic / anaphylactoid reactions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treat", "type": "potential therapeutic event", "roles": [["treatment", "Continuous bladder irrigation of a 1 % alum solution"], ["drug", "alum"], ["route", "Continuous bladder irrigation"], ["treatment disorder", "bleeding urothelium"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["treatment", "zolmitriptan"], ["drug", "zolmitriptan"], ["effect", "spinal cord infarction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "phenelzine"], ["drug", "phenelzine"], ["effect", "Delusional parasitosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "responsible", "type": "adverse event", "roles": [["treatment", "administration of tissue plasminogen activator"], ["drug", "tissue plasminogen activator"], ["effect", "large extent of hemorrhage"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "causing", "type": "adverse event", "roles": [["treatment", "5 - fluorouracil - based chemotherapy"], ["drug", "Dihydropyrimidine dehydrogenase"], ["effect", "severe adverse reactions"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "management", "type": "potential therapeutic event", "roles": [["treatment", "Interferon - beta ( IFN - beta )"], ["drug", "Interferon - beta"], ["treatment disorder", "multiple sclerosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Quetiapine"], ["drug", "Quetiapine"], ["effect", "leucopenia and thrombocytopenia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occur", "type": "adverse event", "roles": [["treatment", "intravitreal ranibizumab"], ["drug", "ranibizumab"], ["route", "intravitreal"], ["effect", "Severe and sustained ocular hypertension"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "adverse event", "roles": [["subject", "four patients"], ["population", "four"], ["treatment", "injection of ranibizumab intravitreally"], ["drug", "ranibizumab"], ["route", "injection"], ["effect", "ocular hypertension"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "Vancomycin"], ["drug", "Vancomycin"], ["treatment disorder", "methicillin - resistant Staphylococcus aureus infections"], ["effect", "nephrotoxicity , ototoxicity , gastrointestinal disturbances , blood disorders , and two types of hypersensitivity reactions - an anaphylactoid reaction known as \" red man syndrome \" and anaphylaxis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "resulted", "type": "adverse event", "roles": [["subject", "a patient with Sjogren 's syndrome"], ["subject disorder", "Sjogren 's syndrome"], ["treatment", "unintentional overdose of oral pilocarpine tablets"], ["drug", "pilocarpine"], ["route", "oral"], ["treatment disorder", "Sjogren 's syndrome"], ["effect", "bradycardia , mild hypotension , and muscarinic symptoms"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induce", "type": "adverse event", "roles": [["treatment", "immunosuppressive drugs such as cyclosporine , cisplatin , tacrolimus , and interferon - alpha"], ["drug", "cyclosporine"], ["drug", "cisplatin"], ["drug", "tacrolimus"], ["drug", "interferon - alpha"], ["effect", "RPLS"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "Case 1 , a 62 - year - old woman"], ["age", "62 - year - old"], ["gender", "woman"], ["subject disorder", "chronic active hepatitis C."], ["treatment", "seven - month use of recombinant interferon alpha - 2a"], ["drug", "recombinant interferon alpha - 2a"], ["duration", "seven - month"], ["time elapsed", "seven - month"], ["treatment disorder", "chronic active hepatitis C."], ["effect", "bilateral optic neuritis with decreased sensation of vibration and increased deep tendon reflex in the lower extremities"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "response", "type": "adverse event", "roles": [["subject", "patients with schizophrenia"], ["subject disorder", "schizophrenia"], ["treatment", "risperidone"], ["drug", "risperidone"], ["treatment disorder", "schizophrenia"], ["effect", "A syndrome of increased affect"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "development", "type": "adverse event", "roles": [["treatment", "Therapy with IFN - beta"], ["drug", "IFN - beta"], ["effect", "autoimmune disorders"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["subject", "the patient"], ["treatment", "low - molecular - weight heparin"], ["drug", "low - molecular - weight heparin"], ["effect", "repeated venous thromboembolism"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "developed", "type": "adverse event", "roles": [["treatment", "rechallenge with controlled release carbamazepine"], ["drug", "carbamazepine"], ["effect", "Hyponatraemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Azathioprine"], ["drug", "Azathioprine"], ["effect", "warfarin resistance"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "valproic acid"], ["drug", "valproic acid"], ["effect", "dementia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "Parenteral - verapamil"], ["drug", "verapamil"], ["route", "Parenteral"], ["effect", "sustained hypotension"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "side - effects", "type": "adverse event", "roles": [["treatment", "Lp - TAE combined with HT"], ["drug", "Lp - TAE"], ["drug", "HT"], ["combination drug", "Lp - TAE"], ["combination drug", "HT"], ["effect", "low - grade fever , localized pain , myelo - suppression and liver dysfunction"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "behavioral change", "type": "potential therapeutic event", "roles": [["treatment", "cinepazide"], ["drug", "cinepazide"], ["treatment disorder", "parkinsonism"], ["effect", "Unique behavioral change"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "toxicity", "type": "adverse event", "roles": [["treatment", "vincristine"], ["drug", "vincristine"], ["effect", "optic nerve toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "experienced", "type": "adverse event", "roles": [["subject", "Two patients , ages 40 and 51 years ,"], ["age", "40 and 51 years"], ["population", "Two"], ["subject disorder", "malignant neoplasms"], ["treatment", "interferon alfa"], ["drug", "interferon alfa"], ["treatment disorder", "malignant neoplasms"], ["effect", "sudden bilateral , sequential visual loss with disc - related field defects and segmental optic disc edema"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "following", "type": "potential therapeutic event", "roles": [["treatment", "intrathecal injection of doxorubicin"], ["drug", "doxorubicin"], ["route", "intrathecal injection"], ["treatment disorder", "toxic myelopathy"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "associated", "type": "adverse event", "roles": [["treatment", "ganciclovir therapy"], ["drug", "ganciclovir"], ["effect", "Generalised cutaneous rash"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "occurs", "type": "adverse event", "roles": [["subject", "1 % of such cases"], ["population", "1 %"], ["treatment", "injection of chymopapain"], ["drug", "chymopapain"], ["route", "injection"], ["effect", "Anaphylaxis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "caused", "type": "adverse event", "roles": [["subject", "a child"], ["age", "child"], ["treatment", "zonisamide"], ["drug", "zonisamide"], ["effect", "Heat stroke - like episode"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "give rise", "type": "adverse event", "roles": [["treatment", "An interaction between methylene blue and serotonergic agents"], ["drug", "methylene blue"], ["drug", "serotonergic agents"], ["combination drug", "methylene blue"], ["combination drug", "serotonergic agents"], ["effect", "serotonin syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "during", "type": "adverse event", "roles": [["subject", "some patients"], ["population", "some"], ["treatment", "olanzapine"], ["drug", "olanzapine"], ["effect", "leukopenia or agranulocytosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "after", "type": "adverse event", "roles": [["treatment", "pegylated interferon alpha - 2a and ribavirin"], ["drug", "pegylated interferon alpha - 2a"], ["drug", "ribavirin"], ["effect", "Adult respiratory distress syndrome"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "result", "type": "adverse event", "roles": [["treatment", "metformin"], ["drug", "metformin"], ["treatment disorder", "Type 2 diabetes"], ["effect", "lactic acidosis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treated", "type": "adverse event", "roles": [["subject", "a thalidomide - treated patient with primary plasma - cell leukemia"], ["subject disorder", "primary plasma - cell leukemia"], ["treatment", "thalidomide"], ["drug", "thalidomide"], ["treatment disorder", "primary plasma - cell leukemia"], ["effect", "Sustained ventricular tachycardia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "diagnosed", "type": "adverse event", "roles": [["subject", "a 29 - year - old man with CD"], ["age", "29 - year - old"], ["gender", "man"], ["subject disorder", "CD"], ["treatment", "3 weeks after infusion with infliximab"], ["drug", "infliximab"], ["route", "infusion"], ["time elapsed", "3 weeks"], ["treatment disorder", "CD"], ["effect", "nodular sclerosing Hodgkin 's lymphoma"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "observed", "type": "adverse event", "roles": [["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["effect", "radiation recall"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["subject", "a patient"], ["treatment", "pulse itraconazole therapy for 24 weeks"], ["drug", "itraconazole"], ["frequency", "pulse"], ["duration", "24 weeks"], ["time elapsed", "24 weeks"], ["effect", "acute cytolytic hepatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["subject", "patients with PTSD"], ["subject disorder", "PTSD"], ["treatment", "lithium"], ["drug", "lithium"], ["treatment disorder", "PTSD"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "died", "type": "adverse event", "roles": [["subject", "She"], ["gender", "She"], ["treatment", "Adriamycin ( doxorubicin ) chemotherapy"], ["drug", "Adriamycin"], ["route", "chemotherapy"], ["effect", "Adriamycin toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "arising", "type": "adverse event", "roles": [["subject", "a postmenopausal woman"], ["gender", "woman"], ["treatment", "tamoxifen therapy"], ["drug", "tamoxifen"], ["effect", "Ovarian cancer"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "induced", "type": "adverse event", "roles": [["treatment", "L - asparaginase"], ["drug", "L - asparaginase"], ["treatment disorder", "leukemia"], ["effect", "pancreatitis"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "receiving", "type": "potential therapeutic event", "roles": [["subject", "An 89 - year - old man"], ["age", "89 - year - old"], ["gender", "man"], ["treatment", "long - term anticoagulation with warfarin sodium ( total weekly dosage of 19 mg )"], ["drug", "warfarin sodium"], ["dosage", "19 mg"], ["frequency", "weekly"], ["treatment disorder", "anticoagulation"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "treatment", "type": "potential therapeutic event", "roles": [["subject", "patients with severe sepsis and high INR"], ["subject disorder", "severe sepsis"], ["subject disorder", "high INR"], ["treatment", "tifacogin"], ["drug", "tifacogin"], ["treatment disorder", "severe sepsis"], ["effect", "no effect on all - cause mortality"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "related", "type": "adverse event", "roles": [["subject", "three patients"], ["population", "three"], ["treatment", "CCNU"], ["drug", "CCNU"], ["effect", "pulmonary toxicity"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "increase", "type": "adverse event", "roles": [["treatment", "Concomitant use of clarithromycin or other potent inhibitors of CYP3A4 with repaglinide"], ["drug", "clarithromycin"], ["drug", "repaglinide"], ["combination drug", "clarithromycin"], ["combination drug", "repaglinide"], ["effect", "blood glucose - lowering effect and increase the risk of hypoglycemia"]]}]}}
{"entity": {"offset": [], "string": []}, "relation": {"offset": [], "string": []}, "event": {"offset": [], "string": [{"trigger": "due", "type": "adverse event", "roles": [["treatment", "diltiazem"], ["drug", "diltiazem"], ["effect", "fever"]]}]}}
